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N-heterocyclic carbenes (NHC) are state of the art ligands in organometallic chemistry. 
They have been widely used as supporting ligands for transition metals to obtain complexes with 
diverse and interesting structural or catalytic properties. 
Using a NHC as a reporter ligand in complexes of the type trans-[PdBr2(
i
Pr2-bimy)L], the 
Huynh group recently developed a new 
13
C NMR based electronic parameter for the evaluation 
of Werner-type and organometallic ligands L in terms of their net electron donating properties. In 
continuation of this study, one topic of this thesis addresses the extension of this electronic 
parameter to a wider scope of monodentate ligands. Moreover, a general 
13
C NMR based 
methodology for the evaluation of bidentate ligands has been developed. 
The functionalization of NHC complexes, which may lead to complexes with better 
chemical, physical and biological properties, is one of the important topics for NHC chemists. As 
a second topic in this work, a versatile and modular postmodification strategy to access 
functionalized-NHC complexes is described. In comparison to the traditional method, where 
metalation of individually pre-functionalized NHC precursors is required, this methodology 
represents a substantial improvement in terms of cost, labor, time and waste reduction. 
Only recently has NHCs been applied as building blocks in metallosupramolecular 
chemistry. As the third major topic and our contribution to this field, we designed a multi-topic 
pro-ligand by functionalizing NHC precursors with a dipropyl-pyridine-dicarboxamide unit. The 
resulting potential pentadentate ligands showed interesting coordination chemistry with gold, 
cobalt and palladium. 
The new compounds synthesized in this work are depicted in the following section (see 
Compounds Synthesized in this Work). 
Compounds Synthesized in this Work 
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1.1 Carbenes and N-heterocyclic Carbenes 
1.1.1 Singlet and Triplet Carbenes  
According to the International Union of Pure and Applied Chemistry (IUPAC) a carbene 
is “the electrically neutral species H2C: and its derivatives, in which the carbon is covalently 
bonded to two univalent groups of any kind or a divalent group and bears two nonbonding 
electrons.”1 Most carbenes contain an sp2-hybridized carbon center and therefore are bent. A free 
carbene may have two spin states, singlet and triplet.
2
 In the singlet carbene, the two nonbonding 
electrons are paired up in the frontier  orbital. Hence, the total spin is zero and the multiplicity is 
one. In contrast, the two electrons could also remain unpaired occupying the  and p orbitals, 
which results in a total spin of one and multiplicity of three (Figure 1.1). 
 
Figure 1.1. Singlet and triplet state of carbenes. 
 
As described by Hund’s rule, the singlet state will have a higher energy than the triplet 
state due to spin pair energy in the  orbital ( = 8 kcal/mol). Hence, for a simple CH2: carbene, 
the triplet carbene is the more stable (ground) state and singlet is the excited state. However, the 
ground state would change from triplet state to singlet upon substituent variations. Harrison et al. 
showed that electron withdrawing substituents could inductively stabilize the  orbital by 
Chapter 1 
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enriching the s character and leaving the p orbital unchanged.
3
 Hoffmann and Baird, on the other 
hand, described that -electron donor substituents could increase the empty p orbital energy 
owing to their mesomeric effects, without affecting the  orbital to a great extent.4 Both these 
substituent effects would increase the energy gap between the  and p orbitals, and therefore the 
singlet ground state would be favored. 
 
1.1.2 N-heterocyclic Carbenes 
For a few decades, carbenes were considered highly reactive transient intermediates in 
organic transformations. Isolation of a free carbene seemed impossible due to the incomplete 
electron octet and coordinative unsaturation. Although carbene chemistry was advanced with 
matrix-isolation of short-lived triplet carbenes,
5
 the discovery of N-heterocyclic carbenes (NHCs), 





Figure 1.2. Representative electronic configuration, resonance structures and Lewis structure of 
NHCs. 
 
NHCs are, as the name suggests, neutral, cyclic species with at least one nitrogen atom 
within the ring and one divalent carbene atom bearing a lone pair of electrons. On one hand, the 
N atoms pull electrons away from the carbene carbon, but on the other hand, they also push 
Chapter 1 
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electrons to the empty p orbital of the carbene carbon center (Figure 1.2). This overall “push-
pull” effect greatly stabilizes the carbene center in the singlet state, and hence NHCs are 
exclusively singlet carbenes in the ground state.
7
 
Isolation of a free NHC was initially attempted by Wanzlick in 1962.
8
 The reaction was 
designed to give the imidazolidin-2-ylidene by elimination of chloroform from the imidazoline 
derivative (Scheme 1.1). However, an enetetramine compound was isolated instead due to 
dimerization of the transient carbene. The generation of the free carbene was corroborated by the 
successful trapping with transition metals afterwards (vide infra). 
 
 
Scheme 1.1. Attempts of preparing a free NHC by Wanzlick. 
 
Only in 1991 was the first free NHC successfully isolated by Arduengo et al via the 
deprotonation of a 1,3-diadamantyl imidazolium salt with NaH in the catalytic amount of DMSO 




Scheme 1.2. Synthesis of the first free NHC by Arduengo. 
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This “bottle-able” species is stable at ambient temperature in the absence of oxygen and 
moisture. The stability of this NHC was initially attributed to the two bulky N-adamantyl groups, 
which help to kinetically stabilize the species by sterically disfavouring dimerization to the 
corresponding olefin. Later on, it was found that the partial aromaticity arising from a certain 
extent of electron delocalization in the five-membered ring would account for a more important 
degree of stabilization at the carbene center.  
The isolation of the first Arduengo NHC marked the renaissance of NHCs and led to a 
great increase of experimental and theoretical studies with a large number of NHCs being 
synthesized and analyzed.
10
 Among them, three major types, namely imidazolin-2-ylidene, 
benzimidazolin-2-ylidene and imidazolidin-2-ylidene, were studied the most extensively (Figure 
1.3). 
 
Figure 1.3. Three major types of NHCs and their properties. 
 
The unsaturated imidazolin-2-ylidenes benefit from aromatic stabilization in comparison 
to the saturated imidazolidin-2-yidenes (vide supra), which allows for a lesser demand for 
proximal steric bulk. Interestingly, benzimidazolin-2-ylidenes have the topology of an 
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unsaturated NHC. However, they show similar stability to the saturated imidazolidin-2-ylidenes 
and tend to dimerize when R is a less bulky substituent (Figure 1.3). This indicates that in 
benzimidazolin-2-ylidenes, the electron delocalization in the five-membered ring is reduced due 
to the already fully delocalized 6π aryl system. Hence, a smaller aromatic stabilization is present 
as compared to that of the unsaturated imidazolin-2-ylidenes. Notably, the sequences of 
increasing downfield shift for the 
13
Ccarbene resonances and enlarging NCN bond angles are the 
same as that observed for the decrease of aromatic characters of these three NHCs. 
Increasing attention has been paid to benzannulated NHCs since the isolation of the first 
representative by Hahn and co-workers.
10h
 However, they are still far less established than the 
other two counterparts in literature. Hence, it is of our interest to explore the chemistry of 
benzimidazolin-2-ylidene and their transition metal complexes. In this work, most of the NHCs 
are derived from benzimidazole. 
 
1.2 Carbenes as Ligands in Transition Metal Complexes 
1.2.1 Fischer and Schrock Carbene Complexes 
Carbenes have already been used as ligands to form metal complexes in the early 1960s. 
Generally, the resulting complexes were classified into Fischer and Schrock types, as named after 
the two respective chemists who isolated the first example of each (Figure 1.4). In the Fischer 
type complex, the metal-carbene bond contains two types of interaction, i.e. -donation from the 
electron lone pair of the carbon to an empty p-orbital of the metal and -back bonding of a filled 
orbital on the metal to the empty pπ orbital of the carbon. The CM donation predominates and 
hence the carbon atom tends to be more positively charged. In the Schrock carbene complex, 
Chapter 1 
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however, two covalent bonds are formed with each polarized to the carbon giving it a partially 
negative charge. 
 
Figure 1.4. Fischer and Schrock type carbene complexes. 
 
In the Fischer type complex, the substituents on the carbon donor are -donating groups, 
such as -OMe and –NMe2. The metal centers are usually late transition metals in low oxidation 
states with other -acceptor ligands such as CO. In the most common model, the carbene ligand 
is considered as a 2e donor derived from a singlet carbene. In contrast, the Schrock type 
complexes have no -donor substitutes bonded to the carbene carbon and no -acceptor ligands 
coordinated to the early transition metal in high oxidation state. In the most common model of 
this type, the carbene is often considered to act as X2-type bis-alkyl ligand, formally derived from 
the triplet carbene. 
 
1.2.2 NHC Complexes 
N-heterocyclic carbene complexes can be regarded as a special subclass of Fischer type 
complexes, in which the strong metal carbene bonds are mainly attributed to the strong electron 
donation of NHCs to the metal center with little back donation from the metal to the NHCs. The 
Chapter 1 
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first NHC complex was prepared by Wanzlick early in 1968 (Scheme 1.3, A).
11
 At almost same 




Scheme 1.3. Synthesis of the first NHC metal complex. 
 
The interest in NHC complexes rapidly increased particularly after Arduengo’s discovery. 
In the last two decades, the coordination chemistry of NHCs has covered almost all the transition 
metals, be it in low or high oxidation states. A straightforward way to prepare NHC complexes is 
to replace ligands on a metal complex by free NHCs.
 10e-f,j-k,m,o,13
 However, the synthesis needs to 
be carried out under an inert atmosphere, and more importantly, the free NHC intermediate must 
be stable as a monomer. This limits the feasibility of the method, especially for the access of 
complexes bearing benzimidazolin-2-ylidenes and imidazolidin-2-ylidenes with non-bulky 
substituents. The second method is based on the reaction of an azolium salt precursor with a basic 
metal complex, which was originally employed by Wanzlick and Öfele. This method circumvents 
the handling of air/moisture sensitive free carbene, and thus it is largely used nowadays.
14
 
Notably, some of the resulting NHC complexes are able to serve as carbene-transfer agents due to 
the labile metalCcarbene bonds. In this regard, Lin and coworkers have developed the silver-
carbene transfer method.
15
 This method makes use of Ag2O as the base to deprotonate azolium 
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salts with formation of the Ag NHC complexes. Via subsequent reactions, the NHC ligands have 
been transferred to a wide range of metals such as Pd(II), Au(I), Pt(II), Rh(I), Rh(III), Ir(I), Ir(III), 
Ru(II), Ru(III), and Ru(IV).
16
 In this work, the last two methods are used to synthesize complexes 
with benzimidazolin-2-ylidenes. 
Another attractive feature of NHCs as ligands for complexes is their good performances 
in homogeneous catalysis, which was firstly studied by Herrmann in 1995.
17
 By comparing the 
performances of the well-known Pd/organophosphane catalysts with a Pd/NHC catalyst in Heck 
coupling reaction, they found that Pd/NHC complexes showed higher thermal and hydrolytic 
stabilities due to the stronger metalcarbene bonds. Hence, addition of excess ligand, often 100 
times than the metal, is avoided. Since then, complexes of NHCs become prevalent catalysts in 
organic reactions including Heck, Suzuki, Sonogashira, Kumada coupling, olefin metathesis, 




1.3 NHC as a Probe in Ligands Donor Strengths Determination 
The knowledge of the electron donating ability of a ligand is of utmost importance in 
coordination chemistry, since it is one of the key factors affecting the complex’s property and 
reactivity.
19
 For decades, a flurry of innovative research endeavors has been initiated with the 
intention to evaluate a ligand’s relative electronic properties experimentally,13a, 20  mostly 
considering monodentate ligands. In summary, there are two widely used methods. The 
dominating one in organometallic chemistry is the Tolman’s electronic parameter (TEP), which is 
the A1 IR stretching frequency of the carbonyl ligands in complexes of the type [Ni(CO)3L], 
where L is the ligand being studied (Figure 1.5).
20a
 The second method, more widely used in 
classical coordination chemistry and introduced by Lever, is based on assessment of 
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electrochemical E0 values of a redox couple, e.g., Ru
II/III
, in analogous complexes differing solely 
in the ligand of interest to be compared. From these values, individual ligand electrochemical 
parameters (LEP) were derived.
21
 Although LEP values are not a direct measure for the donating 
ability, they can be used to predict redox-potentials of metal complexes, which are related to the 
donor strength of their ligands (Figure 1.5). 
 






More recently, Huynh et al. have reported a new electronic parameter that is based on the 
evaluation and comparison of 
13







 It is known that the carbene 
carbon of free NHCs resonates at > 200 ppm and a significant upfield shift of this signal is 
observed upon binding to a transition metal. As has been noted by Lappert in an early work, the 
deshielding effect of this trans co-ligand on the carbene carbon increases with its trans influence, 
which in turn is related to its donating ability.
25
 Similar trend was observed in these complexes 
that a stronger donating ligand L gives rise to a more downfield 
13
C NMR resonance of the 
i
Pr2-
bimy carbene carbon. Hence, using the 
i





resonances of the respective complexes, the electron donating abilities of a series of Werner type 
and organometallic ligands have been ranked on a unified scale (Figure 1.6).  
 





Compared to TEP and LEP, this method can place both organometallic and classical 
Werner-type ligands on a unified scale, and the enhanced sensitivity allows for the detection of 
small differences within the same class of ligands, which are primarily due to subtle differences 
in inductive and mesomeric effects of substituents. Moreover, preparation of the generally air- 
and moisture-stable complex probes is much safer and more convenient. The non-destructive 
analysis by solution NMR for the determination ligands’ donating power, also allows for further 
derivatizations or applications, e.g. in catalysis, of the complex probes.
24b,d,26
  
Compared to monodentate donors, bidentate ligands (L2) can impart greater stabilities in 
their complexes due to the chelate effect, which is highly beneficial and desirable in transition 
metal chemistry. However, the electronic properties of bidentate ligands have been far less 
studied. Notably, Crabtree and co-workers evaluated carbonyl stretching frequencies of cis-
[Mo(CO)4L2] type complexes. These were converted to TEP using a conversion equation, that 
was based on the correlation of bis(monodentate) complexes cis-[Mo(CO)4(L)2] with [Ni(CO)3L]. 
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For ligands, which complexes could not be prepared, DFT calculations were conducted, and 
scaling factors had to be applied.
27,28,29
 The necessity for scaling factors and conversion equations 
based on monodentate ligands in this indirect methodology complicates donor strength evaluation 
and may limit reliability. Apart from these, several groups have compared the relative donor 
strengths of L2 ligands by simple comparisons of carbonyl stretching frequencies in metal 
carbonyl complexes. However, different transition metals, e.g. Rh, W, Mn, and Cr, with different 
oxidation states were used in these studies.
30,31,32,33,34,35
 Similarly, the relative electron donating 
abilities of bidentate ligands have been assessed via comparing the oxidation potentials of 
analogous complexes.
36
 Although Lever’s equation E = SM(ΣEL) + IM, where E is the measured 
oxidation potential (in V vs. NHE), ΣEL is the sum of the EL values for all the ligands, and SM and 
IM are standard parameters depending on the the metal redox couple, spin state and 
stereochemistry, has been established to calculate the LEP values EL,
21
 one should be very 
cautious with the estimated values since, it is just based on a single complex. To the best of our 
knowledge, there is not a general and unified system for the direct determination of electron 
donating abilities of bidentate ligands. 
Hence, one of the objectives of this thesis is the extension of Huynh’s parameter to other 
monodentate and bidentate ligands as well. The results will be discussed in Chapter 2. 
 
1.4 Functionalized-NHC Metal Complexes 
1.4.1 Synthetic Approaches to Functionalized-NHC Metal Complexes 
The nitrogen atoms in the NHCs offer ample possibilities for tuning the ligand structure. 
Through changing the N-substituents, steric demands and electronic properties of the ligand can 
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be altered to provide complexes with enhanced catalytic performances.
37
 More interestingly, 
various functional groups can also be introduced resulting in complexes with wider 
applications.
38
 For example, introduction of a suitable donor group could lead to versatile 
structures in ditopic complexes or enhanced catalytic performance of complexes with hemilabile 
ligands.
39
 Potentially antibacterial compounds have also been made by the introduction of a 
biologically active function.
40
 In addition, complexes of bifunctional ligands were immobilized or 








Routinely, functionalized NHC complexes are obtained by metalation of an already pre-
functionalized NHC precursor (Scheme 1.4, A).
42
 In this “linear” approach, the functional group 
may interfere negatively with the coordination process leading to the unexpected formation of by-
products and lower yields (Scheme 1.5).
42c,43
 Furthermore, versatility and modularity are limited, 
and only a small number of complexes can be obtained from a single functionalized ligand 
precursor. 
An alternative and “divergent” approach, where functional group transformations can be 
conducted with a single and easily accessible NHC complex would represent a substantial 
improvement in terms of cost, labor, time and waste reduction (Scheme 1.4, B).
40b,44
 Moreover, 
new complexes might be envisaged, which are not accessible via the traditional way due to 
incompatibility of the desired functional group with the conditions required for complexation.  
 
 
Scheme 1.5. Isolation of unexpected thiolato-bridged dimeric complex using via metalation of 
thioester-functionalized-azolium salt. 
 
Therefore, the second aim of this thesis is to synthesize suitable parent complexes, which 
will allow further postmodifications to give a large library of newly functionalized NHC 




1.4.2 Functionalized-NHC in Metallosupramolecular Chemistry 
Nowadays, NHCs have become standard ligands in organometallic chemistry and 
particularly in the field of homogeneous catalysis (vide supra). In addition, they have also been 
used to form photoluminescent
45
 and biologically active
46
 complexes. However, only recently has 
their application been extended to metallosupramolecular chemistry.
47
 To date, only a small 
number of homo- and hetero-multimetallic complexes with one, two or three dimensional 










 based on 
polydentate ligands featuring NHC moieties. 
Among the reported architectures, the most common motifs are molecular rectangles and 
squares. As an early example in this field, Hahn reported the construction of a Ni(II) cornered 
molecular rectangle with so-called “Janus type” (facially opposed) di(NHC)s and 4,4’-bipyridine 
ligands.
53
 Subsequently, a number of similar structures were prepared with different NHC linkers 
or metal corners. One representative is the molecular square with pure N,O-carbene bridges.
54
 
Huynh et al reported a rectangular motif bearing mesoionic and remote NHC ligands, in which 
the corners are not formed by the metal atoms, but by the CH2-spacer of the dicarbene and the 
bridging iodido ligands. In addition, they also reported several rare tetranuclear complexes, which 
feature a 8-membered square consisting of alternating four Pd(II) and four S atoms. A few 
examples of star-shaped complexes were developed by Bielawski and Peris using rigid tris(NHC) 
ligands. Metallo- and NHC based supramolecular chemistry was pushed further by Hahn, who 
reported a rare cylindrical structure containing six silver atoms sandwiched between two hexa-
NHC ligands.
55
 Although rotaxanes are very common motifs in supramolecular chemistry, there 









In addition to the above mentioned architectures, double stranded-helices are common 
structures found in nature such as ɑ-helical polypeptides and double-helical nucleic acids. In the 
last few decades, chemists have contributed great efforts to make artificial helices, and one of 
most important results was made by Lehn, who demonstrated the spontaneous formation of a 
double-helical complex (helicate) from bipyridine and Cu(I).
56
 Although a large library of 
helicates is available in literature now, it is worth noting that almost all of them were built from 
Werner-type ligands. Lin and Meyer reported the only two examples of double stranded-helicates 
with NHCs that were obtained via simple coordination of pyridine- or pyridazine-bridged 




Figure 1.8. Reported double stranded-helicates NHC complexes. 
 
Intrigued by the versatile and interesting structures, and given the fact that NHCs could be 
easily functionalized, the last objective of this thesis is to design a polydentate ligand precursor 
and explore its coordination chemistry to build metallosupramolecules. The result will be 
discussed in detail in Chapter 4. 
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2. Donor Strengths Determination of Monodentate and Bidentate 
Ligands Using Their Palladium(II) 1,3-diisopropylbenzimidazolin-2-
ylidene Complexes 
2.1 Donor Strengths Determination of Monodentate Ligands 
The reactivity of the dimeric [PdBr2(
i
Pr2-bimy)]2 complex I towards a wide range of 
Werner-type and organometallic monodentate ligands has been well explored previously.
24
 With 
addition of two equiv pro-ligand (L), the bromido-bridges were straightforwardly cleaved 
resulting in the formation of [PdBr2(
i
Pr2-bimy)(L)] complexes (Scheme 2.1). Notably, both trans- 
and cis-arrangements are possible, depending on the nature of the pro-ligand. However, only the 
trans-[PdBr2(
i
Pr2-bimy)(L)] complexes will be suitable for the determination of electron donating 
abilities of the L ligands. 
 
 
Scheme 2.1. Cleavage reactions of [PdBr2(
i





2.1.1 Electron Donor Strengths of Substituted Pyridines 
Cleavage reactions of [PdBr2(
i
Pr2-bimy)]2 with 11 commercially available pyridines 
smoothly yield two types of complexes trans-[PdBr2(
i
Pr2-bimy)(3-R-Py)] (R = F, 1; Cl, 2; Br, 3; I, 
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4; OH, 5; Ph, 6) and trans-[PdBr2(
i
Pr2-bimy)(4-R-Py)] (R = Cl, 7; Br, 8; I, 9; OH, 10; Ph, 11). 
Pro-ligand 4-F-Py was not included due to its limited availability. In comparison to the parent 
complex, the solubilities of the resulting complexes 111 in common organic solvents, with the 
exception of nonpolar hexane and diethyl ether, have improved significantly. A distinct color 
change from orange to yellow was observed for all the eleven complexes. Formation of 
complexes 5 (3-OH), 10 (4-OH), 6 (3-Ph) and 11 (4-Ph) were evidenced by their ESI mass 
spectra, which show base peaks at m/z 525 or 697 assignable to the [M – Br + CH3CN]
+
 or [M + 
CH3CN + MeOH + H]
+ 
fragments. However, the base peaks for the other complexes are 
consistently observed at m/z 469 attributed to the [M – Py + H]+ fragment due to the loss of the 
halo-pyridine ligand when subjected to ESI MS conditions. The halo-pyridine ligand dissociation 
serves as an indirect sign of their weaker donation (vide infra), and it also demonstrates the strong 






H NMR spectra of complexes trans-[PdBr2(
i






NMR spectroscopy confirms the formation of all complexes as evidenced by the 
additional signals assignable to the pyridine ligands. 
1
H NMR spectra of complexes trans-
[PdBr2(
i
Pr2-bimy)(3-Br-Py)] (3) and trans-[PdBr2(
i
Pr2-bimy)(4-Br-Py)] (8) are displayed in 
Figure 2.1 as a representative for each type. Four additional signals are observed assignable for 
the 3-Br-Py ligand in complex 3, while only two are found for the 4-Br-Py ligand in complex 8 
due to symmetry. The hydrogen signals of the
 i
Pr2-bimy are not much affected by the positioning 
of the substituent. However, they do shift slightly upfield compared to the analogous resonances 
of the parent dinuclear complex. Anagostic CHPd interactions in solution exist in these 
complexes as indicated by the more downfield 
1
H NMR shifts of the NCH protons in 
comparisons to that of the 
i
Pr2-bimyHBr salt ( = 1.071.16 ppm).
58
 Such interaction has been 
explored in depth for (
i








Ccarbene NMR resonances of complexes 111
a
 and Hammett σ constants 










1 3-F 6.30 158.65
b
 0.34 - - - - - 
2 3-Cl 6.30 158.72
b
 0.37 7 4-Cl 6.29 158.98
b
 0.23 
3 3-Br 6.29 158.63
b
 0.39 8 4-Br 6.29 159.03
b
 0.23 
4 3-I 6.29 158.68
b
 0.35 9 4-I 6.28 159.2 0.18 
5 3-OH 6.32 159.6 0.12 10 4-OH 6.32 160.21
b
 -0.37 




Measured in CDCl3 and internally referenced to the solvent signal at 7.26 and 77.7 ppm, 




C NMR spectra. 
b
2 decimal 
placings are given to highlight the small, but discernable differences. 
 
With the substituents being five or six bonds away, the 
13
Ccarbene resonances of the 
i
Pr2-
bimy are still able to tell the differences and shed light on the donor strengths of these pyridine 
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ligands (Table 2.1). Generally, the 4-R-Pys have stronger donating abilities than the respective 3-
R-Py ligands. The OH- and Ph-pyridines are stronger donors than the halo-pyridines within both 
series.  
Substituents may exert two effects on its adjacent aromatic ring, i.e. inductive and 
mesomeric effects. Relative inductive effects of various substituents have been experimentally 
measured and those discussed herein are with decreasing negative inductive effect (I) in the 
order of F > Cl > Br > I > OH > Ph. Strong evidence shows that inductive effects in the meta- and 
para-positions are very similar. Mesomeric effects, on the other hand, are largely position-
dependent, which is highlighted in Figure 2.2 using the OH-pyridine as a model. The positive 
mesomeric effect (M) is brought about by the overlapping of the filled p orbital of the oxygen 
atom with the  system, which leads to extra electron density on the ring. Notably, the additional 
electron density is selectively located at the ortho- and para-positions with respect to the COH 
atom. As shown in the resonance structures, one of the three partial negative charges is located on 
the N atom in the para-OH-pyridine, while all of them are on the C atoms in the meta-OH-
pyridine. This explains the stronger donation of the 4-R-Pys than that of the respective 3-R-Py 
ligands. 
 
Figure 2.2. Resonance structures of OH-pyridines. 
Chapter 2 
21 
The OH- and Ph-substituents have smaller I effects and stronger M effects, both of 
which account for the stronger donating abilities of their pyridines. Interestingly, the relative 
donating abilities of the OH- and the Ph-pyridines are reversed in the two series. In the meta-case, 
the inductive effect dominates; hence the 3-Ph-Py is a reasonably stronger donor. However, in the 
para-analogues, the stronger M of the OH group overcomes the stronger I effect, giving rise to 
a slightly stronger 4-OH-Py ligand.  
A closer inspection of the carbene resonances of complexes 79 involving the 4-halo-
pyridines reveals decreasing donation powers in the order 4-I-Py > 4-Br-Py ≥ 4-Cl-Py. Notably, 
the +M effects of halogen substituents are in the order of F > Cl > Br > I due to the decreasing p-
π orbital overlap of the pyridine ring with increasingly larger halogen atoms. Hence, the result 
obtained above indicates that the smallest –I of iodine atom balances its weakest +M effect, 
giving rise to a stronger net electron donor than the chlorine and bromine analogues. However, 
the stronger +M of Cl is compensated by its more negative –I effect in comparison to those of Br, 
resulting in two comparable electron donors of 4-Br-Py and 4-Cl-Py on this scale. Overall, the 
para-substituted pyridines have decreasing electron-donating properties in the order 4-OH-Py > 
4-Ph-Py > 4-I-Py > 4-Br-Py ≥ 4-Cl-Py. 
The 
13
Ccarbene signals of the meta-halo-pyridine series are scarcely distinguishable with 
differences of less than 0.05 ppm, indicating fairly similar electronic effects of the different 
halogen atoms at the meta-positions. The net electron donating abilities can still be ranked in the 
order of 3-Ph-Py > 3-OH-Py > 3-Cl-Py ≥ 3-I-Py ≥ 3-F-Py ≥ 3-Br-Py. 
In physical organic chemistry, such substituent electronic effects have been established by 
Hammett, based on conductance measurements of ionisation constants of the appropriately 
substituted benzoic acid. Hammett constants p and m are derived from an equation: σ = logKX 
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 logKH, where KH = ionisation constant for benzoic acid in water at 25 °C and KX = ionisation 
constant for a para- and meta-substituted benzoic acid.
60
 An electron-withdrawing substituent 
would cause the benzoic acid to be more acidic, thus giving rise to a positive value of the 
Hammett σ constant; while an electron-donating group would lead to a more negative value.  
The Hammett σp constants of 4-R substituents relevant to this work are as following: 4-
OH (-0.37) > 4-Ph (-0.01) > 4-I (0.18) > 4-Br (0.23)  4-Cl (0.23).61 Notably, the electron donor 
strengths trend obtained by the 
13
C NMR method is in well agreement with it. The meta-
substituent effects to the overall donor abilities, on the other hand, only correlate to m constants 
for different types: 3-Ph (0.06 ) > 3-OH (0.12) > 3-X (0.340.39). 
 
2.1.2 Electron Donor Strengths of Other N, P, As, Sb, S and O Ligands 
Nitrogen donors. Triethylamine (NEt3), 1,5,7-Triazabicyclo[4.4.0]dec-5-ene (TBD) and 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) are widely used as organic bases in catalytic reactions 
(Chart 2.1). In certain cases, they outperform the inorganic bases due to the better solubilities in 
organic solvents, and the fact that they can coordinate and therefore stabilize the active metal 
species.
62
 It is to our surprise that their electron donating abilities to metal centers have not been 
compared. Hence, we herein prepared the analogous 
i
Pr2-bimy/nitrogen base complexes in an 
attempt to reveal their relative net electron donation to palladium, which will be reflected by the 
13
Ccarbene resonances. Two equiv TBD and DBU reacted smoothly with I affording the yellow 
solid products trans-[PdBr2(
i
Pr2-bimy)(TBD)] (13) and trans-[PdBr2(
i
Pr2-bimy)(DBU)] (14). 
However, an excess of triethylamine and prolonged stirring were required to fully convert 






Chart 2.1. Sketches of the three nitrogen organic bases. 
 
Notably, TBD is a bicyclic guanidine derivative in which one imine and one secondary 
amine nitrogen donor are available for coordination. However, the ligand shows selective 
coordination of the imine nitrogen donor to metal centers such as Pd, Cu, Fe and Li.
63
 Indeed, the 
trans-[PdBr2(
i
Pr2-bimy)(TBD)] (13) complex with imine coordination was obtained, which is 
evidenced by X-ray diffraction on a single crystal obtained by slow evaporation of a saturated 
solution in CHCl3/hexane.  
 
Figure 2.3. Molecular structure of 13 showing 50% probability ellipsoids; hydrogen atoms are 
omitted for clarity. Selected bond length [Å] and bond angles [°]: Pd1–C1 1.967(4), Pd1–Br1 
2.4380(7), Pd1–Br2 2.4341(7), Pd1–N3 2.075(4); C1–Pd1–Br1 86.29(13), C1–Pd1–Br2 
89.20(13), Br1–Pd1–N3 93.43(12), Br2–Pd1–N3 91.21(12); PdCBr2N/NHC dihedral angle 88.1°. 
 
The solid state structure depicted in Figure 2.3 confirms the square planar connectivity of 
the 
i
Pr2-bimy, TBD and two bromido ligands to the Pd(II) center. Both the NHC and TBD ligands 
rotate almost perpendicular to the coordination plane to relieve steric congestion. Interestingly, a 
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short contact of the NH proton and the Pd(II) center is noted with NHPd angle of 123.2 and 
distance of 2.619 Å in the solid state. However, retention of such interaction in solution is 
uncertain as the corresponding hydrogen signal is not resolved in the 
1
H NMR spectrum. The two 
trans-arranged bromido ligands slightly tilt towards the carbene ligand possibly indicating 
electron donation to the formally vacant p-orbital of the carbene center.
58
 All related bond 
parameters are as expected and hence will not be further commented upon. 
The three base adducts have good solubilities in most organic solvents. Similar 
1
H NMR 
spectra and ESI MS characteristics were found for these complexes as discussed previously for 
the mixed NHC/Py complexes. In the 
13
C NMR spectra, the three carbene carbon atoms resonate 
in the order of 12 (NEt3, 158.0 ppm) < 14 (TBD, 165.8) < 13 (DBU, 166.3). This trend indicates 
that the saturated amine NEt3 is a weaker donor compared to the unsaturated imines. In addition, 
DBU is a stronger ligand than TBD, which is reasonable by considering the additional I effect 
from the third nitrogen atom in the TBD ligand.  
 
 




The pKa values of the conjugated acids of the three organic bases are: NEt3, ~11; DBU, 
~12 and TBD, > 12. Notably, the stronger basicity of the two imines is due to a highly effective 
conjugated system after protonation under reversible conditions, which is reflected by the number 
of resonance forms (Figure 2.4).
64
 The three versus two resonances structures found for TBD and 
DBU, respectively, explain the stronger basicity of TBD. Correlation of the donor strengths to the 
basicity values shows a consistent result of between the amine and the imines. 
 
Phosphine, arsine and antimony donors. Previously, Huynh et al have used the 
13
C 
NMR spectroscopy to rank the electron donating properties of three phosphine ligands in the 
order of PPh3 < P(mTol)3 < PCy3.
24a
 Herein, the scope was extended to phosphites, including 
P(OMe)3, P(O
i
Pr)3, P(OPh)3 and P(O-2,4-
t
Bu-Ph)3. In addition, evaluation of NPh3, AsPh3 and 
SbPh3 was also attempted to test the feasibility of this method in differentiating the donor 
strengths of ligands from the same group. Besides their electron donating properties, it will also 
be interesting to study the physical and chemical properties of the resulting complexes, as they 
are relatively rare.  
Instant color changes from orange to pale yellow were observed for most reaction 
mixtures indicative of successful bridge cleavage. Initially, the reactions were stirred in CH2Cl2 
and stopped after 30 min to ensure complete consumption of complex I. Notably, the reaction 
with NPh3 did not proceed at all regardless of different reaction time, substance ratios, solvents 
and reaction temperature.  
Similarly to complexes of phosphine, those of phosphite complexes underwent trans-cis 
isomerizations. In comparison to trans-configured amine and imine complexes, the cis-
arrangement is thermodynamically preferred in these cases, due to the so-called “transphobia 
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effect” of phosphorus donors.65 Transphobia is the term used to describe the difficulty of placing 
a P ligand and a C donor trans to each other.
66
 The isomerization is fast for the P(OMe)3 and 
P(O
i
Pr)3 supported complexes. Hence, only the cis-[PdBr2(
i





Pr)3}] (16) complexes were isolated. The process is slower for P(OPh)3 
complex, and signals for both trans/cis-[PdBr2(
i
Pr2-bimy){P(OPh)3}] (17) were captured in the 




Bu-Ph)3}] (18) resists 
isomerization apparently due to the enhanced steric bulk.  
As noted earlier, trans-configured complex probes are required for the determination of 
donor strengths using this method. Hence, direct NMR scale reactions were attempted to capture 
the initially formed trans-isomers for the complexes with P(OMe)3, P(O
i
Pr)3 and P(OPh)3 ligands. 
Complex I and the respective phosphite were mixed in NMR tubes, and the samples were 





Pr)3}] (16) or trans-[PdBr2(
i
Pr2-bimy){P(OPh)3}] (17) complex was 
observed in the respective 
1




C NMR spectroscopy were measured 
immediately thereafter. All the signals were successfully resolved for complex 17 before 
isomerization. However, a mixture of signals due to both trans- and cis-isomers was detected for 
16 in the 
13
C NMR spectrum. To resolve the carbene signal of trans-16 in a shorter time, the 






Pr2-bimy carbene signal 
was detected even with a single scan. Unfortunately, the signals of trans-15 complex could not be 
captured even within such a short time. 
Similar isomerizations were also observed for the AsPh3 and SbPh3 complexes due to the 
transphobia effect, with the latter being faster. Only cis-[PdBr2(
i





Pr2-bimy)(AsPh3)] (19), on the other hand, isomerizes slower 
and could be fully characterized by direct NMR reaction.  
After obtaining the carbene signals of the trans-configured complexes 1619, the 
isomerization processes were purposely monitored by 
1
H NMR spectroscopy. For the P(OPh)3 
complexes 17, 17% of the trans-isomer converted to the cis-complex after 8 days. However, the 
1
H NMR spectrum of the product mixture obtained from the initial reaction (30 min stirring in 
CH2Cl2) shows a trans-cis conversion of up to 50%. Besides the stirring, which might help in the 
conversion by a better mixing, the different solvents would be the key factor in influencing the 
isomerization rate. The more polar CH2Cl2 versus CDCl3 favors the formation of the cis-isomer 
with a larger dipole moment. Hence, by repeating the reaction in a more polar organic solvent 
MeOH, the cis-[PdBr2(
i
Pr2-bimy){P(OPh)3}] (17) was exclusively obtained after 10 hours of 
stirring. 
1
H NMR monitoring of the other trans-complexes in CDCl3 showed that the P(O
i
Pr)3 
complex trans-16 fully converted to cis-16 within two hours. The P(O-2,4-
t
Bu-Ph)3 complex 
trans-18 did not change at all after 10 days. The same NMR sample was then heated in a hot oil 
bath (65 ºC) for several days. No conversion to cis-isomer but decomposition to Pd(0) black was 
detected instead. The isomerization of the AsPh3 complex 19 seems to reach equilibrium after six 
days giving rise to a trans/cis mixture with a ratio of 1:3.5. 
The formation of a trans- or cis-configured product could be best identified by the 
1
H 
NMR signals of methyl groups in the 
i
Pr2-bimy ligand. In the trans-isomers, the structure is 
symmetrical and hence only one doublet is observed. However, they become non-equivalent in 
the cis-isomers and two doublets assignable for the NCH(CH3)2 are found. Moreover, for the 
phosphite complexes, the carbene signals are found as doublets due to CP coupling. The 2J(C,P) 
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cis-15 P(OMe)3 1.74, 1.66 170.8 21.4 
trans-16 P(O
i
Pr)3 1.74 175.3 287.1 
cis-16 P(O
i
Pr)3 1.71, 1.69 172.0 22.9 
trans-17 P(OPh)3 1.51 171.7 289.8 
cis-17 P(OPh)3 1.57, 1.14 169.3 22.9 
trans-18 P(O-2,4-
t
Bu-Ph)3 1.59 171.5 289.6 
trans-19 AsPh3  1.79 169.2 - 
cis-19 AsPh3 1.66, 0.90 169.3 - 
cis-20 SbPh3 1.66, 1.04 167.5 - 
a
Measured in CDCl3 and internally referenced to the solvent signal 
at 7.26 and 77.7 ppm, respectively, relative to tetramethylsilane 








Ccarbene signals of the trans-complexes 1618 indicates an increasing donating 
powers of P(O-2,4-
t
Bu-Ph)3 < P(OPh)3 < P(O
i
Pr)3. The strong electron donation of the P(O
i
Pr)3 is 
reasonable due to the strong +I effects of the isopropyl substituents. The weakest donor strength 
of the P(O-2,4-
t
Bu-Ph)3 ligand compared to P(OPh)3, however, seems questionable. The 
additional electron donating groups of 
t
Bu should lead to a stronger electron donor. The steric 
bulk of this ligand may offer an explanation for the irregularity, as it surely affects the 
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coordination of all other ligands to the Pd(II) center. The difficulty in determining the donor 
strengths of very bulky ligands accurately represents one limitation of the 
13
C NMR based 
method to be studied in future. In comparison to the evaluated phosphine ligands (PPh3, 173.1; 
P(mTol)3, 173.6; PCy3, 176.4 ppm), phoshites are generally weaker donors due to the I effects 
of the oxygen atoms. However, they are all stronger than AsPh3 (trans-19), in line with the results 
obtained by TEP values.
68
  
Single crystals of complexes 15, 16, 17, 19 and 20 were obtained by slow evaporation of 
their solutions in CHCl3/hexane. As a consequence of the transphobia, all complexes crystallize 
in cis-configurations, although the trans-complexes of 16, 17 and 19 were initially dissolved 
(Figure 2.5).  
The Pd(II) centers adopt square planar geometries in all cases. The PdCcarbene lengths of 
the AsPh3 and SbPh3 complexes are essentially equal and shorter than those observed in the 
phosphite complexes with differences beyond the 3σ limit. The PdBr bond lengths trans to 
P/As/SbPh3 (2.4761(4)
58
 /2.4624(3)/2.4699(4) Å) indicate trans-influences of the three ligands 
following in the sequence: AsPh3 < SbPh3 < PPh3, which deviates from the sequence, SbPh3 < 
AsPh3 < PPh3, reported by Wendt.
69
 Due to the various differences in parameters of different 
since crystal data, this deviation is understandable. The corresponding PdBr bond in the 
P(OPh)3 complex is lightly shorter than that of the PPh3 complex, while those of the P(OMe)3, 
P(O
i
Pr)3 complexes are longer. The 
i
Pr2-bimy ligand in all cases is almost perpendicular to the 




Figure 2.5. Molecular structure of cis-15, 16, 17, 19 and 20 showing 50% probability ellipsoids; 
hydrogen atoms are omitted for clarity. Selected bond length [Å] and bond angles [°]: cis-15, 
Pd1–C1 1.980(7), Pd1–Br1 2.4914(9), Pd1–Br2 2.4724(10), Pd1–P1 2.2044(19); C1–Pd1–Br1 
84.78(19), C1–Pd1–P1 89.70(19), Br1–Pd1–Br2 94.21(3), Br2–Pd1–P1 91.30(6); PdCBr2N/NHC 
dihedral angle 89.6°. cis-16, Pd1–C1 1.988(3), Pd1–Br1 2.4853(4), Pd1–Br2 2.4779(4), Pd1–P1 
2.2133(8); C1–Pd1–Br2 85.90(8), C1–Pd1–P1 90.41(8), Br1–Pd1–Br2 92.221(15), Br1–Pd1–P1 
91.33(2); PdCBr2N/NHC dihedral angle 83.8°. cis-17, Pd1–C1 1.992(4), Pd1–Br1 2.4751(5), 
Pd1–Br2 2.4767(5), Pd1–P1 2.2040(10); C1–Pd1–Br1 88.05(11), C1–Pd1–P1 90.43(11), Br1–
Pd1–Br2 94.642(17), Br2–Pd1–P1 86.88.33(3); PdCBr2N/NHC dihedral angle 82.8°. cis-19, 
Pd1–C1 1.970(2), Pd1–Br1 2.4818(3), Pd1–Br2 2.4624(3), Pd1–As1 2.3568(3); C1–Pd1–Br2 
85.44(6), C1–Pd1–As1 90.40(6), Br1–Pd1–Br2 93.915(10), Br1–Pd1–As1 90.094(10); 
PdCBr2N/NHC dihedral angle 88.4°. cis-20, Pd1–C1 1.971(3), Pd1–Br1 2.4699(4), Pd1–Br2 
2.4771(4), Pd1–Sb1 2.4967(3); C1–Pd1–Br1 86.44(9), C1–Pd1–Sb1 95.66(9), Br1–Pd1–Br2 
95.552(14), Br2–Pd1–Sb1 82.489(12); PdCBr2N/NHC dihedral angle 84.2°. 
 
Sulfur and oxygen donors. Thioethers are known to form weak bonds with metal centers, 
which can be important for catalysis as they would dissociate from the metal center and provide 
free coordination sites for substrate activation.
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 However, less attention has been paid to the 
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measurement of their electron donating abilities compared to those of the other ligands. Herein, 
two common thioethers, i.e. dimethylthioether (SMe2) and tetrahydrothiophene (THT) were 
studied. 
Besides, we were also interested in studying the coordination chemistry and electron 
donating properties of analogous neutral oxygen donors. Unfortunately, similar dialkyl ethers 
were not able to cleave the dimeric complex I due to their weak donor properties. Pyridine N-
oxide (PNO) as a formally neutral oxygen donor derivative was prepared by the oxidation of 
pyridines. The increased dipole moment due to charge separation leads to a stronger nucleophilic 
property of the oxygen atom, which may allow the cleavage reaction to proceed. Hence, it was 
chosen for this study. 
The two dialkyl thioether smoothly cleaved complex I, affording complexes trans-
[PdBr2(
i
Pr2-bimy)(SMe2)] (21) and trans-[PdBr2(
i
Pr2-bimy)(THT)] (22). However, an excess of 
PNO had to be heated with complex I to afford the desired complex trans-[PdBr2(
i
Pr2-
bimy)(PNO)] (23). Their solubilities and spectroscopic properties are very similar to those of 
other trans-configured complexes, and hence no further comments are required. 
The two thioethers have very close electron donating properties. However, 
13
C NMR 
spectroscopy could still resolve the small difference as indicated by the 
13
Ccarbene resonances of 
complexes 21 and 22 at 163.5 and 163.6 ppm, respectively. As expected, the cyclic THT ligand is 
slightly stronger than the SMe2 ligand. Complex 23 shows a very upfield 
13
Ccarbene at 155.7 ppm 
indicating a weak donor property of the PNO ligand, which in turn explains the difficulty met in 
the preparation of this complex. 
Single crystals of complexes 22 and 23 were obtained by slow evaporation of their 
saturated solutions in CHCl3/hexane. The molecular structures depicted in Figures 2.6 confirm 
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the coordination of the co-ligands to the Pd(II) metal in trans-arrangements. The stronger THT 
ligand in complex 22 leads to a longer PdCcarbene bond than that of complex 23. 
 
Figure 2.6. Molecular structures of complexes 22 and 23 showing 50% probability ellipsoids; 
hydrogen atoms are omitted for clarity. Selected bond length [Å] and bond angles [°]: 22, Pd1–
C1 1.969(3), Pd1–Br1 2.4286(4), Pd1–Br2 2.4342(4), Pd1–S1 2.3784(7); C1–Pd1–Br1 86.85(8), 
C1–Pd1–Br2 87.63(8), Br1–Pd1–S1 87.13(2), Br2–Pd1–S1 98.76(2); PdCBr2N/NHC dihedral 
angle 87.1°. 23, Pd1–C1 1.935(2), Pd1–Br1 2.4213(3), Pd1–Br2 2.4201(3), Pd1–O1 2.1126(15); 
C1–Pd1–Br1 88.42(6), C1–Pd1–Br2 86.46(6), Br1–Pd1–O1 88.86(4), Br2–Pd1–O1 96.39(4); 
PdCBr2N/NHC dihedral angle 88.2°. 
 
Overall, the donor strengths of the different monodentate ligands can be ranked on a 
unified scale based on the 
13
Ccarbene resonances of the respective complexes (Figure 2.7). 
Generally, the phosphite ligands are the strongest among the ligands studied followed by AsPh3. 
The thioethers have medium donating powers in between some nitrogen donors, and pyridine N-
oxide has the lowest donating ability in this series. 
   
Figure 2.7. Donor abilities of P, As, N, S and O donors on a unified 
13
C NMR scale. 
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2.2 Donor Strengths Determination of Bidentate Ligands 
2.2.1 Electron Donor Strengths of Diimines 
1,2-bidentate nitrogen ligands such as aromatic and aliphatic α-diimines have acquired 
immense importance in coordination chemistry due to the diverse photochemical properties and 
catalytic activities of their complexes. Importantly, it has been reported that the electron donating 
potential of these ligands have prominent influence on these applications.
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 Thus, in extension of 
the Huynh electronic parameter to bidentate ligands, the electron donating abilities of aromatic 
and aliphatic diimine ligands will be determined. 
The synthesis of the respective 
i
Pr2-bimy/diimine complexes involves again the bridge-
cleavage reaction of complex I and concurrent chelate formation by ligand displacement of one 
bromido ligand with the suitable 1,2-diimines
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 {1,10-Phenanthroline-5,6-dione (phen-dione), 
phen, bipy, and 1,4-di(4-R-phenyl)-2,3-dimethyl-1,4-diazabutadienes (R-DAB: R = Br, H, Me, 
OMe, 
t
Bu)}. Subsequent anion metathesis reaction with KPF6 affords the desired [PdBr(
i
Pr2-
bimy)(diimine)]PF6 complexes 24–31 (Scheme 2.2). With the exception of [PdBr(
i
Pr2-bimy)(Br-
DAB)]PF6 (27), all complexes were obtained in spectroscopically pure form in high yields of >80% 
by simply washing with a non-polar solvent such as hexane or diethyl ether. Complex 27 had to 
be purified by column chromatography, and was isolated in a moderate yield of 40%.  
All complexes are pale-yellow solids and stable to air and moisture. Most complexes have 
fairly good solubilities in common polar organic solvents, such as CHCl3, CH2Cl2, CH3CN, DMF 
and DMSO. Two exceptions are compounds [PdBr(
i
Pr2-bimy)(phen-dione)]PF6 (24) and 
[PdBr(
i
Pr2-bimy)(bipy)]PF6 (26), which sparingly dissolve in CHCl3 hampering full NMR 





Scheme 2.2. Synthesis of [PdBr(
i
Pr2-bimy)(diimine)]PF6 complexes 24–31. 
 
Formation of these complexes is indicated by positive mode ESI-MS, which shows base 
peaks owing to the [M – PF6]
+ 




C NMR spectra, signals of the 
respective diimine ligands are observed. As expected, a doubling of ligand signals was observed 
after coordination, which led to inequivalent “transoid” and “cisoid” parts of the diimine ligands 
with respect to the NHC. 
The aromatic signals of the 
i
Pr2-bimy ligand remain largely unchanged upon cleavage of 
complex I and subsequent coordination of the diimine ligands. In the 
1
H NMR spectra, the 
isopropyl C–H resonances are shifted upfield by 0.4–0.7 ppm as compared to that in the precursor 
complex I, and the isopropyl CH3 resonances split into two doublets, indicating a restricted 
rotation of the 
i
Pr2-bimy ligands about the Pd–C bond in complexes 24–31. This is also observed 
in their 
13
C NMR spectra, where two singlets were detected for the isopropyl CH3 groups. With 
exception of complexes 24 and 26, the carbene carbon signals of all complexes were successfully 
obtained in short time due to their good solubilities in CDCl3 (Table 2.3). The poor solubility of 
the phen-dione, bipy complexes 24 and 26, however, hampers the data collection. This problem 
was resolved by 
13





labeled complex I. By doing so, detection of the carbene signals of 24 and 26 in CDCl3 was 
accomplished in a short time (Table 2.3). 
 
Table 2.3. Summary of 
i
Pr2-bimy carbenoid resonances in complexes bearing diimines.  










27 Br-DAB 160.5 
28 H-DAB 162.2 
29 Me-DAB 162.6 





Measured in CDCl3 and internally referenced to the solvent signal 
at 77.7 ppm relative to tetramethylsilane (TMS). 
b
Carbene signal 






Ccarbene resonances of aromatic diimine complexes 24–26 are observed at 160.0, 
161.4 and 162.7 ppm, respectively, indicating increasing donor strengths from phen-dione to 
phen followed by bipy ligand, which is in agreement with –I effects originating from the two 
electron withdrawing carbonyl groups in the phen-dione or the additional benzannulation in the 
phen ligand compared to the bipy parent. The 
13
Ccarbene shifts of DAB complexes 27–29 range 
from 160.5 to 162.6 ppm, showing the intermediate donating ability of the R-DAB chelators (R = 
Br, H, Me) compared to phen-dione and bipy. The OMe-DAB and 
t
Bu-DAB ligands possess 
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stronger donating power than the bipy ligand with their complexes’ carbene signals found at 
162.8 and 163.4 ppm. 
 
Figure 2.8. Donor abilities of aromatic and aliphatic diimines on the 
13
C NMR scale. 
 
Notably, this method can discern differences within the five R-DAB ligands, which only 
differ in their para-substituents five bonds away from the N-donor and seven bonds away from 
the reporter nuclei. Based on the 
13
Ccarbene resonances, the five DAB ligands were clearly ranked 
according to their decreasing donor abilities in the order 
t
Bu-DAB > OMe-DAB > Me-DAB > H-
DAB > Br-DAB. This order is reasonable and consistent with the decreasing positive inductive 
(+I) effect of the para-substituent in the order 
t
Bu > Me > H > Br (Figure 2.8). The positioning of 
the OMe-DAB ligand can be explained by the +M effect of the methoxy group, which not only 
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compensates its –I effect, but even increases electron density via p-π conjugation of its lone pairs 
with the aromatic rings. These results demonstrate that the 
13
C based electronic parameter can be 
extended to the evaluation of bidentate ligands. The method’s unprecedented sensitivity, which 
allows detection of small electronic differences within the same class brought about remote 
ligand modifications not only applies for monodentate ligands, but for bidentate ligands as well. 
 
Figure 2.9. Molecular structures of 25 and 30 in the solid state (hydrogen and counter ion atoms 
are omitted for clarity; ellipsoids drawn at 50% probability). Selected bond lengths [Å] and 
angles [deg] of 25: Pd1–C1 1.977(7), Pd1–N3 2.044(5), Pd1–N4 2.071(5), Pd1–Br1 2.3925(10), 
C1–Pd1–Br1 85.7(2), C1–Pd1–N3 96.9(3), N4–Pd1–N3 81.0(2), N4–Pd1–Br1 96.31(16); 
PdCBr2N/NHC dihedral angle 89.4°. 30: Pd1–C1 1.976(3), Pd1–N3 2.035(3), Pd1–N4 2.087(3), 
Pd1–Br1 2.4119(5), C1–Pd1–Br1 84.01(10), C1–Pd1–N3 99.30(12), N4–Pd1–N3 78.56(11), N4–
Pd1–Br1 98.32(8); PdCBr2N/NHC dihedral angle 81.3°. 
 
Slow evaporation of concentrated solutions of complex 25 and 30 in CHCl3/hexane 
afforded single crystals, which were analyzed by X-ray diffraction. Figures 2.9 depicts their 
molecular structures, in which both palladium centers are coordinated by one NHC, one bromido 
and one chelating diimine ligand. The NHC planes in both complexes are perpendicular to the 
PdCN2Br coordination plane with dihedral angles of 89° and 81° in complexes 25 and 30, 
respectively. In complex 30, the two N-aryl rings tilt towards different directions about the 
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chelating plane with dihedral angles of 63° and 67°. The N3–Pd1–N4 bite angle in complex 25 
(81°) and 30 (79°) are very similar. The similarity is also observed for their Pd–Ccarbene bond 
lengths of 1.977(7) and 1.976(3) Å. 
 
2.2.2 Electron Donor Strengths of Dicarbenes 
In addition to the evaluation of the ubiquitous bidentate diimine ligands, particularly 
interest are being paid to the donor strength determination of chelating dicarbenes due to their 
increasing importance as ligands in catalytic reactions and organometallic chemistry in general.  
 
 
Chart 2.2. Lewis structures of 7 classical diNHCs. 
 
Simple dicarbenes formed by bridging two classical NHCs can differ in their heterocyclic 
backbones, their external N-substituents (R groups) and finally the nature of their linkers (Chart 
2.2). Changes in any of these three parameters may affect their electron donating abilities. In 
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order to study if all these effects can be accurately determined, seven diNHCs were targeted 
(Chart 2.2, A–G), the precursors of which were prepared according to literature procedures.73 
Overall, these salts, and consequently their diNHCs, form three comparable groups, each 
differing in only one parameter: (i) heterocyclic backbone (A2HBr, B2HBr, C2HBr), (ii) N3-
substituent (C2HBr, D2HBr, E2HBr), and (iii) linker length (D2HBr, F2HBr, G2HBr). 
 
Scheme 2.3. Syntheses of [PdBr(
i
Pr2-bimy)(diNHC)]PF6 complexes 32–38 and [Pd2Br4(
i
Pr2-
bimy)2(diNHC)] complexes 39–40. 
 
Generally, the carbene precursors were first reacted with Ag2O to obtain the intermediate 





 (II), under displacement of the CH3CN and one bromido ligand. Anion 
exchange using KPF6 gave the [PdBr(
i
Pr2-bimy)(diNHC)]PF6 complexes 32–36 bearing diNHCs 
A–E, respectively, in moderate to decent yields of over 60% (Scheme 2.3, method 1). Complexes 
37 and 38 with ethylene and propylene bridged diNHCs F and G, however, were only isolated as 
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minor by-products in low yields of 8% (37) and 18% (38) through this route. The major products 
isolated were the dipalladium species 39 and 40 (Scheme 2.3, method 1), in which the diNHCs 
are bridging two palladium(II) centers, instead of chelating to one palladium(II) Lewis acid as 
required for the formation of complexes 37 and 38. The low yields of the latter were attributed to 
the difficult formation of the less stable 7- and 8-membered palladacycles during the 
transmetalation step as opposed to the more stable 6-membered cycles in complexes 32–36. 
To circumvent this, a reversed protocol was attempted for the preparation of 37 and 38, 
whereby the known diNHC complexes III and IV were preformed,
74
 and then subjected to attack 
by the 
i
Pr2-bimy ligand generated in situ by deprotonation of the 1,3-diisopropylbenzimidazolium 
salt with K2CO3. Salt KPF6 was again added to replace the bromide anion affording complexes 
37 and 38 in higher yields of 56% and 85%, respectively (Scheme 2.3, method 2). To the best of 
our knowledge, these hetero-tris(NHC) palladium(II) complexes are the first of their kind to 




Monopalladium complexes 32–38 are off-white solids, while the two bridged dipalladium 
species 39 and 40 are yellow powders. These two neutral complexes have very good solubilities 
in common organic solvents such as diethyl ether, ethyl acetate, CHCl3, CH2Cl2, CH3CN, DMSO, 
etc. On the other hand, the cationic complexes 32–38 are insoluble in ethers and only well soluble 
in polar organic solvents. Surprisingly, the solubilities of 37 and 38 bearing the longer ethylene 
and propylene linked diNHCs are significantly poorer in CHCl3 and CH2Cl2, but remain good in 
CH3CN and DMSO. ESI-MS revealed base peaks from m/z 565 to 745 for the [M – PF6]
+
 cations 
of complexes 32–38, while strong isotopic envelopes centered at m/z 1199 and 1213 were 
recorded for the [M – Br]+ fragments of the dinuclear species 39 and 40. 
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NMR spectra of the complexes were recorded in CDCl3 (32–36, 39, 40) or CD3CN (37, 
38) at 298 K. Most complexes give rise to well-resolved spectra at this temperature with the 
exception of the [PdBr(
i
Pr2-bimy)(A)]PF6 complex (32), where only broad signals are observed 
in its 
1
H NMR spectrum. At room temperature, the 
i
Pr2-bimy NCH and bridging NCH2N protons 
are not resolved due to a fast fluxional behavior. Cooling the sample to 273 K improves the 
resolution, and a well-resolved spectrum was finally obtained when the temperature was further 
decreased to 243 K (Figure 2.10). 
 
 
Figure 2.10. Variable temperature 
1
H NMR spectra of complex 32 in the region of 4.5–9.0 ppm. 
 
When sufficiently resolved, complexes 32–38 share very similar 1H and 13C NMR spectra. 
Besides the doubling of the diNHC signals upon coordination as observed for the diimine 
complexes, further splitting due to diastereotopy of N3-substituents is noted for complexes with 
benzyl and isopropyl groups. For example, complex 36 shows four doublets in its 
1
H NMR 
spectrum, which are attributed to the inequivalent isopropyl CH3 signals of the diNHC ligand. 
Similarly, four AM patterned doublets are observed in the 
1
H NMR spectra of complexes 35, 37 
and 38, assignable to the benzylic protons. In most cases, the linker protons become 
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diastereotopic upon complexation as well. As a representative, two doublets at 8.48 and 6.29 ppm 
are observed for the methylene spacer in the spectrum of complex 32 (Figure 2.10). The coupling 




H NMR signals in these complexes are more complicated than those 
found in the diimine derivatives, showing two septets at 5.25 and 6.02 ppm for the NCH protons. 
This indicates a restricted rotation of the N-substituents in the 
i
Pr2-bimy probe after diNHC 
coordination. 
 




C-HMBC NMR spectrum of complex 33. 
 
The reduced symmetry also leads to a doubling of the 
13
C NMR signals for the diNHC 
ligands and the 
i
Pr2-bimy probe. As expected, three downfield carbene signals are detected in 
these seven complexes, most of which are sufficiently different to be properly assigned in 
accordance to literature values for related complexes.
74
 Complex 33 bearing the 
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dibenzimidazolin-2-ylidene chelator, on the other hand, shows three carbene resonances in a very 
narrow range. Here, HMBC NMR experiments were conducted to assist the correct assignment 
(Figure 2.11). 2D cross-peak correlations between the carbene carbon atoms with the protons in 
the respective N-substituents allow for an unambiguous assignment to the correct carbene atom. 
The detection of the 
i
Pr2-bimy carbene signals in CDCl3 of the poorly soluble complexes 37 and 




 in their 
syntheses. 
The NMR spectra of the dipalladium complexes 39 and 40 are much simpler, with the 
benzylic protons resonating as one singlet at 5.80 and 5.76 ppm, respectively. The equivalent 
ethylene protons in 39 show one singlet and the propylene protons in 40 give rise to a triplet and 
a multiplet in a 4:2 integral ratio. Restricted rotation of the 
i
Pr2-bimy ligand about the Pd–C bond 
in both complexes is evidenced by two septets and doublets assignable to the isopropyl 
substituents. Each complex exhibits only two carbene signals in its 
13
C NMR spectrum, and the 
more downfield signal at 178.8 ppm (39) or 179.1 ppm (40) is assigned to the 
i
Pr2-bimy ligand. 
Table 2.4 summarizes the diagnostic 
13
Ccarbene resonances of the 
i
Pr2-bimy probe in 
complexes 32–38. Generally, they are much more downfield than those in the diimine 
counterparts confirming stronger donating abilities of the diNHC ligands. The group (i) diNHCs 
A–C (ditriazolin-5-ylidenes (ditazy), dibenzimidazolin-2-ylidene (dibimy) and diimidazolin-2-
ylidene (diimi)) in complexes 32–34 differ only in their heterocyclic backbone, and by 
comparison of the 
i
Pr2-bimy reporter signals, an increasing electron donating ability in the order 
of A (ditazy) < B (dibimy) < C (diimi) can be deduced. This backbone influence is consistent 
with that reported for monodentate NHCs, i.e. benzannulation in B and introduction of an 
electronegative nitrogen atom in C result in a successive increase of –I effect and weakening of 
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the respective donors. This trend also agrees with that obtained from the CO stretches calculated 
by Crabtree and coworkers based on a [Mo(CO)4(diNHC)] (diNHC = diimi, ditazy) system
29 
and 
the CO stretches measured by Veige et al. from a [Rh(CO)2(diNHC)]OTf (diNHC = diimi, 
dibimy) system.
33
   
 
Table 2.4. Summary of 
i
Pr2-bimy carbenoid resonances in complexes bearing diNHC chelators. 
complex L2 δ Ccarbene-probe
a
 
32 A 177.1 
33 B 178.7 
34 C 179.9 
35 D 179.51 








Measured in CDCl3 and internally referenced to the solvent signal 
at 77.7 ppm relative to TMS. 
b
Carbene signal obtained from the 
carbene 
13
C-labeled analogue.  
 
In addition, comparison among group (ii) ligands (i.e. C–E) in complexes 34–36 reveals 
that the electronic parameter can also detect N3-substituent effects of diNHCs in the order of D 
(Bn) < C (Me) < E (
i
Pr) in line with their increasing +I effects. Effects induced by the linkers as a 
special type of N-substituent effect in diNHCs of group (iii) have rarely been investigated. From 




Ccarbene resonances in complexes 35 < 37 < 38, it is 
concluded that simple lengthening of the linkers by a CH2 group leads to a detectable increase of 
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donor strength in the order of D (methylene) < F (ethylene) < G (propylene). The very small 
difference between D and F is understandable, since all carbon atoms in the bridges experience –I 
effects of at least one electron withdrawing nitrogen atom. In ligand G the situation is different, 
as the central CH2 group in the bridge exerts a +I effect, which can effectively increase electron 
density. Generally, this result is in line with the fact that the +I effect of an alkyl group increases 
with the chain length, which has also been testified by Ito’s Group via comparing the CO 
stretches of [Mo(CO)4(diNHC)] (diNHC = methylene and ethylene bridged imidazolin-2-
ylidenes).
34
 However no clear trend was detected when similar carbonyl-based methods using 
fac-[(CO)3ReBr(diNHC)] type complexes were employed.
35
 This highlights the better sensitivity 
and broader applicability of this 
13
C NMR based electronic parameter. 
 
Figure 2.12. Donor abilities of dicarbenes on the 
13
C NMR scale. 
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Overall, as can be seen from Figure 2.12, the NHC backbone has the most significant 
influence among the three parameters studied with chemical shift differences > 1.0 ppm. 
Different N3-substituents and linkers within the imidazole-derived system give rise to diNHCs 
(C–G) with varying donating potentials in the order of G (propylene, Bn) > E (methylene, iPr) > 
C (methylene, Me) > F (ethylene, Bn) > D (methylene, Bn). The results obtained provide useful 
information for the electronic fine-tuning of ligands, which is one of the key factors for complex 
stability and their applications. 
Single crystals of 32, 34, 37 and 38 can easily be grown upon standing of concentrated 
solutions (DMSO for 32, CH2Cl2/hexane for 34, CHCl3/hexane for 38) or from diffusion of 
diethyl ether into a solution of 37 in CH3CN.  
The molecular structures are shown in Figure 2.13 along with selected bond parameters. 
The asymmetric unit of complex 34 contains two independent molecules, which have essentially 
identical structure except for several bond parameter differences slightly over 3, and therefore 
only one of them is shown. The cationic complexes 32, 34, 37 and 38 crystallize as mononuclear 
species, in which one 
i
Pr2-bimy, one diNHC and one bromido ligand coordinate the palladium 
centers in distorted square–planar geometries. Complex 34 bearing the methylene bridged diNHC 
ligand C and complex 37 with ethylene-bridged diNHC ligand F have very similar bite angles 
(85.9º vs 84.9º). The bite angle in complex 38 with a propylene-bridged diNHC is only slightly 
bigger with 87.7º. The six- to eight-membered palladacycles all adopt boat-like conformations 
similar to those reported for simple dihalido-diNHC complexes.
74,73,76,77,78
  
Among the three carbene donors in each complex, the 
i
Pr2-bimy ring plane always has the 
largest dihedral angle with respect to the PdC3Br coordination plane (32, 70.2º; 34, 74.3º; 37, 
78.6º; 38, 76.2º). The short methylene bridge of the diNHC ligands prevents an otherwise 
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preferred perpendicular orientation, which result in small dihedral angles ranging from 39.2º to 
52.7º in complexes 32 and 34. Elongation of the spacer in the diNHCs of complexes 37 and 38 
increases the flexibility leading to larger dihedral angles of 62.9º to 74.3º. 
 
 
Figure 2.13. Molecular structures of 32, 34, 37 and 38 in the solid state (hydrogen atoms, counter 
ions, solvent molecules and N-benzyl substituents in complexes 37 and 38 are omitted for clarity; 
ellipsoids drawn at 50% probability). Selected bond lengths [Å] and angles [deg]: 32, Pd1–C1 
2.0251(19), Pd1–C17 1.9977(18), Pd1–C14 2.0190(19), Pd1–Br1 2.4576(3); C1–Pd1–C17 
92.30(7), C14–Pd1–C17 84.14(7), C14–Pd1–Br1 93.01(5), C1–Pd1–Br1 90.77(5). 34, Pd1–C1 
2.038(4), Pd1–C19 2.003(4), Pd1–C14 2.033(4), Pd1–Br1 2.4556(16); C1–Pd1–C19 94.52(17), 
C14–Pd1–C19 85.89(16), C14–Pd1–Br1 91.63(12), C1–Pd1–Br1 87.83(13). 37, Pd1–C1 
2.044(2), Pd1–C14 1.995(2), Pd1–C26 2.026 (2), Pd1–Br1 2.4646(3); C1–Pd1–C14 94.24(9), 
C14–Pd1–C26 84.88(10), C26–Pd1–Br1 91.31(7), C1–Pd1–Br1 90.56(7). 38, Pd1–C1 2.055(4), 
Pd1–C20 1.998(4), Pd1–C14 2.036(4), Pd1–Br1 2.4623(6); C1–Pd1–C20 93.88(15), C14–Pd1–




The Pd–C (iPr2-bimy) distances in these four complexes fall in a narrow range of about 
2.0 Å, which are generally longer than those found in the diimine analogues. This is due to less 
Lewis-acidic metal centers resulting from the coordination of the stronger donating diNHC 
ligands, although no clear correlation between these distances and the electron-donating powers 
among diNHCs was found. 
 
 
Figure 2.14. Molecular structures of 40 in the solid state (hydrogen atoms are omitted for clarity; 
ellipsoids drawn at 50% probability). Selected bond lengths [Å] and angles [deg]: Pd1–C1 
2.014(3), Pd1–Br1 2.4473(5), Pd1–C14 2.042(3), Pd1–Br2 2.4370(5), Pd2–C37 2.031(3), Pd2–
Br3 2.4346(4), Pd2–C27 2.031(3), Pd2–Br4 2.4530(5); C1–Pd1–Br1 87.84(10), C14–Pd1–Br1 
91.66(10), C14–Pd1–Br2 91.61(10), C1–Pd1–Br2 89.34(10), C37–Pd2–Br3 89.63(9), C27–Pd2–
Br3 92.20(9), C27–Pd2–Br4 88.90(9), C37–Pd2–Br4 89.27(9). 
 
Single crystals of dipalladium complex 40 were grown by slow evaporation of a saturated 
solution in diethyl ether. As depicted in Figure 2.14, the complex features two neutral trans 
configured palladium(II) centers. The propylene linked diNHC coordinates in a bridging manner. 
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The dihedral angles between the NHC and the PdC2Br2 coordination planes are generally larger 
for the 
i
Pr2-bimy ligands (78.4º, 85.3º) compared to those of the bridging diNHC ligand (69.9º 
and 66.9º). The Pd–C (iPr2-bimy) bond lengths do not differ significantly from those of the 
cationic chelates 32, 34, 37 and 38, indicating that the cis-positioned co-ligand (Br vs NHC) does 





3. Synthesis of Functionalized-NHC Palladium(II) Complexes Via a 
Postmodification Approach 
3.1 Synthesis of Parent Complexes 
Parent complexes should have reactive sites (i) which have relatively good tolerance 
during preparation; and (ii) that allow easy functionalizations. Palladium-NHC complexes 
featuring bromopropyl N-substituents fulfill these requirements and thus were designed as the 
parent complexes to achieve the goal of postmodifications. 
3.1.1 Synthesis of Mono(NHC)-Pd(II) Parent Complex 
The suitable ligand precursor H that contains a C3Br N-substituent can be prepared 
according to literature, by reacting 1-benzylbenzimidazole with an excess of 1,3-
dibromopropane.
37d
 Initially, it was mixed with one equiv of Pd(OAc)2 and four equiv of NaBr in 
DMSO and stirred at 90 C in an attempt to prepare a dimeric monocarbene–Pd(II) species.58 
However, the main product isolated by column chromatography turned out to be an ester-
functionalized dimeric complex [PdBr2(C3OAc-bimy)]2 (41, Scheme 3.1). Apparently, one equiv 
of acetate deprotonated the benzimidazolium salt, while the 2
nd
 equiv underwent a SN2 reaction 
with the bromopropyl arm forming the ester function. 
 
Scheme 3.1. Synthesis of ligand precursor H and complex precursors 41 and 42. 
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Complex 41 is a dark orange solid, with poor solubilities in common organic solvents 





NMR spectra, where signals characteristic of the COCH3 group are found. Its formation was 
further corroborated by the IR spectrum, in which a band at ~  = 1738 cm
-1
 assignable to the C=O 
double bond is observed. 
 
Figure 3.1. Molecular structure of 41 showing 50% probability ellipsoids; hydrogen atoms are 
omitted for clarity. Selected bond lengths [Å] and bond angles [deg]: Pd1-C1 1.943(5), Pd1-Br1 
2.4421(7), Pd1-Br1A 2.5330(7), Pd1-Br2 2.3992(7); C1-Pd11-Br1 90.65(16), Br1-Pd1-Br1A 
88.42(2), Br1A-Pd1-Br2 93.49(2), Br2-Pd1-C1 87.57(16); PdCBr3/NHC dihedral angle: 82.8°. 
 
The identity of 41 was additionally ascertained by X-ray diffraction analysis on a single 
crystal obtained by slow evaporation of a CH2Cl2/hexane solution (Figure 3.1). As expected, 
complex 41 is a dimeric monocarbene–Pd(II) complex with two bridging bromido ligands. The 
molecule lies at an inversion center. The coordination sphere at each square planar Pd center is 
completed by an ester–NHC and a terminal bromido ligand. The two alkyl ester N-substituents 
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point in different directions resulting in an anti-arrangement with respect to the coordination 
plane. The carbene plane deviates from the coordination plane with a dihedral angle of ~83°. 
In order to prevent the ester-substitution, the milder Ag-carbene transfer was investigated 
(Scheme 3.1). Salt H was hence reacted with Ag2O to afford the Ag NHC intermediate. Without 
isolation, the product was directly added to [PdBr2(CH3CN)2] in a 1:1 ratio to afford the desired 
product [PdBr2(C3Br-bimy)]2 (42) in 86% yield. 
 
Scheme 3.2. Cleavage of complex 42 to 43. 
 
 
Figure 3.2. Molecular structure of 43 showing 50% probability ellipsoids; hydrogen atoms are 
omitted for clarity. Selected bond lengths [Å] and bond angles [deg]: Pd1-C1 1.939(3), Pd1-Br1 
2.4276(5), Pd1-N3 2.071(3), Pd1-Br2 2.4299(5); C1-Pd11-Br1 87.75(9), Br1-Pd1-N3 93.44(8), 




Compared to 41, the target complex 42 is a red brown solid with poorer solubilities in the 
chlorinated solvents. Its 
1
H NMR spectrum in d6-DMSO shows the absence of the acidic NCHN 
proton as found in the salt H. Further evidence was obtained by X-ray diffraction analysis on a 
single crystal obtained by slow evaporation of a concentrated solution in CH3CN. As depicted in 
Figure 3.2, the dinuclear complex 42 was cleaved by CH3CN during crystallization (Scheme 3.2), 
giving rise to a mononuclear CH3CN adduct trans-[PdBr2(C3Br-bimy)(CH3CN)] (43). As 
expected, the Pd(II) center is square planar with the CH3CN ligand arranged trans to the NHC 
ligand. 
Similarly, dimeric complex 42 could undergo bridge-cleavage reaction with pyridine 
affording the more stable pyridine adduct trans-[PdBr2(C3Br-bimy)(Py)] (44, Scheme 3.3), which 
was anticipated to be better suitable for postmodifications. Complex 44 is soluble in most organic 
solvents excluding hexane and diethyl ether.  
 
 
Scheme 3.3. Synthesis of mono(NHC)-Pd(II) parent complex 44.  
 
An isotopic pattern at m/z 594 in the positive mode ESI mass spectrum assignable to the 
cationic [M – Br]+ fragment corroborates its formation. Its 1H NMR spectrum shows pyridine 
signals, which are shifted downfield in comparison to the free pro-ligand. The benzylic and 
propylene protons resonate as one singlet, two triplets and one quintet, respectively (Figure 3.3). 
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The carbene carbon resonates at 164.6 ppm in the 
13
C NMR spectrum, which falls in the range 




H NMR spectrum for the trans-[PdBr2(C3Br-bimy)(Py)] complex 44. 
 
3.1.2 Synthesis of Bis(NHC)-Pd(II) Parent Complex 
In order to obtain a bis(NHC) complex for postmodifications, the ratio of the Ag-carbene 
intermediate to [PdBr2(CH3CN)2] was increased to 2:1 to afford the trans-[PdBr2(C3Br-bimy)2] 
complex 45 as the major product (Scheme 3.4).  
 
 
Scheme 3.4. Synthesis of bis(NHC)-Pd(II) parent complex 45. 
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Notably, the sequence of addition showed a significant influence on the product yield. 
When the Ag species was added into the solution of [PdBr2(CH3CN)2] in CH3CN, only 50% of 
the bis(NHC) complex 45 was isolated. The dinuclear [PdBr2(C3Br-bimy)]2 complex 42 was 
isolated as the side product in 43% yield. However, the yield of 45 was quantitative when the 
[PdBr2(CH3CN)2] was added dropwise to the Ag-NHC. 
Complex 45 is a pale-yellow powder with good solubilities in THF, CH2Cl2, DMSO, and 
DMF, but it is poorly soluble in ethanol and non-polar solvents, such as hexane and diethyl ether. 





H NMR spectrum for the trans-[PdBr2(C3Br-bimy)2] complex 45 in the aliphatic 
region. 
 
Due to the unsymmetrical nature of the NHC ligands, two sets of signals with slightly 






 Two closely spaced carbene 
signals are observed at 182.6/182.5 ppm. These values are indicative of trans configured 
dibromido-bis(benzimidazole-derived NHC) complexes,
59a
 while more highfield values are 
expected for their cis isomer. The more intense signal at 182.6 is assigned to the trans-anti 
rotamer, while the weaker signal at 182.5 is attributed to the trans-syn form. This assignment is 
further corroborated by their 
1
H NMR spectra, where two sets of well separated signals are 
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observed for the aliphatic protons. These can be unambiguously assigned by considering the 
shielding effect exerted by phenyl ring of the benzyl substituent.
80
 In the anti-rotamer the 
bromopropyl arm is situated in the shielded area of the phenyl ring giving rise to more upfield 
signals (Figure 3.4, small signals of impurities were possible due to hydrolysis products). The 
benzylic CH2 protons in the anti-rotamer, on the other hand, do not experience this shielding 
effect and appear more downfield. In the syn form, the situation is reversed, and the bromopropyl 
signals are more downfield, while the benzylic protons are more upfield. The chemical shift 
differences of equivalent groups in the anti- and syn-rotamers decrease in the order of BrCH2 
(0.39 ppm) > NCH2Ph (0.23 ppm) > CH2 (0.22 ppm) > NCH2 (0.13 ppm), indicating the relative 
sensitivity of these functions to the shielding effect of the phenyl ring. This trend is generally 
observed for most of the complexes (vide infra). As expected, the anti-rotamer was generated as 
the major product due to steric reasons. 
 
 
Figure 3.5. Molecular structure of 45 showing 50% probability ellipsoids; hydrogen atoms are 
omitted for clarity. Selected bond length [Å] and bond angles [°]: Pd1–C1 2.024(4), Pd1–Br1 




Single crystals of 45 were grown by slow evaporation of a saturated solution in CH2Cl2, 
and the molecular structure determined by X-ray diffraction analysis is shown in Figure 3.5. The 
Pd(II) center is coordinated by two trans-anti oriented carbene and two bromido ligands in a 
square-planar geometry. The two benzimidazolin-2-ylidene rings are coplanar as a result of 
symmetry, but twisted from the coordination plane with a dihedral angle of 75º. 
 
 
Scheme 3.5. Hydrolysis of trans-[PdBr2(C3Br-bimy)2] (45) to trans-[PdBr2(C3OH-bimy)2] (46). 
 
Coalescence of trans-anti and trans-syn rotamers in a similar bis(NHC)-Pd(II) complex 




 and a 
similar study was conducted on complex 45 in CDCl3. However, no change was observed upon 
raising the temperature to 50 C. To achieve higher temperatures, d6-DMSO was used as the 
solvent instead. No ratio change or coalescence was recorded up to 100 C suggesting a higher 
rotational barrier about the Pd–C bond in this case. With further increase of the temperature to 
110 C, two sets of new signals close to the original ones appeared, which remained after cooling 
the sample back to room temperature indicating the formation of a new rotameric pair. In order to 
achieve full conversion, the same sample was heated at 110 C for one day. Subsequent NMR 
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analysis showed that the original signals due to complex 45 were completely replaced by two 
new sets of signals indicating rotamers of a new species. Notably, a new triplet is observed at 
4.62 ppm, which upon successful hydrogen-deuterium exchange by addition of D2O was assigned 
to OH protons. Additional evidence was found in the positive mode ESI mass spectrum of the 
sample, where a new base peak was observed at m/z 719 with the correct isotopic pattern for the 
[M – Br]+ fragment of the alcohol-functionalized complex 46 (Scheme 3.5, only the trans-anti 
rotamers are presented for clarity). 
 
3.2 Synthesis of Functionalized-NHC Palladium Complexes 
3.2.1 Synthesis of Mono(functionalized NHC)-Pd(II) Complexes 
Postmodifications by nucleophilic substitution were first conducted on the mono(NHC)-
Pd(II) parent complex 44. The treatment with KOAc or NaN3 exclusively yielded the respective 
ester- and azido-functionalized NHC complexes trans-[PdBr2(C3OAc-bimy)(Py)] (47) and trans-
[PdBr2(C3N3-bimy)(Py)] (48) in high yields without affecting the bromido ligands (Scheme 3.6). 
Notably, possible olefinic byproducts due to base-catalyzed HBr elimination of the bromopropyl 
side arm were not observed. Complex 47 can also be obtained by bridge-cleavage reaction of 
dimer [PdBr2(C3OAc-bimy)]2 (41) with pyridine. 
Reaction with NaI on the other hand is expected to affect both bromo-substituents as well 
as the bromido ligands. In order to avoid halide scrambling in this reaction, 10 equiv of NaI was 
added to 44, which cleanly afforded the trans-[PdI2(C3I-bimy)(Py)] (49) complex bearing an 
iodo-functionalized NHC. The combination of a better iodo leaving group at the sidearm with 
stronger coordinating iodido ligands makes 49 an even better precursor for (here 2nd generation) 
postmodifications. Thus, its SN2 reactions with the nucleophiles NaN3, KSCN and KSAc yielded 
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three new derivative complexes trans-[PdI2(C3X-bimy)(Py)] ( X = N3, (50), SCN (51), SAc (52)). 
Notably, complexes 51 and 52 are not obtainable via palladation of the respective pre-
functionalized azolium salts.
81
 This fact highlights the importance of the current postmodification 
protocol, which not only complements the traditional methodology, but also provides 
functionalized NHC compounds that are otherwise not accessible. 
 
Scheme 3.6. Postmodifications of mono(NHC)-Pd(II) complex 44. 
 
Complexes 4851 are yellow to orange powders, while complexes 47 and 52 are 
brownish solids. All these complexes remain well soluble in common polar organic solvents. 
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Apart from the spectroscopic signatures of the functional group itself, such postmodifications can 
be best traced by monitoring the 
1
H NMR signal of the -methylene group with respect to the 
reactive site. Other resonances of the ligands remain largely unaffected by the postmodifications. 
 
Table 3.1. α-CH2, Ccarbene NMR resonances of complexes 41–44, 47–52.
 a
 
complex X δ (1H) δ (13Ccarbene) 
41 OAc 4.26 160.6 
 42
b





 Br 3.65 161.8 
44 Br 3.67 164.6 
47 OAc 4.31 164.3 
48 N3 3.60 164.4 
49 I 3.43 163.3 
50 N3 3.60 163.0 
51 SCN 3.28 163.9 
52 SAc 3.14 162.9 
a
Measured in CDCl3. 
b





Ccarbene signal could not be resolved. 
 
Table 3.1 summarizes and compares the -CH2 
1
H NMR resonances for complexes 
4144 and 47–52. Comparing those of the dimers 41 and 42 reveals that the ester group in 41 is 
more deshielding than the bromo substituent in 42, which reflects their inductive effects. The 
same trend can be observed for their respective mononuclear pyridine adducts 44 and 47. The 
reduced I effect of the azido group in 48 and 50, on the other hand, leads to an upfield shift. The 
identical -CH2 chemical shift for complexes 48 and 50 also reveals that substitution of bromido 
versus iodido ligands has no significant effect on the postmodifications. Overall, the negative 
inductive effects of the functional groups investigated here can be ranked in the order SAc < SCN 
< I < N3 < Br < OAc based on the comparison of the -CH2 
1
H NMR signals of their respective 
complexes. The 
13
C NMR signals for the carbene carbon atoms of the pyridine complexes 44, 
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47–52 are found in the narrow range of 162.9–164.6 ppm. Generally, the trans-[PdI2(C3X-
bimy)(Py)] complexes have higher field 
13
Ccarbene resonances than the trans-[PdBr2(C3X-
bimy)(Py)] analogous. Apparently, the carbene carbon atoms in the former are more shielded by 
the more electron rich iodido ligands, and hence, more upfield 
13
Ccarbene resonances are found. 
Those of the dimeric complexes 41 and 43 are shifted upfield indicating more Lewis acidic metal 
centers. 
 
Figure 3.6. Molecular structures of 49 and 51 showing 50% probability ellipsoids; solvent 
molecules and hydrogen atoms are omitted for clarity. Selected bond length [Å] and bond angles 
[°]: 49, Pd1-C1 1.960(3), Pd1-I1 2.6112(4), Pd1-N3 2.102(3), Pd1-I2 2.6115(4); C1-Pd1-I1 
88.18(9), I1-Pd1-N3 92.71(8), N3-Pd1-I2 91.63(8), C1-Pd1-I2 87.78(9); PdCNI2/NHC dihedral 
angle 81.8°. 51, Pd1-C1 1.959(6), Pd1-I1 2.6061(13), Pd1-N3 2.100(5), Pd1-I2 2.6049(13); C1-
Pd1-I1 89.24(18), I1-Pd1-N3 90.63(16), N3-Pd1-I2 93.08(16), C1-Pd1-I2 87.03(18); 
PdCNI2/NHC dihedral angle 81.5°. 
 
The solid state molecular structures of complexes 49 and 51 have also been determined by 
single crystal X-ray diffraction and are depicted in Figure 3.6. Apart from the different functional 
groups, the mononuclear complexes have a very similar structure. Both contain a square planar 
Pd(II) center that is coordinated by one functionalized benzimidazolin-2-ylidene, two trans-
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iodido and one pyridine ligand. As expected the carbene planes are oriented almost 
perpendicularly to the coordination planes by angles of ~82°. 
 
 
Scheme 3.7. Synthesis of propyl-thiolato-bridged complex 53. 
 
It is conceivable that the functional groups in complexes 50–52 could be subjected to a 3rd 
generation postfunctionalization. To demonstrate such feasibility, complex 52 was chosen for a 
NaOH base-assisted hydrolysis reaction, which led to the formation of the anticipated thiolato-
donor functionalized NHC complex dimer 53 in a good yield (Scheme 3.7). This complex is an 
orange solid, which is well soluble in chlorinated solvents such as CHCl3, CH2Cl2, but slightly 
soluble in DMSO. Its formation is supported by ESI-MS, which shows a base peak at m/z 903 for 
the [M – I]+ fragment. In the 1H NMR spectrum, the benzylic protons become diasterotopic upon 
dimerization and resonate as two doublets centered at 6.37 and 5.32 ppm, respectively, with a 
coupling constant of 
2
J(H,H) = 15.8 Hz. All six methylene protons of each propyl-thiolato-bridge 
are also diasterotopic, giving rise to multiplets ranging from 6.251.72 ppm. In comparison to the 
aformentioned functionalized complexes, the electron rich thiolato donors in this complexes lead 
to a more downfield shift of the 
13
Ccarbene resoance at 174.8 ppm.
43
 
Single crystals of 53 were grown by slow evaporation in CHCl3/hexane, and the 
molecular structure determined by X-ray diffraction analysis is shown in Figure 3.7. Complex 53 
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is a dimeric species, in which the two Pd(II) centres are coordinated and bridged by two -
thiolato-functionalized NHCs in a chelating fashion. The square-planar coordination sphere at 
each Pd(II) is completed by one terminal iodido ligand. Both dihedral angles between these 
[PdCS2I] coordination planes and the carbene ring planes amount to ~63°, which deviate 
substantially from the favored perpendicular orientation (90°) due to the chelating binding mode 
of the S-functionalized carbene ligand. The [Pd2S2] core of 53 is significantly bent with a hinge 
angle of ~128°, which is slightly larger than the reported value of ~119° for a similar complex 
bearing a shorter ethyl-thiolato-chelate.
43 
 
Figure 3.7. Molecular structures of 53 showing 50% probability ellipsoids; solvent molecules 
and hydrogen atoms are omitted for clarity. Selected bond length [Å] and bond angles [°]: Pd1-
C1 2.000(8), Pd1-I1 2.6345(11), Pd1-S2 2.357(2), Pd1-S1 2.311(2), Pd2-C18 1.998(9), Pd2-I2 
2.6471(12), Pd2-S2 2.311(2), Pd1-S1 2.354(2); C1-Pd1-I1 92.4(2), I1-Pd1-S2 98.16(6), S2-Pd1-
S1 77.93(8), C1-Pd1-S1 91.6(2), C18-Pd2-I2 92.9(2), I2-Pd2-S1 98.02(6), S1-Pd2-S2 77.98(8), 
C18-Pd2-S2 91.2(2); PdCS2I/NHC dihedral angle 63.2°. 
 
The oxidation of the thiolato-bridges of complex 53 may lead to the formation of a 
dinuclear or mononuclear complex bearing sulfur donors of higher oxidation states, such as 
sulfinate, sulfenate, or sulfonate. Oxidation of the thiolato group of a Ni(II) complex to the 
sulfinate ligand by aerial oxygen or H2O2 has been reported.
82
 A previous study by Huynh’s 
group also showed that the thioether function of a dibenzimidazolium salt was easily oxidized to 
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a sulfoxide group by 3 equiv of H2O2 in acetic acid at ambient temperature.
83
 Complex 53 was 
therefore treated with the same reagents, and DMF was added to ensure a homogeneous reaction. 
However, the compound remained intact below 70 °C and started to decompose to palladium 
black at higher temperatures. The fact that 53 is resistant to oxidation by H2O2 may be ascribed to 




Scheme 3.8. Synthesis of propyl-sulfonate complex 54. 
 
Indeed, thiolato to sulfonate oxidation occurs with complex 53 when Oxone (KHSO5) is 
used, which is a cheap and strong oxidant. The reaction proceeds smoothly at ambient 
temperature with 3 equiv of Oxone in a DMF/H2O mixture with excess of NMe4I, which provides 
additional iodido ligands as well as a suitable counter cation (Scheme 3.8). Other alkali or 
ammonium salts proved less suitable for the isolation and crystallization of the product. With 2 
equiv of Oxone a lower yield of the sulfonate species was obtained, and no sulfinate or sulfenate 
intermediates could be detected. In contrast, Oxone was reported to be a chemoselective reagent 
for the oxidation of organic sulfides to sulfoxides and further to sulfones.
84
 
Presumably, a dinuclear complex was obtained after oxidation, which was subsequently 
cleaved by CH3CN, resulting in the formation of the mononuclear complex trans-
(NMe4)[PdI2(C3SO3-bimy)(CH3CN)] (54). Complex 54 is a red solid, which is moderately 
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soluble in DMF, CH3CN, and DMSO, and slightly soluble in H2O. Its negative ion ESI mass 
spectrum shows a predominant signal at m/z 689 attributed to the [M  NMe4  CH3CN]

 
fragment (Figure 3.8). 
 
 
Figure 3.8. Isotopic pattern of the [M  NMe4  CH3CN]

 fragment of complex 54 in the 




H NMR spectrum of complex 54 recorded in CD3CN shows a similar pattern to that 
of the CH3CN adduct complex trans-[PdBr2(C3Br-bimy)(CH3CN)] (43). All the methylene 
signals do not show the diastereotopic patterns of 53, implying a pendant sulfonate moiety. A 
singlet at 3.10 ppm attributed to NMe4
+
 supports the successful incorporation of the ammonium 
cation. Moreover, a triplet was observed for the cation at 56.2 ppm in the 
13
C NMR spectrum due 
to the coupling with the NMR-active 
14
N nucleus. The carbene carbon atom resonates at 159.9 
ppm, which is shifted upfield in comparison to that of the dimeric thiolato complex 53. 
This new template-assisted methodology was expanded to make sulfonate NHC 
complexes with different linkers. Of particular interest is the synthesis of a complex with a 
xylenyl linker, which is not obtainable via the conventional route (vide supra). Since only the 
corresponding dimeric thiolato complex was targeted, the compound was prepared using the 
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traditional route in analogy to the literature procedure. Ligand precursor J was prepared from the 
reaction of KSAc with the bromo-o-xylenyl-substituted benzimidazolium salt I, which was in 
turn synthesized by reacting 1-benzylbenzimidazole with o-xylene dibromide. Subsequent 
reaction of J with Pd(OAc)2 smoothly gave rise to complex 55 in a yield of 76% (Scheme 3.9). 
 
 
Scheme 3.9. Synthesis of xylenyl-thiolato-bridged complex 55. 
 
 
Figure 3.9. Molecular structure of 55 showing 50% probability ellipsoids; solvent molecules and 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and bond angles [deg]: 
Pd1−C1 2.002(8), Pd1−Br1 2.4641(12), Pd1−S1A 2.363(2), Pd1−S1 2.300(2); C1−Pd1−Br1 
94.79(6), C1−Pd1−S1 92.2(2), Br1−Pd1−S1A 96.79(6), S1A−Pd1-S1 76.47(9), C1−Pd1−S1A 




Similar to 53, complex 55 shows poor solubility in DMSO and precipitated from the 
reaction mixture. It was isolated as a yellow powder after simple filtration and washing with H2O. 
The solid is slightly soluble in CHCl3, CH2Cl2, and DMF. The formation is corroborated by 
positive ESI-MS, where a predominant signal at m/z 979 is observed for the [M − Br]+ fragment. 
The aliphatic protons again become diastereotopic upon complex formation. Due to insufficient 
solubility, its 
13
C NMR spectrum could not be obtained. The identity of complex 55 was further 
confirmed by X-ray diffraction of a single crystal obtained via slow evaporation of a saturated 
CHCl3/toluene solution. As depicted in Figure 3.9, the solid state structure is similar to that of 
complex 53 with a butterfly shape. 
 
 
Scheme 3.10. Synthesis of xylenyl-sulfonate complex 56. 
 
Subsequent oxidation of complex 55 using the same condition established for 54, 
straightforwardly afforded complex 56 with a xylenyl-sulfonate function (Scheme 3.10). 
Similarly, a distinct base peak at m/z 659 was recorded in its negative ESI mass spectrum owning 
to the [M − NMe4 − CH3CN]
−
 fragment. In the 
1
H NMR spectrum, three singlets are found at 
6.41, 6.13, and 4.17 ppm due to the SCH2 protons and the two NCH2 protons. The NMe4 signal is 
Chapter 3 
68 
not much affected by the different complex anions, and remains at ∼3.1 ppm. In its 13C NMR 
spectrum, the chemical shift of the carbene carbon atom is found at 162.6 ppm, which is more 
downfield than that of propyl sulfonate complex 54 (159.9 ppm). 
 
 
Figure 3.10. Molecular structure of 56 showing 50% probability ellipsoids; hydrogen atoms are 
omitted for clarity. Selected bond lengths [Å] and bond angles [deg]: Pd1−C1 1.949(5), Pd1−Br1 
2.4280(10), Pd1−N3 2.077(5), Pd1−Br2 2.4409(10); C1−Pd1−Br1 88.23(15), C1−Pd1−Br2 
88.03(15), Br1−Pd1−N3 93.45(15), Br2−Pd1−N3 90.44(15), C1−Pd1−N3 177.28(2), 
Br1−Pd1−Br2 174.52(2); PdCNBr2/NHC dihedral angle 85.7(8)°. 
 
Single crystals of complex 56 were obtained by diffusion of diethyl ether to a CH3CN 
solution. Figure 3.10 shows the expected molecular structure. Notably, the phenyl ring of the 
linker is almost perpendicular to the carbene ring with a dihedral angle of 89°. 
 
3.2.2 Synthesis and Catalytic Activities of Bis(functionalized NHC)-Pd(II) Complexes 
First generation postfunctionalizations of the bis(NHC) parent complex 45 were 
conducted with various nucleophiles (Scheme 3.11). In general, the exposure of the complex to 
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nucleophiles can lead to two types of reactions, i.e. (i) nucleophilic substitution at C-Br, and (ii) 
ligand displacement at the Pd(II) center. Since PdNHC bonds are strong, displacements of the 
bromido ligands are more likely in the latter case.  
Scheme 3.11. First generation postmodifications of bis(NHC)-Pd(II) complex 45. 
 
The reactions with an excess (10 equiv) of KOAc, HNEt2 or NaN3 exclusively yielded 
complexes trans-[PdBr2(C3X-bimy)2] (X = OAc, (57), NEt2, (58), N3, (59)) in almost quantitative 
yields showing selectivity for the nucleophilic substitution at the bromopropyl tethers. On the 
other hand, complexes of the type trans-[PdX2(C3X-bimy)2] (X = I, (60), SPh, (61), SCN, (62)) 
were formed when excess KI, NaSPh and KSCN were used. This reactivity difference is ascribed 
to the soft nature of the palladium Lewis acid, which prefers binding of the softer iodide and 
sulphur containing ligands over bromido coordination. Reducing the amount of the nucleophiles 
to 2.2 equivalents with respect to parent complex 45 gave complicated mixtures of unreacted 45, 
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partially exchanged complexes and fully substituted complexes. Among the three complexes 60–
62, only trans-[Pd(SCN)2(C3SCN-bimy)2] was obtained by heating. The reaction at ambient 
temperature gave selectively complex [Pd(SCN)2(C3Br-bimy)2] (63), where only ligand 
displacement took place. 
 





complex X coligand δ (1H) δ (13Ccarbene) 
main signals 
in ESI MS 
45 Br Br 3.63, 3.25 182.57, 182.49 843 [M – Br]
+
 
46 OH  Br 3.64, 3.34 181.17, 181.10 719 [M – Br]
+
 
57 OAc Br 4.31, 3.99 182.58, 182.54 803 [M – Br]
+
 
58 NEt2 Br 2.69, 2.39 182.53, 182.49 909 [M]
+
 
59 N3 Br 3.60, 3.23 182.62, 182.58 769 [M – Br]
+
 
60 I I 3.38, 3.03 181.84, 181.75 985 [M – I]
+
 
61 SPh SPh 3.25, 3.02 191.07, 191.02 931 [M – SPh]
+
 
62 SCN SCN 3.19, 2.79 180.82, 180.73 








Measured in CDCl3. 
b 
Measured in d6-DMSO. 
c 
The carbene signals for the trans-anti and trans-syn 
rotamers are coincident. 
 
Complexes 57–63 share similar NMR spectra with their parent complex 45 and the 
alcohol-functionalized counterpart 46. Two sets of signals are generally observed for the trans-




Ccarbene NMR data. In 
accord with results obtained for the monocarbene series, an increase of the negative inductive (–I) 
effect in the order of SCN < SPh < I < N3 < Br < OH < OAc was concluded on grounds of a 
gradual downfield shift of the α-CH2 
1
H NMR signals. Complexes 45 and 57–59 have very 
similar 
13
Ccarbene resonances at ~182.5 ppm in CDCl3 due to a similar coordination sphere, which 
is not affected by different functionalities five bonds away. The bigger difference in complex 46 
(181.1 ppm) is a result of solvent effects arising from the d6-DMSO solvent used. On the other 
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hand, displacement of the bromido ligands from the Pd(II) center leads to significant changes of 
the 
13
Ccarbene resonances compared to those observed for 45 as evidenced by values ranging from 
180.7–191.0 ppm for complexes 60–63, respectively. Complexes 62 and 63 have very close 
13
Ccarbene signals as they solely differ in the terminal functionality of the propyl arm. 
 
Figure 3.11. Molecular structures of 57, 61, 62 and 63 showing 50% probability ellipsoids; for 
the sake of clarity, solvent molecules, hydrogen atoms, phenyl rings of the coligands in 61 or the 
N-benzyl substituents in 62 and 63 are omitted. Selected bond length [Å] and bond angles [°]: 57, 
Pd1–C1 2.020(3), Pd1–Br1 2.4359(3); C1–Pd1–Br1 92.49(8), C1–Pd1–Br1A 87.51(8); 
PdC2Br2/NHC dihedral angle 79.6°. 61, Pd1–C1 2.027(2), Pd1–S2 2.3541(6); C1–Pd1–S2 
87.15(7), C1–Pd1–S2A 92.85(7); PdC2S2/NHC dihedral angle 72.7°. 62, Pd1–C1 2.016(4), Pd1–
S1 2.3229(11); C1–Pd1–S1 87.27(11), C1–Pd1–S1A 92.73(11); PdC2S2/NHC dihedral angle 
89.3°. 63, Pd1–C1 2.024(4), Pd1–S1 2.3399(12); C1–Pd1–S1 92.46(13), C1–Pd1–S1A 87.54(13); 
PdC2S2/NHC dihedral angle 86.3°. 
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Formation of theses complexes is also supported by ESI-MS. Base peaks of [M – Br]+ 
fragments for complexes 57 and 59 or the molecular ion [M]
+
 for 58 are observed, while those for 
complexes 60 and 61 are assigned to [M – X]+ fragments. Complexes 62 and 63 show weak 
palladium-containing isotopic pattern for [M + H + CH3CN]
+
 or [M – SCN]+ fragments. 
Single crystals of complexes 57 and 61–63 were obtained by slow evaporation of their 
saturated solutions in CH2Cl2/CH3CN (57) or CH2Cl2 (61–63). Their molecular structures are 
depicted in Figure 3.11. All the five complexes crystallized as trans-anti rotamers with the 
palladium centers coordinated by two functionalized carbenes and two anionic coligands in 




Scheme 3.12. Second generation postmodifications of bis(NHC)-Pd(II) complex 60. 
 
Second generation postmodifications of trans-[PdI2(C3I-bimy)2] (60) were subsequently 
conducted. The softer iodido ligands in this complex are expected to form stronger Pd–I bonds in 
order to prevent the further ligand exchange reactions and therefore direct selectivity to 
substitutions at the iodo-propyl tether. Indeed complexes of the type trans-[PdI2(C3X-bimy)2] (X 
= N3, (64), SPh, (65), SAc, (66), SCN, (67)) were afforded in reactions with the respective 
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nucleophiles (Scheme 3.12). The low yield of complex 66 is attributed to hydrolysis of the 
thioester function by the wet solvent, but attempts to isolate defined hydrolysis products were to 
no avail. 
All four complexes showed base peaks for the respective [M – I]+ fragments in their ESI 
mass spectra indicating the successful reactions. Similar to all the other functionalized complexes, 
their formations are further discerned by their α-CH2 
1
H NMR resonances in accord with the 
inductive effects of the newly introduced function, which are listed in Table 3.3. As expected, the 
13
Ccarbene resonances at ~181.7 ppm show little variations. 
 
Table 3.3. α-CH2, Ccarbene NMR resonances and ESI mass signals of complexes 60, 64–67
a 
Complex X δ (1H) δ (13Ccarbene) 
Main signals 
in ESI Mass 
60 I 3.38, 3.03 181.84, 181.75 985 [M – I]
+
 
64 N3 3.59, 3.28 181.85, 181.82 815 [M – I]
+
 
65 SPh 3.12, 2.85 181.71, 181.66 951 [M – I]
+
 
66 SAc 3.12, 2.81 181.69, 181.61 881 [M – I]
+
 




Measured in CDCl3. 
 
The solid state structure of trans-[PdI2(C3SCN-bimy)2] (67) was obtained by an X-ray 
diffraction study on single crystals obtained by slow evaporation of a saturated solution in 
CHCl3/hexane. The structure depicted in Figure 3.12 confirms the successful and selective 
substitution of the iodopropyl arm. The Pd(II) center is coordinated by two iodido ligands and 





Figure 3.12. Molecular structure of 67 showing 50% probability ellipsoids; hydrogen atoms are 
omitted for clarity. Selected bond length [Å] and bond angles [°]: Pd1–C1 2.038(3), Pd1–I1 
2.6043(3); C1–Pd1–I1 88.00(8), C1–Pd1–I1A 92.00(8); PdC2I2/NHC dihedral angle 76.8°. 
 
Second generation postmodification was also conducted on the amino-functionalized-
NHC complex trans-[PdBr2(C3NEt2-bimy)2] (58) by ethylating the two tertiary amino functions 
to afford the ammonium-functionalized complex trans-[PdBr2(C3NEt3-bimy)2]Br2 (68) (Scheme 
3.13). After the reaction mixture was heated overnight, complex 68 was collected as the 
precipitate. Minor amounts of undesired mono-alkylated side product can be washed off with 
CH3CN. 
The solubility of complex 68 decreases going from MeOH to CH3CN and chlorinated 
solvents. It is insoluble in hexane, diethyl ether and water. Evidence of its formation can be found 
in its ESI spectrum, which shows a base peak at m/z 1047 attributed to the [M – Br]+ fragment 
and a weaker signal at m/z 483 for the [M – 2Br]2+ dication. Two sets of signals due to the trans-
anti and trans-syn rotamers are still observed in its NMR spectra, while the anti:syn rotameric 
ratio increases from to 1.9 for the parent 58 to 4.5 in complex 68. The increased preference for 
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the anti rotamer can be rationalized by the intramolecular electrostatic repulsion between the two 
positive charged ammonium groups only present in the syn-rotamer. 
 
 
Scheme 3.13. Synthesis of propyl ammonium complex 68. 
 
Mizoroki-Heck Catalysis study. The addition of excess tetraalkylammonium salts to 
stabilize palladium catalysts in C-C coupling reactions to enhance reaction rates is known as 
Jeffery conditions.
17,85,86,87
 Complex trans-[PdBr2(C3NEt3-bimy)2]Br2 (68) can be regarded as a 
potential Pd-catalyst that is already decorated with two tetraalkylammonium moieties and two 
bromide counter anions. Therefore, the catalytic activity of complex 68 was evaluated and 
compared to that of its analogues trans-[PdBr2(C3X-bimy)2] (X = Br, (45), OAc, (57), NEt2, (58)) 
to discern any influences brought about by different functionalities. We were particularly 
interested to see if the tetraalkylammonium bromide tether would lead to any notable increased 
catalytic activity.  
The double Mizoroki-Heck coupling of 1,4-dibromobenzene with t-butyl acrylate at 1 mol% 
catalyst loading was chosen as a standard test reaction. Under these conditions, complex 68 
indeed displayed the best activity in forming the 1,4-phenylene-dicinnamate in a yield of 82%. 
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However, the yield is not as good as that with a [PdCl(IMes)(N,N-dimethylbenzylamine)] 
complex, where only 0.5 mol% was required to afford 81% product formation.
88
 Among 45, 57 
and 58, the amino-functionalized complex performed better than the ester analogue followed by 
the parent bromo-complex (Table 3.4, entries 1–4), which is understandable since the amine 
moiety is easily protonated to form an ammonium tether in the course of the catalytic reaction. As 
expected, addition of 1.5 equiv of tetrabutylammonium bromide (TBAB) to the reaction with 45 
or 58 significantly improves the product yield from 56 and 76% to 92 and 93%, respectively, 
which is merely ~10% better than that of the reaction with pure 68 containing only catalytic 
amounts of a tethered ammonium salt. In comparison, additional TBAB improves the activity of 
68 further giving a near-quantitative yield of 98%. 
The reaction scope was extended to other polyhalogenated benzenes using complex 68 
without additional TBAB. Good and comparable yields of approximately 84% were obtained for 
the all three isomers of dicinnamates (entries 4–6). Increasing the number of the bromo-
substituents on the benzene ring to three and four allowed us to isolate the respective tri- and 
tetra-cinnamates (69) as major products (76% and 38%, entries 7 and 8). The yield of the tri-
cinnamate is higher than that previously obtained using a Pd(OAc)2/tri-o-tolylphophine catalytic 
system (62%).
89
 Partially olefinated substrates were observed as minor by-products as well. In 
comparison, reaction with 1,2-dichlorobenzene only gave the monocinnamate as a major product 
in a low yield of 10% (entry 9). The yield of monocinnamate was improved to 23% from reaction 
with 1,2,4,5-tetrachlorobenzene (entry 10). In these more challenging cases, the addition of 
TBAB could only led to a small improvement of the yields of the major product 
(monocinnamate). Besides the benzene halides, bromoheterocycles were coupled with tert-butyl 
acrylate with good yields of up to 92% (entries 11 and 12). 
Chapter 3 
77 
Table 3.4. Mizoroki-Heck coupling reactions.
a
 
entry cat. aryl halide product yieldb 





2 57 1,4-dibromobenzene  65% 
3 58 1,4-dibromobenzene  76%(93
c
) 
4 68 1,4-dibromobenzene  82%(98
c
) 
5 68 1,2-dibromobenzene 
  
84% 
6 68 1,3-dibromobenzene 
 
84% 
7 68 1,3,5-tribromobenzene 
 
76% 
8 68 1,2,4,5-tetrabromobenzene 
 
38% 










11 68 3-bromopyridine 
 
92% 




Reaction conditions: 1/n mmol of aryl halide (n = number of halide on aryl 
ring); 1.5 mmol of tert-butyl acrylate; 1.5 mmol of NaOAc; 3 mL of DMF; 0.01 
mmol of precatalyst; 130ºC, 20 h. 
b
Isolated yields for an average of two runs. 
c
With addition of 1.5 equiv of [N(n-C4H9)4]Br. 
 
A preliminary study was carried out to identify any active Pd(0) species derived from 
complex 68 by formate reduction. For this purpose, silver formate was added to 68, and instant 
AgBr precipitation was seen indicating the successful anion metathesis to yield complex trans-
[PdBr2(C3NEt3-bimy)2](HCO2)2 (70). The presence of the HCO2
– anion is corroborated by a 
downfield 1H singlet at 8.61 ppm and a 13C signal at 167.7 ppm. All other signals remain largely 
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unchanged upon metathesis. In addition, a base peak is observed at m/z 483 for the [M – 
2HCO2]
2+
 ion in the positive ESI mass spectrum. 
 
Scheme 3.14. Reduction of trans-[PdBr2(C3NEt3-bimy)2]Br2 (68) to [Pd(C3NEt3-bimy)2]X2 (71). 
 
Interestingly, the NMR sample of 70 showed a color change from grey to yellow on 
standing, and a small amount of Pd black was also observed. NMR analysis of this resulting 
yellow mixture showed enormous differences: (i) the 1H NMR spectrum shows only one set of 
signals; (ii) the integral ratio of for the formate 1H singlet at 8.61 ppm is reduced; (iii) the original 
two 13Ccarbene signals at 182.4 and 182.2 ppm for the rotamers of 70 have been replaced by a new 
and more downfield 13Ccarbene signal at 193.4 ppm. Both the color change and the spectroscopic 
differences suggest that Pd(0) species might be generated. In particular, the enhanced downfield 
shift of the carbene carbon is indicative of a more electron rich metal center in line with a 
reduction of Pd(II) to Pd(0).90  
Scheme 3.14 displays a possible pathway, which is supposedly initiated by a ligand 
exchange between inner and outer sphere involving bromido and formato ligands. The resulting 
ionization isomer of 70 subsequently undergoes decarboxylation generating an intermediate 
hydrido species, which reductively eliminates HBr to give the respective Pd(0) species 
[Pd
0
(C3NEt3-bimy)2]X2 (71, X = Br and HCO2).
91 The absence of rotamers for 71 as indicated by 
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the NMR analysis is consistent to observations made for other d10 metal complexes, i.e. Ag(I), 
Au(I), with linearly coordinated bis(NHC) ligands.
92
 Such bis(NHC)-Pd(0) complexes are only 
known with imidazoe-derived carbenes,
90
 which were prepared by either metal vapor 
condensation or ligand exchange. Hence, complex 71 is the first example of a 14 electron Pd(0) 
complex coordinated by two benzimidazolin-2-ylidene ligands, which is generated by reduction 
of Pd(II) with fomate salt. It is noteworthy that the mechanism study is only preliminary, further 
research has to be done to comfirm that complex 71 is the real catalyst. Since the catalytic 
condition is rather forcing, further ligand dissociation and hetergeneization to Pd(0) nanoparticles 
















4. Multi-metallic Complexes Bearing Dipropyl-pyridine-2,6-
dicarboxamide bridged diNHC Ligands 
Pyridine-2,6-dicarboxamide has been extensively explored as a pincer ligand towards a 
large library of transition metals such as Fe(III), Co(III), Ni(II), Cu(II), Cu(III), Ru (III), Pd(II), 
Pt(II), and Au(III).
93
 Remarkably, this dianionic ligand has the ability to decrease the redox 
potential of metal center in high oxidation state and thereby stabilizes the resulting complexes. 
The combination of pyridine-2,6-dicarboxamide with carbene ligands will result in multidentate 
ligands, which have both coordination sites to hard and soft Lewis acid metals centers. This may 
help in the complexes preparation, and probably, direct self-assembling. 
 
4.1 Synthesis and Characterization of Ligand Precursors 
The dipropyl-pyridine-2,6-dicarboxamide bridged dibenzimidazolium salts with benzyl 
(LBn) and methyl (LMe) N-substituents were prepared as summarized in Scheme 4.1. Pyridine 
2,6-dicarboxylic acid chloride was reacted with 3-chloropropylamine, which was generated from 
its hydrochloride salt by reacting with triethylamine, to afford the bis(3-chloropropyl)pyridine-
2,6-dicarboxamide (K) in a yield of 64%. Subsequent reaction with benzyl- or methyl-
benzimidazole gave only trace amounts of the dicationic salts. Addition of NaI promoted the 
double alkylations. However, prolonged heating for 48 h was required to achieve satisfactory 
yields (> 80%) of the desired salts LBn and LMe. The reaction was further optimized by using 
microwave irradiation, which shortened the reaction time extensively to 3 h, yet gave better 
yields of 98% and 89%, respectively. These two salts are well soluble in polar solvents such as 




Scheme 4.1. Synthesis of dipropyl-pyridine-2,6-dicarboxamide bridged dibenzimidazolium 
ligand precursors 
 
Anion metathesis with AgBF4 smoothly gave the dipropyl-pyridine-2,6-dicarboxamide 
bridged dibenzimidazolium salts MBn and MMe. Compared with their iodide analogues these two 
white solid salts generally show better solubilities in organic solvents including DCM, CH3CN, 
DMSO, and MeOH. In addition, the MMe salt is sparingly soluble in H2O. Formation of these 
four salts is supported by ESI-MS. For LBn/MBn, base peaks at m/z 790/750 assignable to [M – 
I/BF4]
+
 cations and weaker signals at m/z 332 attributed to [M – 2I/BF4]
2+
 dications are observed. 
The respective signals of salts LMe and MMe were found at m/z 638/598 and 256. Moreover, their 
1
H NMR spectra show a downfield singlet in the range of 9.14–9.99 ppm characteristic for the 
acidic NCHN protons. The CONH protons resonate as triplets in the more upfield region of 8.54–




, both the NCHN and CONH protons 
shift upfield, suggesting weaker hydrogen bonding strengths with BF4

. The propyl chains in all 
cases appear as one triplet (NCH2) and two multiplets (NHCH2CH2) in the region of 2.28–4.62 
ppm. The benzylic or the methyl protons on the other hand resonate as singlets at ~5.65 or ~4.00 
ppm, respectively. The 
13
C NMR resonances for the NCHN and CO carbon atoms are not much 
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affected by the different N-substituents or counter anions resonating at ~142.8 and ~164.9 ppm, 
respectively. 
 
Figure 4.1. Molecular structure and perspective view of MBn showing 50% probability ellipsoids; 
solvent molecules and most hydrogen atoms are omitted for clarity. Selected bond lengths [Å] 
and bond angles [deg]: N1-C1 1.328(3), N2-C1 1.326(3), N6-C28 1.321(3), N7-C28 1.331(3), 
O1-C18 1.227(3), O2-C24 1.231(3), N4-C19 1.339(3), N4-C23 1.338(3); N1-C1-N2 110.6(2), 
N6-C28-N7 110.9(2), N3-C18-C19 114.5(2), N5-C24-C23 115.61(19), N19-N4-C23 117.4(2).  
 
The identity of the MBn salt was further confirmed by X-ray diffraction of a single crystal 
obtained via slow evaporation of a saturated solution in CHCl3. Figure 4.1 depicting its molecular 
structure shows the expected connectivity. The amide protons (N3H and N5H), one of the 
NCHN protons (C28H) and several aliphatic protons cooperatively form hydrogen bonding 
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interactions with one BF4

 anion, embedding it inside a cationic cage-like structure (A). The 
molecular salts are arranged into an infinite chain via intermolecular hydrogen bonds between the 
BF4

 anions and the various CH protons (C). Besides, offset face to face  interactions are 
noted between the two perfectly coplanar pyridine rings from the neighboring molecules with a 




4.2 Synthesis and Characterization of Gold Complexes 
4.2.1 Synthesis and Characterization of Metallocyclic NHC-Silver(I), Gold(I) and Gold(III) 
Complexes 
The reactivity of the MBn or MMe salts towards Ag2O was attempted in CH3CN (Scheme 
4.2). The reaction mixture was heated to 60 ºC to afford the respective [Ag(diNHC)]BF4 
complexes [diNHC = dipropyl-pyridine-2,6-dicarboxamide bridged dibenzimidazolin-2-ylidene 
with N-benzyl (72Bn) or -methyl substituents (72Me)]. Complex 72Me is less soluble in CH3CN 
and precipitated out, whereas complex 72Bn has a better solubility and remained in solution. 
These two complexes are isolated as white solids exhibiting good stability when kept in the dark. 
However, their solutions in CH3CN or DMSO show signs of decomposition and turn yellow after 
several days.
95
 The occurrence of reaction is well evidenced by the disappearance of the 
characteristic downfield signal for the NCHN protons of the salt precursors in the 
1
H NMR 
spectra. In addition, signal broadening appears for all the aliphatic protons upon metallocycle 
formation, which is apparently attributed to a rigid structure arising from dicarbene ligand 
coordination. As with many Ag NHC complexes, the carbene signal could not be resolved despite 
prolonged acquisition time.
96





 fragments are found in their positive mode ESI mass spectra, supporting the 
formation of the desired complexes. 
Scheme 4.2. Synthesis of silver and gold complexes. 
 
The silver complexes 72Bn,Me were subsequently reacted with [AuCl(THT)] in CH2Cl2 in 
an attempt to synthesize the corresponding gold complexes.
15
 Instant formation of AgCl 
precipitate indicated the successful transmetalation. The reaction was stopped after 4 h, and a 
product mixture of mononuclear complexes [Au(diNHC)]BF4 (73) and dinuclear complexes 
[Au(diNHC)]2(BF4)2 (74) was observed in both cases. Complexes 73Bn and 74Bn were separated 
by column chromatography using CHCl3/CH3CN [7:2 (v/v)]. Unexpectedly, the dinuclear 
complex 74Bn eluted first followed by the mononuclear complex 73Bn with Rf values of 0.3 and 
0.15, respectively. Complex 73Me and 74Me, on the other hand, have very similar Rf values using 
varying solvent mixtures as mobile phase and could not be efficiently separated after column 
chromatography. Additional washing with CH3CN allows for the separation of the two 
complexes, whereby the mononuclear complex 73Me dissolves, while the dinuclear complex 74Me 
remains insoluble. The two dinuclear complexes were isolated in slightly higher yields of 39/50% 
(74Bn/Me) compared to the mononuclear complexes, for which yields of 36/35% (73Bn/Me) were 
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obtained. All four complexes are white solids. The digold complexes are air stable both in solid 
state and solutions. In contrast, the monogold complexes show limited stability as optically 





H NMR spectra of monogold 73Bn and digold 74Bn complexes in the range of 2.2 to 
10.0 ppm in CDCl3. 
 
In the NMR spectra of all four complexes, only one set of signals was observed indicating 
the dicarbene ligands are symmetrically bonded. The 
13
Ccarbene resonances are found at 
190.8191.9 ppm, which fall in the range typically observed for bis(NHC)-Au complexes.97 The 
1
H NMR spectra in the range of 2.210.0 ppm of complexes 73Bn and 74Bn are displayed in 
Figure 4.2. The CONH hydrogen signals of the digold complex 74Bn is significantly downfield 
shifted by 0.45 ppm compared to those in the monogold complex 73Bn, presumably due to 
stronger short contacts with the BF4

 anions (vide infra). The NCH2Ph and CH2 protons, on the 
other hand, are resonating at higher field in the dinuclear complex 74Bn. Generally, the 
mononuclear and dinuclear complexes have similarly patterned NMR spectra. The 
1
H NMR 
spectra of the complexes 73Me and 74Me are similar to their benzyl-substituted analogous and 
hence will not be discussed in detail. 
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The similarity of the NMR spectra and the identical weight percentage for carbon, 
hydrogen and nitrogen elements due to the same empirical formula of the respective mononuclear 
and dinuclear complex pairs make their differentiation using these methods difficult. 
Nevertheless, ESI MS spectrometry turns out to be a useful tool. Although respective complex 
pairs show their base peaks at same m/z values, 858 (73/74Bn) or 706 (73/74Me), respectively, the 
isotopic peak spacing of 0.5 observed for dinuclear complexes 74Bn/Me indicate doubly charged 
cations, which are assignable to their [M – 2BF4]
2+
 fragments (Figure 4.3). 
 
 
Figure 4.3. Isotopic pattern of the base peaks belonging to monogold 73Bn and digold 74Bn 
complexes in the respective positive ESI mass spectrum. 
 
Single crystals of complex 73Me and 74Bn were obtained by diffusion of diethyl ether to 
the respective saturated solutions in CH3CN. The solid state molecular structures determined by 
X-ray diffraction analysis are depicted in Figure 4.4 and 4.5, respectively. They confirm the 
expected nuclearity and compositions as found by ESI-MS. Surprisingly, the two almost coplanar 
NHC moieties (dihedral angle of 3.2) of the bidentate ligand in 73Me are found in an anti-
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arrangement, resulting in a twisted 18-membered metallocyle. Notably, this phenomenon was 
only observed in the solid state as solution NMR data show a symmetrical bonding mode of the 
ligand (vide supra). Hence, the unusually twisted geometry formed upon crystallization, is due to 
a better molecular packing in order to achieve a more dense structure. Additionally, offset face to 
face  interactions are noted between the two neighboring pyridine rings with a separation of 
3.285 Å. Weak hydrogen bonding interactions are observed between the two CONH hydrogen 
atoms with one fluorine atom of the BF4

 anion (omitted in Figure 4.4 for the sake of clarity). The 





Figure 4.4. Molecular structure of 73Me showing 50% probability ellipsoids; BF4
 
anion and 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and bond angles [deg]: Au1-C1 
2.029(4), Au1-C22 2.025(4), C1-Au1-C22 177.72(13). 
   
The cation in digold complex 74Bn has C2 symmetry with the rotational axis 
perpendicular to the average plane of the molecule and passing through the center. In comparison 
to what is observed for 73Me, the two NHC moieties (dihedral angle of 4.2) coordinated to the 
same Au center in complex 74Bn are retained in a syn-arrangement in the solid state in line with 
the symmetrical ligand bonding also observed by solution NMR spectroscopy. The two N-
substituents point towards opposite directions with respect to the NHC planes to relieve steric 
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hindrance. In addition, the AuCcarbene distances are 2.0420(1) and 2.0546(1) Å and longer than 
those in mononuclear complex 73Me. Numerous hydrogen bonding contacts are noted between 
the methylene and CONH hydrogen atoms with BF4

 anions. As an interesting result, one BF4

 
anion sits right in the center of the 36-membered-metallocycle. This phenomenon provides hints 
for a potential application of this cationic molecule for anion recognition, which is an area 





Figure 4.5. Molecular structure of 74Bn showing 50% probability ellipsoids; BF4
 
anion and 
hydrogen atoms are omitted for clarity unless referred in text. Selected bond lengths [Å] and 
bond angles [deg]: Au1-C1 2.042(9), Au1-C24 2.055(10), C1-Au1-C24A 178.6(5). 
 
Oxidation of the monogold(I) complexes 73Bn,Me with PhICl2
99
 yielded the respective 
monogold(III) complexes 75Bn and 75Me as pale yellow powders (Scheme 4.2). In comparison to 
the parent complexes, their solubilities in common organic solvents have significantly decreased. 
In addition, their 
1
H NMR spectra show even broader signals for the CONH and the propylene 
protons at room temperature, which did not sharpen at different temperatures (223373 K). The 
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carbene resonances shifted to much higher field at ~163 ppm in line with the more Lewis acidic 
gold centers.
24e,95,100
 The base peaks in ESI mass spectra at m/z 928 and 776, respectively, further 
corroborate the coordination of two additional chlorido ligands. Oxidation of the dinuclear 
complexes 74Bn and 74Me gave rise to insoluble compounds, which hamper the characterization 
and identification. 
 
4.2.2 Synthesis and Characterization of a Macrocyclic Bimetallic Trinuclear [Au(I), 
Co(III)] Double Helical Complex 
Complex 74Bn is a potential metallo-ligand with six donors capable of bis(pincer) 
coordination. After deprotonation, each N’,N,N’-pincer includes one neutral nitrogen and two 
anionic amide nitrogen donors, which together are suitable for a hexa-coordination to a metal 
center. Cobalt(III) is known to favor octahedral coordination and can be largely stabilized by 
such ligands.
93d,93h,101
 Hence, it was chosen to be studied.  
 
Scheme 4.3. Synthesis of mixed Au(I)/Co(III) complex 76. 
 
Complex 74Bn was reacted with CoCl26H2O in the presence of excess NaH under 
nitrogen gas (Scheme 4.3). A series of color changes from purple → pale blue → grey was 
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observed during the reaction. Exposure of the mixture to air afforded a finally brownish 
suspension. After simple filtration and washing with hexane, complex 76 was isolated as a 
brownish-yellow solid soluble in organic solvents such as CHCl3, CH2Cl2, CH3CN, DMSO, and 
MeOH, but insoluble in hexane, toluene and diethyl ether. Its formation was evidenced by a high-
resolution ESI mass spectrum, in which a base peak at 1771.4702 assignable to the [M  BF4]
+
 
(calcd: 1771.4675) with a peak spacing of one was found. The cation is balanced by one BF4

 
anion, which was also detected in the negative ESI mass spectrum. Magnetic susceptibility 
measurements of the resulting compound both in solid and solution states showed that complex 
76 is diamagnetic in nature, indicating that the ground state of the Co
3+
 center is low-spin (Figure 
4.6). 
 
Figure 4.6. Possible spin states of d
6
 metal complexes. 
 
1
H NMR analysis of the resulting compound at room temperature afforded only multiple 
broad signals in line with its complicated helical structure. The multiple signals are possible due 
to diastereotopy of the methylene protons upon Co
3+
 coordination. Variable-temperature NMR 
(243313 K) experiments were conducted; however, the resolution did not improve. In the 13C 
NMR spectrum, the 
13
CCO resonance at 169.5 ppm is shifted to lower-field by 4.6 ppm in 
comparison to that of the complex precursor, which is in line with decreased electron density of 
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the amide moieties upon coordination to a Lewis acid. In contrast, the 
13
CNCN signal is observed 
at 190.1 ppm, which is shifted to higher field, probably due to the shielding effect exerted by the 
electron cloud of the cobalt ion. 
The identity of complex 76 was unambiguously confirmed by X-ray diffraction analysis 
on single crystals obtained by slow evaporation of a saturated solution in CH2Cl2/toluene. As 
depicted in Figure 4.7, two metallo-bis(pincer) ligand strands interwined each other around the 
center Co
3+ 
ion with a meridional configuration. As a result, the macrocyclic molecule forms a 
racemic double-stranded helix with loss of the C2 symmetry found for its precursor 74Bn (only the 
P-form is shown in Figure 4.7). 
 
Figure 4.7. Molecular structure of P-76 showing 50% probability ellipsoids; BF4

 anion and 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and bond angles [deg]: Au1-C1 
2.013(6), Au1-C18 2.005(6), Au2-C35 2.013(8), Au2-C52 2.024(8), Co1-N9 1.862(5), Co1-N11 
1.985(5), Co1-N12 1.949(5), Co1-N10 1.860(5), Co1-N13 1.974(5), Co1-N14 1.949(5), C1-Au1-
C18 176.7 (3), C35-Au2-C52 173.6(3), N9-Co1-N10 176.5(2), N9-Co1-N11 81.6(2), N9-Co1-





A closer inspection of the structure shows that the C2 symmetry found for complex 74Bn 
is lost upon Co coordination. Around the Co center, the bond distances of the four equatorial 
CoN bonds [1.949(5)1.985(5) Å] are significantly longer than the two axial ones [1.860(5) and 
1.862(5) Å] with the differences beyond the 3 limit. Moreover, the four equatorial CoN bonds 
are tilted towards the respective pyridine rings with NCo1N angles measuring 163.1° and 
162.5°. For the two Au coordination spheres, the CAuC bond angles of 173.6° and 176.7° 
further deviate from perfect linearity. Strikingly, the two planes of the NHC coordinated to the 
Au2 center are almost perpendicular to each other. In contrast, those coordinated to Au1 are 
closer to co-planarity similar to those observed in complex 74Bn, but with an increased dihedral 
angle of 15.3°. 
 
4.3 Synthesis and Characterization of Palladium(II) complexes 
In an attempt to extend the coordination chemistry of the pentadentate diNHC ligand to 
group 10 metals, the Ag complexes 72Bn/Me were reacted with [PdCl2(CH3CN)2] in the presence 
of tetramethylammonium chloride to afford the respective Pd-diNHC complexes  (Scheme 4.4).  
 
Scheme 4.4. Synthesis of trans-[PdCl2(diNHC)] complexes 77Bn/Me. 
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Notably, only mononuclear complexes of the formula trans-[PdCl2(diNHC)]  (diNHC = 
dipropyl-pyridine-2,6-dicarboxamide bridged dibenzimidazolin-2-ylidene with N-benzyl (77Bn) 
or -methyl substituents (77Me)) were isolated as air-stable pale yellow solids. Generally, complex 
77Bn has better solubilities in polar organic solvents such as chlorinated solvents, CH3CN, and 
DMSO. Both of them are not soluble in less polar solvents including hexane, diethyl ether, and 
ethyl acetate. Formation of these complexes is supported by positive mode ESI-MS, which shows 







C NMR spectra of salt precursor MBn (CD3CN) and trans-[PdCl2(diNHC)] 




NMR spectra, only one set of signals were observed indicating a symmetrical 
bonding of the ligand in both cases. However, the CH2 protons become diastereotopic owing to 
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the restricted rotational freedom arising from palladation. For complex 77Bn, eight signals are 
observed for the four chemically distinct CH2 groups. The benzylic protons appear as two 
doublets at 6.44 and 5.19 ppm with geminal coupling constants of 
2
J(H,H) = 15.1 Hz, while the 
propylene protons are resonating as six multiplets centered at 5.77, 4.57 (NCH2), 3.73, 3.60 
(NHCH2) and 2.82, 2.49 (CH2CH2CH2) ppm. Its carbene and carbonyl carbon atoms are observed 
at 180.3 and 164.3 ppm, respectively (Figure 4.8). Complex 77Me has a similar splitting pattern 
for the propylene protons, while the NCH3 protons resonate as one singlet at 3.97 ppm. The 
chemical shifts of the carbene and carbonyl carbon atoms are found at 179.4 and 164.1 ppm, 
respectively. The signal for the CONH hydrogen atoms of both complexes remain as one triplet 
at 9.20 and 9.12 ppm, respectively. 
 
Figure 4.9. Molecular structures of 77Bn and 77Me showing 50% probability ellipsoids; most 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and bond angles [deg]: 77Bn, 
Pd1-C1 2.037(3), Pd1-Cl1 2.3009(9), Pd1-C28 2.044(3), Pd1-Cl2 2.3295(9), C1-Pd1-Cl1 
90.02(9), Cl1-Pd1-C28 91.04(9), C28-Pd1-Cl2 89.73(9), Cl2-Pd1-C1 89.31(9), C1-Pd1-C28 
173.38(13), Cl1-Pd1-Cl2 178.84(3); PdC2Cl2/NHC(left, right) dihedral angle: 69.9, 63.2°. 77Me, 
Pd1-C1 2.010(5), Pd1-Cl1 2.3069(13), Pd1-C22 2.059(5), Pd1-Cl2 2.3255(12), C1-Pd1-Cl1 
89.09(14), Cl1-Pd1-C22 88.13(14), C22-Pd1-Cl2 96.73(14), Cl2-Pd1-C1 86.27(14), C1-Pd1-C22 




Single crystals of complexes 77Bn/Me suitable for X-ray diffraction studies were obtained 
by either slow diffusion of diethyl ether into a solution in CH3CN (77Bn) or slow evaporation of a 
saturated solution in CHCl3 (77Me). Their molecular structures are depicted in Figure 4.9 with 
selected bond parameters. Both 77Bn and 77Me crystallize as mononuclear complexes, in which 
the palladium centers are coordinated by two chlorido ligands and the trans-spanning diNHC 
ligand in square planar modes. 18-membered metallocycles are formed as results. Similar to 
the gold(I) analogue, the metallocycle of complex 77Me is twisted due to the anti-arrangement 
of the two NHC moieties in the solid state. In contrast, the two NHC moieties in complex 
77Bn remain syn to each other due to the steric congestions induced by the benzyl substituent. 
As consequences, the two NHC planes in complex 77Bn are closer to coplanarity with a 
dihedral angle of 6.7º versus 14.5º in complex 77Me. The two PdCcarbene distances in complex 
77Bn are essentially equal [2.037(3) and 2.044(3) Å], while they are slightly different in complex 
77Me [2.059(5) and 2.010(5) Å]. Nevertheless, they all fall in the range of those typically 
observed for trans-[PdCl2(NHC)2] complexes.
102
 Additionally, the molecules of complex 77Bn 
are paired up by intermolecular hydrogen bonding between CONH hydrogen atoms and chlorido 
ligands. In contrast, short intramolecular contacts between the closer spaced chlorido ligand 
and CONH protons are noted in complex 77Me. 
The salt precursors showed different reactivities when triethylamine was added as a base 
(Scheme 4.5). Only the CONH groups were deprotonated, and subsequent addition of 




)]BF4 (78Bn/Me). These cationic 
complexes are not soluble in hexane, diethyl ether, and ethyl acetate, but readily soluble in the 
polar organic solvents including CHCl3, CH2Cl2, CH3CN and DMSO. Surprisingly, the methyl-
substituted complex 78Me is soluble in MeOH and H2O as well. In the positive mode ESI mass 
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spectra, base peaks due to the [M  BF4]
+
 fragments are observed at m/z 802 and 652, 
respectively, confirming the formation of these cationic complexes. 
 




)]BF4 complexes 7Bn/Me. 
 
NMR spectroscopic studies reveal significant downfield shifts of the 
13
C carbonyl carbon 
signals (MBn/Me: 164.9/164.8, 78Bn/Me: 171.7 ppm for both) and the absences of the CONH 
protons, which were found in the salt precursors. These observations indicate the successful 




 pincer moieties to the palladium centers (Figure 4.10). Not 














The identity of complex 78Me was also corroborated by X-ray diffraction analysis of a 
single crystal obtained via diffusion of diethyl ether to its solution in CH3CN. The molecular 
structure depicted in Figure 4.11 confirms the coordination of the N’,N,N’ pincer to the Pd(II) 
center with two azolium moieties dangling. One chlorido ligand coordinates to the fourth site 
resulting in a square planar geometry. Similar to the observations made for the cobalt complex 76, 
the two equatorial PdN bonds [2.042(2) and 2.036(2) Å] are significantly longer than the axial 
PdN bond [1.924(2) Å]. 
 
Figure 4.11. Molecular structure of 78Me showing 50% probability ellipsoids; hydrogen atoms, 
BF4 anion and solvent molecules are omitted for clarity. Selected bond lengths [Å] and bond 
angles [deg]: Pd1-Cl1 2.3211(7), Pd1-N3 2.042(2), Pd1-N4 1.924(2), Pd1-N5 2.036(2), N3-Pd1-
Cl1 100.68(7), Cl1-Pd1-N5 98.45(7), N5-Pd1-N4 80.56(9), N4-Pd1-N3 80.23(9), Cl1-Pd1-N4 
177.92(7), N3-Pd1-N5 160.69(9). 
 
Having successfully installed one Pd(II) to this potential pentadentate ligand either via 
carbene (77) or N’,N,N’ pincer coordination (78), attempts were made to introduce a second 
palladium metal by treating complexes 77Bn and 78Bn with Pd(OAc)2 in the presence of excess 
tetramethylammonium chloride as a source for additional anionic ligands (Scheme 4.6). 
Surprisingly, both reactions gave a tetranuclear-complex 79 as a common product instead of the 
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expected symmetrical dinuclear complex. Complex 79 has two types of Pd(II) centers. One of 




pincer and its fourth coordination site is taken up by one NHC 
arm, resulting in the formation of an additional seven-membered-metallocycle as the driving 
force. The second Pd(II), on the other hand, is coordinated by the remaining NHC together with 
one terminal and two bridging chlorido ligands, giving rise to a tetranuclear species. 
 
Scheme 4.6. Synthesis of tetranuclaer complex 79 and dipalladium pyridine adduct 80. 
 
Formation of the tetranuclear complex 79 was first proven by ESI-MS, which shows an 




H NMR spectrum shows the 
disappearance of all acidic CONH and NCHN protons characteristic for their salt precursors. 
Two carbonyl carbon signals are observed at 173.0 and 171.7 ppm in the 
13
C NMR spectrum with 
the two carbene carbon atoms resonating at 180.8 and 161.5 ppm. This suggests the coordination 




pincer and NHC in an asymmetric mode, which is further corroborated by the 
signal doubling of all the other proton and carbon atoms of the ligand (Figure 4.12). Two 
CONCH2 and three CH2CH2CH2 proton signals are not resolved or coincide with solvent signals. 
The 
13
Ccarbene signal at 161.5 ppm is assigned to the carbene donors of the bridging dipalladium 
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unit by comparison with analogues signals of reported dimeric [PdX2(NHC)]2 complexes.
103
 Such 
dimeric complexes are known to be readily cleaved by pyridines.
59c
 Hence, formation of the 
“dimeric” tetrapalladium complex 79 was indirectly corroborated via isolation of a dipalladium 
pyridine adduct 80 as a result from reaction of 79 with pyridine (Scheme 4.6). The dipalladium 
complex 80 shows slightly better solubilities in common organic solvents. Characterizations with 
ESI-MS and elemental analysis confirm its formation. In addition, NMR spectroscopy shows 
additional pyridine signals and a prominent downfield shift of the second carbene carbon from 






C NMR spectra of tetranuclar complex 79 (CD3CN). 
 
To study a possible pathway for the formation of the tetranuclear complex 79, complex 
precursor [PdCl(N’,N,N’)]BF4 (78Bn) was treated with 0.6 equiv Ag2O. The reaction proceeded 
smoothly at ambient temperature yielding complex 81, in which one carbene was generated and 
replaced the chlorido ligand on the Pd(II) center, while the other azolium moiety remained intact 
and dangling (Scheme 4.7). A remarkable shift of base peak from m/z 802 to 766 in the positive 
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mode ESI mass spectrum was observed due to the loss of chlorido ligand upon cyclization. The 
unsymmetrical bonding of the ligand leads to signal doubling in NMR spectra. Expectedly, the 
1
H NMR signals of the dangling benzimidazolium moiety resemble that of the precursor salt MBn. 
In contrast, the cyclized unit gives rise to diasterotopic hydrogen signals as what observed for the 
tetranuclear complex 79. 
 
Scheme 4.7. Synthesis of complex 81. 
 
Complex 81 was then reacted with Pd(OAc)2 and tetramethylammnoiun chloride. Indeed, 
the tetranuclear complex 79 was isolated again (Scheme 4.8). Hence, formation of the 
tetranuclear complex 79 from complex 78Bn is a two-step process involving a first carbene 
generation and pincer-Pd(II) coordination followed by a second carbene formation, Pd(II) 
coordination and subsequent dimerization. 
 
Scheme 4.8. Synthesis of tetranuclaer complexes 79 and hetero-bimetallic [Pd(II)/Au(I)] 
complex 82 from complex 81. 
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Table 4.1. Selected NMR data of salts MBn/Me, their Ag(I)-complexes 72Bn/Me, and Pd(II)-
complexes 7782. 
complex NC(H)N CON(H) NC(H)N CON(H) C2, C6 
MBn
a
 9.35 8.75 142.7 164.9 149.7 
MMe
a
 9.14 8.54 142.9 164.8 149.5 
72Bn
a





 - 9.02 -
d





9.20 180.3 164.3 149.8 
77Me
c
 - 9.12 179.4 164.1 149.3 
78Bn
c
 9.98 - 
- 






- 143.4 171.7 153.1 
79
a
 - - 180.8, 161.5 173.0, 171.7 152.8, 152.4 
80
a
 - - 180.9, 165.5 173.0, 171.6 152.7, 152.4 
81
c
 9.67 - 179.4, 142.5 173.3, 171.7 152.3, 151.9 
82
a
 - - 180.7, 179.0 172.9, 171.8 152.6, 152.5 
a 
Measured in CD3CN. 
b 
Measured in d6-DMSO. 
c 
Measured in CDCl3. 
d
The signals were not 
resolved despite of prolonged acquisition time. 
 
The remaining benzimidazolium salt moiety in complex 81 could also offer access to 
hetero-bimetallic complexes. It was hence reacted with 0.6 equiv Ag2O in the presence of 1 equiv 
tetramethylammonium chloride to afford the Ag NHC complex intermediate. Without isolation, 
the Ag NHC complex was directly used for the subsequent transmetalation to Au(I) by reacting 
with [AuCl(THT)] (Scheme 4.8).  
The yellow hetero-bimetallic (palladium, gold) complex 82 was yielded with good 
solubilities in CHCl3, CH2Cl2, CH3CN, and DMSO. ESI-MS shows a base peak at 998 for the [M 
+ H]
+
 fragemnt. In comparison to the NMR spectra recorded for the complex precursor 81, the 
1
H 
NMR spectrum of complex 82 shows the absence of the NCHN acidic proton signal. Moreover, 
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the second set of the propylene protons become diasterotopic upon coordination to the gold(I) 
center.  
 








C NMR spectrum of complex 82 in CD3CN shows two downfield signals at 
180.7 and 179.0 due to the two distinct carbene carbon atoms. The signal at 180.7 ppm can be 
readily assigned to the PdCcarbene as it is similar to that observed in the tetranuclear complex 79 
(180.8 ppm) or the pyridine cleaved complex 80 (180.9 ppm). The difference of 1.0 ppm 
compared to that of the precursor complex 81 (179.4 ppm, CDCl3) is likely due to the different 
solvent effect. The new 
13
Ccarbene signal at 179.0 ppm is in the range typically reported for 










which shows correlation peaks of the 180.7 ppm signal to the two diasterotopic benzylic protons 
of PdNHC. In contrast, the benzylic protons of the AuNHC remain as a singlet and a cross-
peak correlating to the 179.0 ppm is observed (Figure 4.13). 
 
 
Figure 4.14. Molecular structure of 82 showing 50% probability ellipsoids; solvent molecules, 
hydrogen atoms and the benzyl substituents on N1 and N7 are omitted for clarity Selected bond 
lengths [Å] and bond angles [deg]: Pd1-C1 1.984(3), Pd1-N3 2.015(3), Pd1-N4 1.957(3), Pd1-N5 
2.045(3), Au1-C28 1.975(3), Au1-Cl1 2.2679(3), C1-Pd1-N3 93.97(12), N3-Pd1-N4 80.80(11), 
N4-Pd1-N5 79.70(11), N5-Pd1-C1 105.55(12), N4-Pd1-C1 174.52(12), N3-Pd1-N5 160.46(11), 
C28-Au1-Cl1 179.05(10); PdCN3/NHC dihedral angle: 55.3°. 
 
Single crystals suitable for X-ray diffraction analysis were obtained for complex 82 via 
diffusion of diethyl ether into a concentrated solution in CH3CN. The determined structure 
confirms the expected connectivity (Figure 4.14). The palladium is coordinated by the N’,N,N’ 
pincer and one NHC in a square planar geometry. The dihedral angle between the PdCN4 
coordination plane and the NHC plane is 55.3. The gold, on the other hand, is coordinated by the 




This dissertation deals with synthesis, functionalization and application of transition metal 
(mainly palladium) complexes bearing benzannulated N-heterocyclic carbene ligands. The 









Chapter 2 described the synthesis of complexes with the formula [PdBr2(
i
Pr2-bimy)(L)] 





various monodentate ligands L. Based on the 
13
Ccarbene NMR resonances of the trans-[PdBr2(
i
Pr2-
bimy)(L)] complexes, the electron donating abilities of the ligands L including substituted 
pyridines, other nitrogen bases, phosphites, triphenylarsine, thioethers and pyridine N-oxide were 
ranked. The study was also extended to bidentate ligands via the synthesis and characterization of 
15 cationic complexes of the type [PdBr(
i
Pr2-bimy)(L2)]PF6 (2438) (L2 = aromatic 1,2-diimines, 
diazabutadienes or methylene-, ethylene- and propylene-bridged di-N-heterocyclic carbenes) 




Ccarbene NMR signals of 
the
 i
Pr2-bimy reporter ligand in the chelate complexes reflect the net electron donating abilities of 
the L2 ligands. 
Notably, this method is sufficiently sensitive to detect subtle changes within the same 
type of ligands. Based on the data, it can be concluded that substituents (up to five bonds away) 
do influence the electronic properties of ligands in general including pyridines, phosphites, 
thioethers, diazabutadienes and diNHCs (N-substituents or linkers). In addition, the ligands 
backbones of diimines (benzannulated or carbonyl groups), NHCs (unsaturated, benzannulated, 
or heteroatom) have a significant influence on their donor strengths. These findings, although in 
some cases contradicting previous results obtained from carbonyl-based systems, are reasonable 
and able to reflect the influence of inductive and mesomeric effects more correctly. 
Although most of the electron donating property was accurately determined, the difficulty 
in determining the donor strengths of very bulky ligands accurately represents one limitation of 
the 
13
C NMR based method to be studied in future. In addition, the current study of bidentate 
ligands was only restricted to the symmetrical and neutral ligands. The exploration of 
asymmetrical or anionic types using this method is challenging at this stage, yet an interesting 
area for future research. 
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Chapter 3 introduced a new postmodification method to prepare mono- and bis-
(functionalized-NHC) complexes (4752 and 5767), which was mainly realized via nucleophilic 
substitution reactions of the two parent complexes trans-[PdBr2(C3Br-bimy)(Py)] (44) and trans-
[PdBr2(C3Br-bimy)2] (45). Depending on the nature of the nucleophiles, competing co-ligand 
displacements also occurred in several cases. The resulting complexes could undergo further 
postmodifications. For example, third generation base-assisted hydrolysis of the mono-(thioester-
functionalized) NHC complex 52 gave rise to a propyl-thiolato-bridged dinuclear complex 53, 
which was subsequently oxidized by Oxone affording a sulfonate-functionalized NHC complex 
54. Moreover, second generation ethylation of the amino NHC complex 58 yielded a 
tetraalkylammonium-functionalized complex trans-[PdBr2(C3NEt3-bimy)2]Br2 (68), which 
showed a positive effect in catalyzing the Mizoroki-Heck coupling reactions compared to its 
parent complexes. 
 




Notably, the thioester or thiocyanate functionalized NHC complexes are not accessible 
via the traditional way due to the incompatibilities with coordination conditions. Moreover, the 
new synthetic approach to the sulfonate NHC complex proved necessary as it is feasible to 
synthesize analogous complex with a xylenyl linker, which is also not obtainable via 
prefunctionalization due to the unavailability of the corresponding sultone precursor. All these 
highlight the importance of the current postmodification protocol, which not only complements 
the traditional methodology, but also provides functionalized NHC compounds that are otherwise 
not accessible. 
Further research employing different types of postmodification reactions is needed to 
increase the modularity and diversity of this approach. For instance, copper catalyzed azide–
alkyne cycloaddition (Click) reactions of the azido–NHC complexes to form triazole NHC-
complexes, or their Staudinger reduction to form NHC complexes bearing a primary amino group 
can be considered. Moreover, the SCN-functionalized NHC complexes could be hydrolyzed to a 
thiocarbamate in the Riemschneider thiocarbamate synthesis. It is also feasible that such a 
strategy could be useful in the anchoring of NHC based complexes on various solid supports for 
immobilization and use in heterogeneous catalysis. In addition, extension of this approach to 
other heterocycles and haloalkyl/aryl spacers as well as to other metal centers is conceivable to 
extend its generality and applicability. 
Chapter 4 presented the application of benzimidazolin-2-ylidenes functionalized with a 
dipropyl-pyridine-2,6-dicarboxamide bridge, as building blocks in metallosupramolecular 
chemistry. The silver dicarbene complexes 72Bn/Me were obtained by reacting the 
dibenzimidazolium salts MBn/Me with Ag2O. Transmetalation to gold(I) afforded two 
metallocyclic monogold and digold complexes with same empirical formula. The di-Au(I) 
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complex could be further deprotonated at the amide groups and in the presence of CoCl26H2O, 
affording a bimetallic gold-cobalt trinuclear complex 76 with a double-stranded helicate 
architecture.  
 




The silver intermediates 72Bn/Me could also react with palladium, giving only the mono-
Pd(II) complexes 77Bn/Me. Deprotonation of complex 77Bn with Pd(OAc)2 afforded an unexpected 





)]BF4 complex 78Bn, which in turn was prepared by palladation of the 
dipropylpyridine-2,6-dicarboxamide bridged dibenzimidazolium salts MBn in the presence of 
NEt3 base. Formation of 79 from 78Bn proved to be a two-step process as evidenced by the 
isolation of the intermediate complex 81, which could also serve as a complex precursor to the 
hetero-bimetallic palladium-gold complex 82. 
The coordination chemistry of the dipropyl-pyridine-2,6-dicarboxamide bridged 
dibenzimidazolin-2-ylidene ligand described here is preliminary. Future investigation may be 
extended to other metals such as Fe, Ru, Ir, Cu and Ni. The versatile coordination geometries of 
different metal centers may lead to more diverse architectures. In addition, applications of the 
resulting complexes will be worth exploring. For instance, the phenomenon that one BF4

 anion 
sits right in the center of the 36-membered-metallocycle in the solid state structure of complex 
74Bn provided hints for a potential future exploration of such molecules for anion recognition. In 
addition, the multimetallic complexes may show cooperative effects in catalysis, or the hetero-




6. Experimental Section 
General considerations 
Unless otherwise noted all operations were performed without taking precautions to 
exclude air and moisture. All solvents and chemicals were used as received without any further 








P NMR spectra were recorded on a Bruker 
ACF 300 spectrometer or a Bruker AMX 500 spectrometer. The chemical shift () were 





externally to CF3CO2H (
19
F) and 85% H3PO4 (
31
P). ESI mass spectra were measured using a 
Finnigan LCQ spectrometer. Elemental analyses were performed on an Elementar Vario Micro 
Cube elemental analyzer at the Department of Chemistry, National University of Singapore. 
Complex [PdBr2(
i
Pr2-bimy)]2 (I) was prepared according to literature.
58
 [PdBr2(CH3CN)2] 
was prepared by stirring PdBr2 in CH3CN at 50°C for 3 h. Fresh NaSPh was prepared via reaction 




Pr2-bimy)(R-Py)] (111). The suitable pyridine 
(0.10 mmol) was added to the solution of complex I (47 mg, 0.05 
mmol) in CH2Cl2 (15 mL) and stirred for 2 h. The volatile was 
removed under reduced pressure and the residue washed with small amount of diethyl ether to 
give the product as yellow solids. 
R = 3-F, (1). Yield: 55 mg, 0.10 mmol, 97%. 
1
H NMR (500 MHz, CDCl3): δ 9.12 (t, 1 H, 
Py–H), 9.02 (d, 1 H, Py–H), 7.58 (dd, 2 H, Ar–H), 7.55–7.52 (m, 1 H, Py–H), 7.39–7.35 (m, 1 H, 
Py–H), 7.22 (dd, 2 H, Ar–H), 6.30 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 1.79 (d, 3J(H,H) = 7.0 Hz, 
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H} NMR (125.77 MHz, CDCl3): 159.8 (d, 
1
J(C,F) = 253.9 Hz, Py–C), 158.6 
(Ccarbene), 149.6 (d, 
3
J(C,F) = 4.6 Hz, Py–C), 142.5 (d, 2J(C,F) = 30.2 Hz, Py–C), 134.1 (Ar–C), 
125.8 (d, 
2





(282.38 MHz, CDCl3): –46.3 (F). Anal. Calcd for C18H22Br2FN3Pd: C, 38.22; H, 3.92; N, 7.43. 
Found: C, 38.36; H, 3.67; N, 7.38. MS (ESI): m/z 469 [M – Py + H]+.  
R = 3-Cl, (2). Yield: 58 mg, 0.10 mmol, >99%. 
1
H NMR (500 MHz, CDCl3): δ 9.18 (d, 1 
H, Py–H), 9.07 (d, 1 H, Py–H), 7.77–7.76 (m, 1 H, Py–H), 7.59 (dd, 2 H, Ar–H), 7.33–7.30 (m, 1 
H, Py–H), 7.22 (dd, 2 H, Ar–H), 6.30 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 1.79 (d, 3J(H,H) = 7.0 




H} NMR (125.77 MHz, CDCl3): δ 158.7 (Ccarbene), 152.4, 151.4, 138.6, 
134.1, 133.3, 125.5, 123.0, 113.3 (Ar–C), 55.3 (NCH), 21.2 (CH3). Anal. Calcd for 
C18H22Br2ClN3Pd: C, 37.14; H, 3.81; N, 7.22. Found: C, 37.31; H, 3.80; N, 7.22. MS (ESI): m/z 
469 [M – Py + H]+. 
R = 3-Br, (3). Yield: 60 mg, 0.1 mmol, 96%. 
1
H NMR (500 MHz, CDCl3): δ 9.26 (d, 1 H, 
Py–H), 9.11 (m, 1 H, Py–H), 7.93–7.91 (m, 1 H, Py–H), 7.59 (dd, 2 H, Ar–H), 7.28–7.25 (m, 1 H, 
Py–H), 7.22 (dd, 2 H, Ar–H), 6.29 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 1.79 (d, 3J(H,H) = 7.0 Hz, 




H} NMR (125.77 MHz, CDCl3): 158.6 (Ccarbene), 154.4, 151.7, 141.5, 134.1, 
125.9, 123.0, 121.3, 113.3 (Ar–C), 55.3 (NCH), 21.2 (CH3). Anal. Calcd for C18H22Br3N3Pd: C, 
34.51; H, 3.54; N, 6.71. Found: C, 34.75; H, 3.35; N, 6.75. MS (ESI): m/z 469 [M – Py + H]+. 
R = 3-I, (4). Yield: 45 mg, 0.07 mmol, 67%. 
1
H NMR (500 MHz, CDCl3): δ 9.36 (s, 1 H, 
Py–H), 9.12 (d, 1 H, Py–H), 8.09 (d, 1 H, Py–H), 7.59 (dd, 2 H, Ar–H), 7.22 (dd, 2 H, Ar–H), 





H} NMR (125.77 MHz, CDCl3): 159.0 (Ar–C), 158.7 (Ccarbene), 152.0, 147.0, 
134.1, 126.3, 123.0, 113.3, 92.9 (Ar–C), 55.3 (NCH), 21.2 (CH3). Anal. Calcd for 
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C18H22Br2IN3Pd: C, 32.10; H, 3.29; N, 6.24. Found: C, 32.23; H, 3.21; N, 6.27. MS (ESI): m/z 
469 [M – Py + H]+. 
R = 3-OH, (5). Yield: 58 mg, 0.10 mmol, >99%. 
1
H NMR (500 MHz, CDCl3): δ 8.63 (d, 
1 H, Py–H), 8.54 (d, 1 H, Py–H), 7.59 (dd, 2 H, Ar–H), 7.23 (dd, 2 H, Ar–H), 7.18–7.15 (m, 1 H, 
Py–H), 7.09–7.06 (m, 1 H, Py–H), 6.32 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 1.80 (d, 3J(H,H) = 7.0 




H} NMR (125.77 MHz, CDCl3): δ 159.6 (Ccarbene), 153.6, 145.1, 141.9, 
134.2, 125.27, 125.25, 123.0, 113.3 (Ar–C), 55.3 (NCH), 21.3 (CH3). Anal. Calcd for 
C18H23Br2N3OPd: C, 38.36; H, 4.11; N, 7.46. Found: C, 38.52; H, 3.90; N, 7.37. MS (ESI): m/z 
525 [M – Br + CH3CN]
+
. 
R = 3-Ph, (6). Yield: 62 mg, 0.10 mmol, 99%. 
1
H NMR (500 MHz, CDCl3): δ 9.39 (d, 1 
H, Py–H), 9.12 (dd, 1 H, Py–H), 7.95 (d, 1 H, Py–H), 7.62–7.59 (m, 4 H, Ar–H & Py–H), 7.49 (t, 
2 H, Ar–H), 7.44–7.41 (m, 2 H, Ar–H), 7.21 (dd, 2 H, Ar–H), 6.37 (m, 3J(H,H) = 7.0 Hz, 2 H, 
NCH), 1.81 (d, 
3




H} NMR (125.77 MHz, CDCl3): δ 159.8 
(Ccarbene), 152.0, 151.7, 138.4, 137.1, 136.8, 134.1, 129.8, 129.3, 127.9, 124.9, 122.9, 113.2 (Ar–
C), 55.2 (NCH), 21.2 (CH3). Anal. Calcd for C24H27Br2N3Pd: C, 46.22; H, 4.36; N, 6.74. Found: 
C, 45.99; H, 4.02; N, 6.60. MS (ESI): m/z 697 [M + CH3CN + MeOH + H]
+
. 
R = 4-Cl, (7). Yield: 47 mg, 0.08 mmol, 80%. 
1
H NMR (500 MHz, CDCl3): δ 9.08 (d, 2 
H, Py–H), 7.58 (dd, 2 H, Ar–H), 7.36 (d, 2 H, Py–H), 7.21 (dd, 2 H, Ar–H), 6.29 (m, 3J(H,H) = 
7.0 Hz, 2 H, NCH), 1.78 (d, 
3




H} NMR (125.77 MHz, CDCl3): 
δ 158.98 (Ccarbene), 154.1, 147.2, 134.1, 125.6, 122.9, 113.2 (Ar–C), 55.2 (NCH), 21.2 (CH3). 
Anal. Calcd for C18H22Br2ClN3Pd: C, 37.14; H, 3.81; N, 7.22. Found: C, 37.21; H, 3.72; N, 7.14. 
MS (ESI): m/z 469 [M – Py + H]+. 
Chapter 6 
113 
R = 4-Br, (8). Yield: 56 mg, 0.09 mmol, 89%. 
1
H NMR (500 MHz, CDCl3): δ 8.94 (d, 2 
H, Py–H), 7.58 (dd, 2 H, Ar–H), 7.53 (d, 2 H, Py–H), 7.21 (dd, 2 H, Ar–H), 6.29 (m, 3J(H,H) = 
7.0 Hz, 2 H, NCH), 1.78 (d, 
3




H} NMR (125.77 MHz, CDCl3): 
δ 159.03 (Ccarbene), 153.9, 136.1, 134.1, 128.7, 123.0, 113.3 (Ar–C), 55.2 (NCH), 21.2 (CH3). 
Anal. Calcd for C18H22Br3N3Pd: C, 34.51; H, 3.54; N, 6.71. Found: C, 34.52; H, 3.59; N, 6.27 




C NMR spectra are attached in the appendix. MS (ESI): m/z 
469 [M – Py + H]+. 
R = 4-I, (9). Yield: 47 mg, 0.07 mmol, 70%. 
1
H NMR (500 MHz, CDCl3): δ 8.79 (d, 2 H, 
Py–H), 7.73 (d, 2 H, Py–H), 7.58 (dd, 2 H, Ar–H), 7.21 (dd, 2 H, Ar–H), 6.28 (m, 3J(H,H) = 7.0 
Hz, 2 H, NCH), 1.78 (d, 
3




H} NMR (125.77 MHz, CDCl3): δ 
159.2 (Ccarbene), 153.3, 134.7, 134.1, 123.0, 113.3, 109.0 (Ar–C), 55.2 (NCH), 21.2 (CH3). Anal. 
Calcd for C18H22Br2IN3Pd: C, 32.10; H, 3.29; N, 6.24. Found: C, 32.48; H, 3.25; N, 6.14. MS 
(ESI): m/z 469 [M – Py + H]+. 
R = 4-OH, (10). Yield: 58 mg, 0.10 mmol, >99%. 
1
H NMR (500 MHz, CDCl3): δ 8.59 (d, 
2 H, Py–H), 7.59 (dd, 2 H, Ar–H), 7.21 (dd, 2 H, Ar–H), 6.67 (d, 2 H, Py–H), 6.32 (m, 3J(H,H) = 
7.0 Hz, 2 H, NCH), 1.79 (d, 
3




H} NMR (125.77 MHz, CDCl3): 
δ 165.1 (Ar–C), 160.2 (Ccarbene), 153.8, 134.2, 123.0, 113.3, 113.1 (Ar–C), 55.2 (NCH), 21.3 
(CH3). Anal. Calcd for C18H23Br2N3OPd: C, 38.36; H, 4.11; N, 7.46. Found: C, 38.56; H, 3.76; N, 
7.59. MS (ESI): m/z 525 [M – Br + CH3CN]
+
. 
R = 4-Ph, (11). Yield: 54 mg, 0.09 mmol, 87%. 
1
H NMR (500 MHz, CDCl3): δ 9.16 (d, 2 
H, Py–H), 7.63–7.60 (m, 4 H, Ar–H), 7.56–7.55 (d, 2 H, Py–H), 7.49–7.48 (m, 3 H, Ar–H), 7.22 




H} NMR (125.77 MHz, CDCl3): δ 160.2 (Ccarbene), 153.4, 150.8, 137.3, 134.1, 130.5, 129.9, 
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127.7, 122.9, 122.8, 113.2 (Ar–C), 55.2 (NCH), 21.2 (CH3). Anal. Calcd for C24H27Br2N3Pd: C, 







Pr2-bimy)(TEA)] (12). 2.5 equiv of triethylamine (TEA) 
(35 µL, 0.25 mmol) was added to the suspension of I (47 mg, 0.05 
mmol) in CH2Cl2 (20 mL) and stirred overnight. The volatiles were 
removed in vacuo, affording the product as a yellow powder (57 mg, 
0.10 mmol, >99%). 
1
H NMR (300 MHz, CDCl3): δ 7.52 (dd, 2 H, Ar–H), 7.15 (dd, 2 H, Ar–H), 
6.22 (m, 
3
J(H,H) = 7.1 Hz, 2 H, NCH), 3.03 (m, 
3
J(H,H) = 7.1 Hz, 6 H, NCH2), 1.74 (d, 
3
J(H,H) 
= 7.1 Hz, 12 H, CH3), 1.34 (t, 
3




H} NMR (75.48 MHz, 
CDCl3): 158.0 (Ccarbene), 134.0, 122.6, 113.0 (Ar–C), 54.7 (NCH), 48.9 (NCH2), 20.9 (CH3), 10.8 
(NCH2CH3). Anal. Calcd for C19H33Br2N3Pd: C, 40.06; H, 5.84; N, 7.38. Found: C, 38.71; H, 




C NMR spectra are attached in the appendix. 




Pr2-bimy)(TBD)] (13). Compound 1,5,7-
Triazabicyclo[4.4.0]dec-5-ene (TBD) (14 mg, 0.10 mmol) was added 
to the suspension of dimer I (47 mg, 0.05 mmol) in CH2Cl2 (20 mL) 
and stirred for 1 h. Solvent was removed under reduced pressure. The 
residue was washed with hexane (3  10 mL) and dried in vacuo, affording the product as a 
yellow powder (61 mg, 0.10 mmol, >99%). 
1
H NMR (300 MHz, CDCl3): δ 7.50 (dd, 2 H, Ar–H), 
7.13 (dd, 2 H, Ar–H), 6.27 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH), 3.49 (t, 3J(H,H) = 5.6 Hz, 2 H, 
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TBD–CH2), 3.26 (t, 
3
J(H,H) = 5.8 Hz, 2 H, TBD–CH2), 3.10–3.05 (m, 4 H, TBD–CH2), 1.90 (m, 
4 H, TBD–CH2), 1.74 (d, 
3




H} NMR (75.48 MHz, CDCl3): 
165.8 (Ccarbene), 152.4 (C=N), 134.0, 122.5, 113.0 (Ar–C), 54.8 (NCH), 48.4, 48.0, 46.8, 40.1, 
23.9, 22.8 (TBD–C), 21.4 (CH3). Anal. Calcd for C20H31Br2N5Pd: C, 39.53; H, 5.14; N, 11.52. 




Pr2-bimy)(DBU)] (14). Complex 14 was prepared in 
analogy to complex 13 from 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU) (15 µL, 0.10 mmol) and dimer I (47 mg, 0.05 mmol). Yield: 
62 mg, 0.10 mmol, >99%. 
1
H NMR (500 MHz, CDCl3): δ 7.52 (dd, 
2 H, Ar–H), 7.16 (dd, 2 H, Ar–H), 6.31 (br–s, 2 H, NCH), 3.56 (t, 3J(H,H) = 5.5 Hz, 2 H, DBU–
CH2), 3.40–3.38 (m, 2 H, DBU–CH2), 3.27–3.26 (m, 2 H, DBU–CH2), 3.23 (t, 
3
J(H,H) = 6.0 Hz, 
2 H, DBU–CH2), 1.98 (m, 2 H, DBU–CH2), 1.89 (m, 2 H, DBU–CH2), 1.77 (d, 
3
J(H,H) = 7.0 Hz, 




H} NMR (125.77 MHz, 
CDCl3): 166.3 (Ccarbene), 163.9 (C=N), 134.1, 122.6, 113.0 (Ar–C), 54.9 (NCH), 54.1, 48.5, 47.6, 
38.7, 30.0, 28.6, 25.0, 23.1 (DBU–C), 21.4 (CH3). Anal. Calcd for C22H34Br2N4Pd: C, 42.57; H, 






Pr2-bimy){P(OMe)3}] (cis-15). Complex I (24 mg, 0.03 
mmol) and trimethylphosphite (6 µL, 0.05 mmol) were dissolved in 
CDCl3 (0.6 mL) for direct NMR analysis. 
1
H NMR (300 MHz, CDCl3): 
δ 7.61 (dd, 2 H, Ar–H), 7.28 (dd, 2 H, Ar–H), 5.79 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 3.83 (d, 
3
J(P,H) = 13 Hz, 6 H, OCH3), 3.77 (d, 
3
J(P,H) = 13 Hz, 3 H, OCH3), 1.74 (d, 
3
J(H,H) = 7.0 Hz, 6 
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H, NCH(CH3)2), 1.66 (d, 
3




H} NMR (75.48 MHz, 
CDCl3): 170.8 (d, 
2
J(C,P) = 21.4 Hz, Ccarbene), 133.8, 123.5, 113.7 (Ar–C), 55.2 (br–s, NCH), 
55.0 (d, 
2
J(P,C) = 5.5 Hz, OCH3), 73.4 (d, 
2




H} NMR (121.49 MHz, CDCl3): 101.0 (P). Anal. Calcd for C16H27Br2N2O3PPd: C, 32.43; H, 









complex I (9.4 mg, 0.01 mmol) and triisopropylphosphite (5 µL, 
0.02 mmol) were dissolved in CDCl3 (0.6 mL) for direct NMR 
spectroscopic analysis. 
1
H NMR (300 MHz, CDCl3): δ 7.56 (dd, 2 H, ArH), 7.21 (dd, 2 H, 
ArH), 5.91 (m, 3J(C,H) = 4.3 Hz, 3J(H,H) = 7.1 Hz, 2 H, NCH), 5.15 (m, 3J(P,H) = 8.6 Hz, 
3
J(H,H) = 6.1 Hz, 3 H, OCH), 1.77 (d, 
3
J(H,H) = 7.1 Hz, 12 H, NCH(CH3)2), 1.42 (d, 
3
J(H,H) = 




H} NMR (75.48 MHz, CDCl3): 175.3 (d, 
2





H} NMR (121 MHz, CDCl3): 113.4 (d, 
2






Pr)3}] (cis-16). Complex I (47 mg, 0.05 
mmol) and triisopropylphosphite (25 µL, 0.10 mmol) were dissolved in 
CH2Cl2 (10 mL) and stirred for 0.5 h. The solvent was removed under 
reduced pressure and the residue was washed with diethyl ether to give the off-white product (57 
mg, 0.08 mmol, 84%). 
1
H NMR (500 MHz, CDCl3): δ 7.58 (dd, 2 H, ArH), 7.23 (dd, 2 H, 
ArH), 5.82 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 5.15 (brm, 3 H, OCH), 1.71 (d, 3J(H,H) = 7.0 Hz, 
6 H, NCH(CH3)2), 1.69 (d, 
3
J(H,H) = 7.0 Hz, 6 H, NCH(CH3)2), 1.19 (d, 
3





H} NMR (125.77 MHz, CDCl3): 172.0 (d, 
2
J(C,P) = 22.9 Hz, Ccarbene), 133.8, 
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123.3, 113.4 (Ar–C), 73.4 (d, 2J(P,C) = 4.6 Hz, OCH), 55.1 (d, 4J(P,C) = 1.8 Hz, NCH), 24.5 (d, 
3




H} NMR (202.45 MHz, CDCl3): 
90.4 (P). Anal. Calcd for C22H39Br2N2O3PPd: C, 39.04; H, 5.81; N, 4.14. Found: C, 39.06; H, 




Pr2-bimy){P(OPh)3}] (trans-17). Complex I (24 
mg, 0.03 mmol) and triphenylphosphite (13 µL, 0.05 mmol) 
were dissolved in CDCl3 (0.6 mL) for direct NMR analysis. 
1
H 
NMR (300 MHz, CDCl3): δ 7.507.30 (m, 11 H, ArH), 





H} NMR (75.48 MHz, CDCl3): 171.7 (d, 
2
J(C,P) = 289.8 Hz, Ccarbene), 151.8 (d, 
2
J(C,P) = 5.5 Hz, ArC), 134.0 (d, 4J(C,P) = 9.3 Hz, ArC), 130.2, 125.7, 123.0 (ArC), 122.2 (d, 
3




H} NMR (202.45 MHz, 




Pr2-bimy){P(OPh)3}] (cis-17). Complex I (47 mg, 0.05 
mmol) and triphenylphosphite (26 µL, 0.10 mmol) were suspended in 
MeOH (10 mL) and stirred overnight. The off-white solid product was 
isolated by filtration and further dried in vacuo. Yield: 72 mg, 0.09 mmol, 93%. 
1
H NMR (500 
MHz, CDCl3): δ 7.55 (d, 2 H, ArH), 7.347.29 (m, 11 H, ArH), 7.277.22 (m, 6 H, ArH), 
5.32 (m, 
3
J(H,H) = 7.0 Hz, 2 H, NCH), 1.57 (d, 
3
J(H,H) = 7.0 Hz, 6 H, CH3), 1.14 (d, 
3
J(H,H) = 




H} NMR (125.77 MHz, CDCl3): 169.3 (d, 
2
J(C,P) = 22.9 Hz, Ccarbene), 
151.1 (d, 
2
J(C,P) = 8.3 Hz, ArC), 133.9, 130.8, 126.7, 123.6 (ArC), 122.0 (d, 3J(C,P) = 4.6 Hz, 
Chapter 6 
118 




H} NMR (202.45 MHz, CDCl3): 86.3 
(P). Anal. Calcd for C31H33Br2N2O3PPd: C, 47.81; H, 4.27; N, 3.60. Found: C, 48.13; H, 4.46; N, 








Bu-Ph)3}] (18). This 
complex was synthesized by reacting complex I (47 mg, 
0.05 mmol) and tris(2,4-di-tert-butyltriphenyl)phosphite 
(65 mg, 0.10 mmol) for 30 min in CH2Cl2 before dried in 
vacuum. Yield: 120 mg, 0.01 mmol, >99%. 
1
H NMR (500 
MHz, CDCl3): δ 8.09 (dd, 3 H, ArH), 7.53 (dd, 2 H, ArH), 7.44 (d, 3 H, ArH), 7.227.20 (m, 
5 H, ArH), 5.66 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 1.62 (s, 27 H, C(CH3)3), 1.59 (d, 
3
J(H,H) = 




H} NMR (125.77 MHz, CDCl3): 171.5 (d, 
2
J(C,P) = 289.6 Hz, Ccarbene), 149.3 (d, 
2
J(C,P) = 3.7 Hz, ArC), 146.8 (ArC), 139.5 (d, 3J(C,P) 
= 5.5 Hz, ArC), 134.1 (d, 4J(C,P) = 9.2 Hz, ArC), 125.5, 123.4, 122.9 (ArC), 120.1 (d, 3J(C,P) 





H} NMR (202.45 MHz, CDCl3): 103.6 (P). Anal. Calcd for C55H81Br2N2O3PPd: C, 







Pr2-bimy)(AsPh3)] (trans-19). Complex I (24 mg, 
0.03 mmol) and triphenylarsine (15 mg, 0.05 mmol) were 
dissolved in CDCl3 (0.6 mL) for direct NMR measurement. 
1
H 
NMR (500 MHz, CDCl3): δ 7.697.68 (m, 6 H, Ar–H), 7.59 (dd, 2 
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H, ArH), 7.447.39 (m, 9 H, ArH), 7.22 (dd, 2 H, ArH), 6.15 (m, 3J(H,H) = 7.1 Hz, 2 H, 
NCH), 1.79 (d, 
3




H} NMR (125.77 MHz, CDCl3): 169.2 




Pr2-bimy)(AsPh3)] (cis-19). The upper complex was left in 
CDCl3 for 6 d to isomerize to this complex as major product. 
1
H NMR 
(500 MHz, CDCl3): δ 7.47 (dd, 2 H, ArH), 7.38 (t, 
3
J(H,H) = 7.3 Hz, 4 
H, ArH), 7.337.27 (m, 5 H, ArH), 7.257.19 (m, 8 H, ArH), 5.90 (m, 3J(H,H) = 7.0 Hz, 2 H, 
NCH), 1.66 (d, 
3
J(H,H) = 7.0 Hz, 6 H, CH3), 0.89 (d, 
3





NMR (125.77 MHz, CDCl3): 169.3 (Ccarbene), 135.2, 134.1, 132.7, 131.3, 129.7 (2 ), 113.4 
(ArC), 55.4 (NCH), 21.6, 19.9 (CH3). Anal. Calcd for C31H33AsBr2N2Pd: C, 48.06; H, 4.29; N, 






Pr2-bimy)(SbPh3)] (20). Complex I (24 mg, 0.03 mmol) and 
triphenylantimony (18 mg, 0.05 mmol) were dissolved in CDCl3 (0.6 mL) 
for direct NMR measurement. 
1
H NMR (500 MHz, CDCl3): δ 7.49 (dd, 2 
H, Ar–H), 7.36 (ps–t, 3 H, Ar–H), 7.31 (ps–d, 6 H, Ar–H), 7.25 (dd, 2 H, Ar–H), 7.20 (ps–t, 6 H, 
Ar–H), 5.88 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 1.66 (d, 3J(H,H) = 7.0 Hz, 6 H, CH3), 1.04 (d, 
3




H} NMR (125.77 MHz, CDCl3): 167.5 (Ccarbene), 136.1, 134.4, 
131.4, 130.1, 129.9, 123.5, 113.3 (Ar–C), 55.3 (NCH), 21.4, 20.2 (CH3). Anal. Calcd for 
C31H33Br2N2PdSb: C, 45.32; H, 4.05; N, 3.41. Found: C, 45.25; H, 3.99; N, 3.44. MS (ESI): m/z 







Pr2-bimy)(SMe2)] (21). Complex 21 was prepared in 
analogy to the pyridine complexes as a yellow solid from the reaction of 
dimethyl sulfide (8 µL, 0.10 mmol) and complex I (47 mg, 0.05 mmol) in 
CH2Cl2 (10 mL). Yield: 53 mg, 0.10 mmol, >99%. 
1
H NMR (500 MHz, CDCl3): δ 7.58 (dd, 2 H, 
Ar–H), 7.12 (dd, 2 H, Ar–H), 6.04 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH), 2.47 (s, 6 H, SCH3), 1.74 (d, 
3




H} NMR (125.77 MHz, CDCl3): 163.5 (Ccarbene), 134.1, 
123.1, 113.4 (Ar–C), 55.2 (NCH), 21.8 (SCH3), 21.3 (CH3). Anal. Calcd for C15H24Br2N2PdS: C, 











Pr2-bimy)(THT)] (22). Complex 22 was also prepared 
in analogy to the pyridine complexes as a yellow solid from the 
reaction of tetrahydrothiophene (THT) (9 µL, 0.10 mmol) and complex 
I (47 mg, 0.05 mmol) in CH2Cl2 (10 mL). Yield: 56 mg, 0.10 mmol, >99%. 
1
H NMR (500 MHz, 
CDCl3): δ 7.56 (dd, 2 H, Ar–H), 7.20 (dd, 2 H, Ar–H), 6.04 (m, 
3
J(H,H) = 6.9 Hz, 2 H, NCH), 
3.30 (br–s, 4 H, SCH2), 2.07 (br–s, 4 H, CH2), 1.74 (d, 
3





NMR (125.77 MHz, CDCl3): 163.6 (Ccarbene), 134.1, 123.0, 113.3 (Ar–C), 55.1 (NCH), 36.4 
(SCH2), 30.8 (CH2), 21.3 (CH3). Anal. Calcd for C17H26Br2N2PdS: C, 36.68; H, 4.71; N, 5.03. 






Pr2-bimy)(PNO)] (23). Complex I (47 mg, 0.10 
mmol) and pyridine N-oxide (24 mg, 0.25 mmol) were heated in 
CHCl3 (20 mL) at 70C overnight. The resulting solution was 
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concentrated to 3 mL before diethyl ether (20 mL) was added. The orange precipitate was 
collected and dried as the product (101 mg, 0.18 mmol, 90%). 
1
H NMR (300 MHz, CDCl3): δ 
8.59 (br–s, 2 H, Ar–H), 7.51 (dd, 2 H, Ar–H), 7.45 (br–s, 3 H, Ar–H), 7.15 (dd, 2 H, Ar–H), 6.38 
(m, 
3
J(H,H) = 7.1 Hz, 2 H, NCH), 1.72 (d, 
3




H} NMR (75.48 
MHz, CDCl3): 155.7 (Ccarbene), 142.4, 133.9, 126.5 (2 ), 122.8, 113.0 (Ar–C), 55.2 (NCH), 21.1 
(CH3). Anal. Calcd for C18H23Br2N3OPd: C, 38.36; H, 4.11; N, 7.46. Found: C, 38.17; H, 4.16; N, 






Pr2-bimy)(phen-dione)]PF6 (24). Complex I (94 mg, 
0.10 mmol) was suspended in CH2Cl2 (10 mL) and solutions of 
1,10-penanthroline-5,6-dione (43 mg, 0.20 mmol) in CH2Cl2 (3 
mL) and KPF6 (200 mg, 1.00 mmol) in acetone (5 mL) were added stepwise. The reaction 
mixture was stirred overnight, and the all volatiles were removed under reduced pressure. The 
residue was washed with H2O (3  10 mL) and diethyl ether (5  10 mL) before it was dried in 
vacuo to give the product as a yellow solid (126 mg, 0.17 mmol, 85%). 
1
H NMR (500 MHz, 
CD3CN): δ 9.50 (d, 1 H, ArH), 8.788.72 (m, 2 H, ArH), 8.028.00 (m, 2 H, ArH), 7.91 (dd, 
2 H, ArH), 7.717.68 (m, 1 H, ArH), 7.45 (dd, 2 H, ArH), 6.07 (m, 3J(H,H) = 7 Hz, 2 H, 
NCH), 1.76 (d, 
3
J(H,H) = 7 Hz, 6 H, CH3), 1.68 (d, 
3





(125.77 MHz, CD3CN): 175.6, 175.5 (CO), 159.8 (Ccarbene), 157.1, 156.7, 155.8, 155.4, 140.8, 




H} NMR (202.45 MHz, CD3CN): 143.3 (m, 
1





(282.38 MHz, CD3CN): 3.4 (d, 
1
J(P,F) = 708 Hz, PF6). Anal. Calcd for C25H24BrF6N4O2PPd: C, 


























Pr2-bimy)(phen)]PF6 (25). Complex I (94 mg, 0.10 
mmol) was suspended in CH2Cl2 (10 mL) and solutions of 
phenanthroline (36 mg, 0.20 mmol) in CH2Cl2 (3 mL) and KPF6 
(200 mg, 1.00 mmol) in acetone (5 mL) were added stepwise. The 
reaction mixture was stirred overnight, and all volatiles were removed under reduced pressure. 
CH2Cl2 (30 mL) was added to the residue and the suspension was filtered. The solvent of the 
filtrate was removed under vacuum, giving the crude product as a yellow solid. The product was 
further purified by recrystallization from chloroform/hexane. Yield: 138 mg, 0.19 mmol, 96%. 
1
H 
NMR (500 MHz, CDCl3): δ 9.65 (d, 1 H, ArH), 8.858.83 (m, 1 H, ArH), 8.778.75 (m, 1 H, 
ArH), 8.18 (d, 2 H, ArH), 8.027.97 (m, 3 H, ArH), 7.77 (dd, 2 H, ArH), 7.43 (dd, 2 H, 
ArH), 6.11 (m, 3J(H,H) = 7 Hz, 2 H, NCH), 1.82 (d, 3J(H,H) = 7 Hz, 6 H, CH3), 1.72 (d, 
3
J(H,H) 




H} NMR (125.77 MHz, CDCl3): 161.4 (Ccarbene), 151.9, 151.6, 147.8, 
147.1, 141.9, 140.7, 134.3, 132.2, 131.4, 128.9 (2 ), 127.7, 126.6, 124.7, 114.1 (ArC), 55.9 




H} NMR (202.45 MHz, CDCl3): 144.1 (m, 
1





H} NMR (282.38 MHz, CDCl3): 2.5 (d, 
1
J(P,F) = 712 Hz, PF6). Anal. Calcd for 
C25H28BrF6N4PPd: C, 41.95; H, 3.94; N, 7.83. Found: C, 41.81; H, 3.66; N, 7.73. MS (ESI): m/z 








Pr2-bimy)(bipy)]PF6 (26). Complex 26 was prepared in 
analogy to 25 from I (47 mg, 0.05 mmol), 2,2’-bipyridine (16 mg, 0.10 
mmol) and KPF6 (100 mg, 0.50 mmol). Yield: 63 mg, 0.09 mmol, 91%. 
1
H NMR (500 MHz, d6-DMSO): δ 9.23 (d, 1 H, ArH), 8.748.70 (m, 
2 H, ArH), 8.458.38 (m, 2 H, ArH), 8.06 (dd, 2 H, ArH), 7.927.88 (m, 2 H, ArH), 7.61 (t, 
1 H, ArH), 7.45 (dd, 2 H, ArH), 6.03 (m, 3J(H,H) = 7 Hz, 2 H, NCH), 1.71 (d, 3J(H,H) = 7 Hz, 
6 H, CH3), 1.64 (d, 
3




H} NMR (125.77 MHz, d6-DMSO): 161.4 
(Ccarbene), 156.5, 155.4, 152.3, 149.9, 141.61, 141.55, 133.0, 128.5, 127.8, 124.5, 123.8, 123.6, 




H} NMR (202.45 MHz, d6-DMSO): 143.0 
(m, 
1




H} NMR (282.38 MHz, d6-DMSO): 5.8 (d, 
1
J(P,F) = 711 Hz, 
PF6). Anal. Calcd for C23H26BrF6N4PPd: C, 40.05; H, 3.80; N, 8.12. Found: C, 40.08; H, 3.65; N, 




C-labeled complex was obtained by the same 
procedure starting from the 
13




H} NMR (125.77 MHz, CDCl3): δ 162.7 






Pr2-bimy)(R-DAB)]PF6 (27–31). Complexes 2731 
were prepared in analogy to 25 from I (94 mg, 0.10 mmol), the 
respective diimine R-DAB (0.20 mmol) and KPF6 (200 mg, 
1.00 mmol). 
R = Br, (27). This complex was further purified by column chromatography (SiO2, 
EA/hexane: 1/2). Yield: 74 mg, 0.08 mmol, 40%. 
1
H NMR (500 MHz, CDCl3): δ 7.60 (d, 2 H, 
ArH), 7.51 (dd, 2 H, ArH), 7.36 (d, 2 H, ArH), 7.21 (dd, 2 H, ArH), 7.12–7.08 (m, 4 H, 




J(H,H) = 7 Hz, 6 H, CH(CH3)2), 1.62 (d, 
3





(125.77 MHz, CDCl3): 182.7, 179.9 (C=N), 160.5 (Ccarbene), 147.1, 144.7, 133.7, 133.4, 132.7, 





H} NMR (202.45 MHz, CDCl3): 143.8 (m, 
1





(282.38 MHz, CDCl3): 4.1 (d, 
1
J(P,F) = 713 Hz, PF6). Anal. Calcd for C29H32Br3F6N4PPd: C, 





C NMR spectra are attached in the appendix. MS (ESI): m/z 783 [M  PF6]
+
. 
R = H, (28). Yield: 151 mg, 0.20 mmol, 98%. 
1
H NMR (500 MHz, CDCl3): δ 7.46 (dd, 2 
H, ArH), 7.41 (t, 2 H, ArH), 7.23 (d, 5 H, ArH), 7.197.14 (m, 4 H, ArH), 7.03 (t, 1 H, 
ArH), 5.90 (m, 3J(H,H) = 7 Hz, 2 H, NCH), 2.27 (s, 3 H, CH3), 2.24 (s, 3 H, CH3), 1.66 (d, 
3
J(H,H) = 7 Hz, 6 H, CH(CH3)2), 1.59 (d, 
3





(125.77 MHz, CDCl3): 182.5, 179.7 (C=N), 162.2 (Ccarbene), 148.3, 146.2, 133.6, 130.0, 129.3, 





H} NMR (202.45 MHz, CDCl3): 143.7 (m, 
1





(282.38 MHz, CDCl3): 4.2 (d, 
1
J(P,F) = 713 Hz, PF6). Anal. Calcd for C29H34BrF6N4PPd: C, 




R = Me, (29). Yield: 152 mg, 0.19 mmol, 95%.  
1
H NMR (500 MHz, CDCl3): δ 7.48 (dd, 
2 H, ArH), 7.20 (psd, 2 H, ArH), 7.16 (dd, 2 H, ArH), 7.107.08 (m, 4 H, ArH), 6.97 
(psd, 2 H, ArH), 5.89 (m, 3J(H,H) = 7 Hz, 2 H, NCH), 2.32 (s, 3 H, NCCH3), 2.27 (s, 3 H, 
NCCH3), 2.23 (s, 3 H, CH3), 2.12 (s, 3 H, CH3), 1.65 (d, 
3
J(H,H) =7 Hz, 6 H, CH(CH3)2), 1.61 (d, 
3




H} NMR (125.77 MHz, CDCl3): 182.4, 179.7 (C=N), 
162.6 (Ccarbene), 146.0, 143.8, 138.9, 137.7, 133.6, 130.5, 129.8, 123.5, 122.8, 121.9, 113.7 







H} NMR (202.45 MHz, CDCl3): 143.7 (m, 
1





(282.38 MHz, CDCl3): 4.0 (d, 
1
J(P,F) = 713 Hz, PF6). Anal. Calcd for C31H38BrF6N4PPd: C, 
46.66; H, 4.80; N, 7.02. Found: C, 46.74; H, 4.61; N, 7.33. MS (ESI): m/z 653 [M  PF6]
+
. 
R = OMe, (30). Yield: 156 mg, 0.19 mmol, 94%. 
1
H NMR (500 MHz, CDCl3): δ 7.48 (dd, 
2 H, ArH), 7.177.13 (m, 6 H, ArH), 6.91 (d, 2 H, ArH), 6.66 (d, 2 H, ArH), 5.91 (m, 
3
J(H,H) = 7 Hz, 2 H, NCH), 3.74 (s, 3 H, OCH3), 3.61 (s, 3 H, OCH3), 2.28 (s, 3 H, CH3), 2.24 (s, 
3 H, CH3), 1.65 (d, 
3
J(H,H) = 7 Hz, 6 H, CH(CH3)2), 1.61 (d, 
3




H} NMR (125.77 MHz, CDCl3): 182.5, 179.8 (C=N), 162.8 (Ccarbene), 159.6, 159.1, 141.5, 
139.5, 133.6, 124.5, 123.6, 123.5, 115.0, 114.4, 113.7 (ArC), 56.2, 56.1 (OCH3), 55.3 (NCH), 




H} NMR (202.45 MHz, CDCl3): 143.7 (m, 
1




H} NMR (282.38 MHz, CDCl3): 4.0 (d, 
1
J(P,F) = 713 Hz, PF6). 
Anal. Calcd for C31H38BrF6N4O2PPd: C, 44.86; H, 4.61; N, 6.75. Found: C, 44.80; H, 4.58; N, 





Bu, (31). Yield: 152 mg, 0.17 mmol, 86%.
1
H NMR (500 MHz, CDCl3): δ 7.467.42 
(m, 4 H, ArH), 7.167.13 (m, 4 H, ArH), 7.10 (s, 4 H, ArH), 5.87 (m, 3J(H,H) = 7 Hz, 2 H, 
NCH), 2.31 (s, 3 H, CH3), 2.29 (s, 3 H, CH3), 1.68 (d, 
3
J(H,H) = 7 Hz, 6 H, CH(CH3)2), 1.57 (d, 
3





(125.77 MHz, CDCl3): 181.9, 179.7 (C=N), 163.4 (Ccarbene), 151.9, 150.8, 145.5, 143.7, 133.6, 
126.6, 126.1, 123.4, 122.5, 121.9, 113.5 (ArC), 55.3 (NCH), 35.3, 35.1 (C(CH3)3), 32.0, 31.5 




H} NMR (202.45 MHz, CDCl3): 




H} NMR (282.38 MHz, CDCl3): 4.0 (d, 
1
J(P,F) = 713 
Hz, PF6). Anal. Calcd for C37H50BrF6N4PPd: C, 50.38; H, 5.71; N, 6.35. Found: C, 50.63; H, 5.60; 







Pr2-bimy)(diNHC)]PF6 (32–36). The dicarbene precusor salts (0.20 mmol) and 
silver oxide (47 mg, 0.20 mmol) were stirred in MeOH (10 mL) and CH2Cl2 (5 mL) at ambient 
temperature for three hours. To the resulting suspension was slowly dropped in the solution of 
complex II in CH3CN. KPF6 (200 mg, 1.00 mmol) was then added to the suspension and the 
mixture was stirred overnight. Solvent was removed under reduced pressure, 50 mL of CH2Cl2 
was added to the residue and the suspension was filtered. The filtrate was concentrated to 5 mL 
and added to diethyl ether (50 mL). The precipitate was collected and dried to give the products 
as off-white solids. 
 
Dicarbene = A, (32). Yield: 93 mg, 0.13 mmol, 65%. 
1
H NMR (500 
MHz, CDCl3, 243K): δ 9.47 (s, 1 H, ArH), 9.07 (s, 1 H, ArH), 8.48 (d, 
2
J(H,H) = 13 Hz, 1 H, NCHHN), 7.69 (d, 1 H, ArH), 7.57 (d, 1 H, 
ArH), 7.327.26 (m, 2 H, ArH), 6.29 (d, 2J(H,H) = 13 Hz, 1 H, 
NCHHN), 5.79 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 5.14 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 4.24 (s, 3 
H, NCH3), 3.38 (s, 3 H, NCH3), 1.831.81 (m, 6 H, CH(CH3)2), 1.57 (d, 
3
J(H,H) = 7 Hz, 3 H, 
CH(CH3)2), 1.18 (d, 
3




H} NMR (125.77 MHz, CDCl3): 
177.1 (Ccarbene-probe), 170.5 (Ccarbene-trans), 163.8 (Ccarbene-cis), 143.7, 142.1, 134.0, 124.0, 114.2 





NMR (202.45 MHz, CDCl3): 143.7 (m, 
1




H} NMR (282.38 MHz, 
CDCl3): 4.5 (d, 
1
J(F,P) = 714 Hz, PF6). Anal. Calcd for C20H28BrF6N8PPd: C, 33.75; H, 3.97; N, 






Dicarbene = B, (33). Yield: 126 mg, 0.16 mmol, 78%. 
1
H NMR (500 
MHz, CDCl3): δ 8.04 (d, 1 H, ArH), 7.85 (d, 1 H, ArH), 7.74 (d, 1 H, 
ArH), 7.56 (d, 1 H, ArH), 7.447.40 (m, 2 H, ArH), 7.377.28 (m, 6 
H, ArH), 7.05 (d, 2J(H,H) = 14 Hz, 1 H, NCHHN), 6.68 (d, 2J(H,H) = 
14 Hz, 1 H, NCHHN), 6.02 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 5.41 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 4.27 (s, 3 H, NCH3), 3.60 (s, 3 H, NCH3), 1.971.93 (m, 6 H, 
CH(CH3)2), 1.62 (d, 
3
J(H,H) = 7 Hz, 3 H, CH(CH3)2), 1.03 (d, 
3




H} NMR (125.77 MHz, CDCl3): 179.1 (Ccarbene-trans), 178.7 (Ccarbene-probe), 172.2 (Ccarbene-cis), 
135.2, 134.2, 133.9, 133.8, 133.3, 133.2, 126.4, 125.9, 125.7, 125.2, 124.00, 123.97, 114.3, 114.1, 
112.2, 111.8, 111.6, 111.2 (ArC), 57.8 (NCH2N), 55.7, 55.5 (NCH), 36.9, 35.4 (NCH3), 22.4, 




H} NMR (121.49 MHz, CDCl3): 143.5 (m, 
1




H} NMR (282.38 
MHz, CDCl3): 3.9 (d, 
1
J(F,P) = 712 Hz, PF6). Anal. Calcd for C30H34BrF6N6PPd: C, 44.49; H, 




Dicarbene = C, (34). Yield: 135 mg, 0.19 mmol, 95%. 
1
H NMR (500 
MHz, CDCl3): δ 7.68 (d, 1 H, ArH), 7.57 (d, 1 H, ArH), 7.45 (d, 1 H, 
ArH), 7.36 (d, 1 H, ArH), 7.307.26 (m, 2 H, ArH), 6.956.94 (m, 2 
H, ArH), 6.27 (s, 2 H, NCH2N), 5.90 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 
5.25 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 4.05 (s, 3 H, NCH3), 3.23 (s, 3 H, NCH3), 1.87 (d, 
3
J(H,H) 
= 7 Hz, 3 H, CH(CH3)2), 1.81 (d, 
3
J(H,H) = 7 Hz, 3 H, CH(CH3)2), 1.56 (d, 
3
J(H,H) = 7 Hz, 3 H, 
CH(CH3)2), 1.17 (d, 
3




H} NMR (125.77 MHz, CDCl3): 
179.9 (Ccarbene-probe), 168.6 (Ccarbene-trans), 161.1 (Ccarbene-cis), 134.0, 133.6, 123.8, 123.7, 123.3, 
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123.0, 121.9 (2 ), 114.1, 114.0 (ArC), 63.4 (NCH2N), 55.4, 55.2 (NCH), 39.7, 38.3 (NCH3), 




H} NMR (202.45 MHz, CDCl3): 143.6 (m, 
1
J(F,P) = 




H} NMR (282.38 MHz, CDCl3): 4.4 (d, 
1
J(F,P) = 713 Hz, PF6). Anal. Calcd 
for C22H30BrF6N6PPd: C, 37.23; H, 4.26; N, 11.84. Found: C, 36.87; H, 3.96; N, 11.66. MS (ESI): 




Dicarbene = D, (35). Yield: 156 mg, 0.18 mmol, 90%. 
1
H NMR 
(500 MHz, CDCl3): δ 7.60 (d, 1 H, ArH), 7.577.56 (m, 2 H, 
ArH), 7.49 (d, 1 H, ArH), 7.347.33 (m, 5 H, ArH), 7.28 (t, 2 H, 
ArH), 7.19 (t, 1 H, ArH), 7.09 (t, 2 H, ArH), 6.99 (psd, 1 H, 
ArH), 6.686.67 (m, 3 H, ArH), 6.45–6.37 (m, 2 H, NCH2N), 6.19 (d, 
2
J(H,H) = 15 Hz, 1 H, 
NCHHPh), 5.51 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 5.42 (d, 
2
J(H,H) = 15 Hz, 1 H, NCHHPh), 5.39 
(m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 4.71 (d, 
2
J(H,H) = 15 Hz, 1 H, NCHHPh), 4.43 (d, 
2
J(H,H) = 15 
Hz, 1 H, NCHHPh), 1.79 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.63 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.44 
(d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.27 (d, 
3




H} NMR (125.77 MHz, 
CDCl3): 179.51 (Ccarbene-probe), 169.0 (Ccarbene-trans), 161.3 (Ccarbene-cis), 137.4, 134.0, 133.8, 129.8, 
129.6, 129.4, 128.8, 128.7, 128.3, 124.3, 123.8, 123.3, 122.0, 121.2, 113.9 (ArC), 63.8 





NMR (202.45 MHz, CDCl3): 143.4 (m, 
1




H} NMR (282.38 MHz, 
CDCl3): 4.2 (d,
1
J(F,P) = 712 Hz, PF6). Anal. Calcd for C34H38BrF6N6PPd: C, 47.37; H, 4.44; N, 











Dicarbene = E, (36). Yield: 95 mg, 0.12 mmol, 62%. 
1
H NMR (500 
MHz, CDCl3): δ 7.73 (d, 1 H, ArH), 7.68 (d, 1 H, ArH), 7.57–7.55 (m, 
2 H, ArH), 7.31–7.27 (m, 2 H, ArH), 7.027.00 (m, 2 H, ArH), 6.51 
(d, 
2
J(H,H) = 13 Hz, 1 H, NCHHN), 6.26 (d, 
2
J(H,H) = 13 Hz, 1 H, 
NCHHN), 5.83 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 5.53 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 5.44 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 4.31 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 1.90 (d, 
3
J(H,H) = 7 Hz, 3 H, 
CH3), 1.84 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.62 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.57 (d, 
3
J(H,H) = 
7 Hz, 3 H, CH3), 1.42 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.32 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.17 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 0.61 (d, 
3




H} NMR (125.77 MHz, 
CDCl3): 180.0 (Ccarbene-probe), 167.2 (Ccarbene-trans), 159.9 (Ccarbene-cis), 134.0, 133.6, 124.7, 123.9 (2 
), 122.8, 118.4, 117.6, 114.0, 113.9 (ArC), 63.4 (NCH2N), 55.5, 55.2, 53.45, 53.39 (NCH), 




H} NMR (202.45 MHz, CDCl3): 143.5 
(m, 
1




H} NMR (282.38 MHz, CDCl3): 4.2 (d, 
1
J(F,P) = 712 Hz, PF6). 
Anal. Calcd for C26H38BrF6N6PPd: C, 40.77; H, 5.00; N, 10.97. Found: C, 40.54; H, 4.85; N, 




Dicarbene = F, (37). This complex could be obtained in analogy to 
the previous complexes (method 1) with further purification using 
colum chromatography (DCM/MeOH: 40/1) in low yield (14 mg, 
0.02 mmol, 8%). The yield was increased by using a different 
protocol (method 2): complex III (121 mg, 0.20 mmol), 1,3-diisopropylbenzimidazolium salt (57 
mg, 0.20 mmol), K2CO3 (34 mg, 0.24 mmol) and KPF6 (200 mg, 1.00 mmol) were mixed in 
DMSO (10 mL) and heated at 90ºC overnight. The solvent was removed by vacum distillation. 
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The resulting residue was suspended in CH2Cl2 (30 mL) and then extracted with H2O (4  20 
mL). Drying of the organic phase over Na2SO4 followed by removal of the solvent in vacuo 
afforded an orange solid. The solid was washed with CHCl3 (20 mL) to give the off white 
product. Yield: 98 mg, 0.11 mmol, 56%.
1
H NMR (500 MHz, CD3CN): δ 7.73 (d, 1 H, ArH), 
7.51 (d, 1 H, ArH), 7.44 (t, 2 H, ArH), 7.39 (d, 1 H, ArH), 7.35 (d, 1 H, ArH), 7.30 (t, 1 H, 
ArH), 7.27 (psd, 1 H, ArH), 7.247.20 (m, 2 H, ArH), 7.07 (d, 2 H, ArH), 7.01 (t, 1 H, 
ArH), 6.80 (t, 2 H, ArH), 6.76 (d, 1 H, ArH), 6.33 (d, 2J(H,H) = 16 Hz, 1 H, NCHHPh), 6.27 
(d, 2 H, ArH), 6.055.98 (m, 1 H, NCHHCH2), 5.58 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 5.45 (d, 
2
J(H,H) = 16 Hz, 1 H, NCHHPh), 5.41 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 4.824.76 (m, 2 H, 
NCHHPh and NCHHCH2), 4.544.48 (m, 3 H, NCHHPh and NCH2CH2), 1.691.66 (m, 6 H, 
CH3), 1.29 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.13 (d, 
3





(125.77 MHz, CD3CN): 180.4 (Ccarbene-probe), 166.1 (Ccarbene-trans), 161.4 (Ccarbene-cis), 138.9, 135.6, 
134.3, 133.6, 130.2, 129.4, 129.1, 128.8, 127.6, 127.3, 125.1, 124.6, 124.5, 124.01, 123.96, 123.0, 
114.32, 114.28 (ArC), 55.5, 55.4, 55.3, 54.1 (NCH and NCH2Ph), 49.7, 47.8 (NCH2), 21.8, 21.0, 




H} NMR (202.45 MHz, CD3CN): 144.0 (m, 
1




H} NMR (282.38 MHz, CDCl3): 3.4 (d, 
1
J(F,P) = 708 Hz, PF6). Anal. Calcd for 
C35H40BrF6N6PPd: C, 47.99; H, 4.60; N, 9.59. Found: C, 47.91; H, 4.31; N, 9.78. MS (ESI): m/z 




C-labeled complex was obtained though the same procedure starting from 
the C2 
13




H} NMR (125.77 MHz, CDCl3): δ 






Ethylene bridged dipalladium complex (39). Yield: 44 
mg, 0.03 mmol, 34%. 
1
H NMR (500 MHz, CDCl3): δ 
7.607.58 (m, 2 H, ArH), 7.557.53 (m, 2 H, ArH), 
7.50 (psd, 4 H, ArH), 7.40 (t, 4 H, ArH), 7.34 (t, 2 H, 
ArH), 7.227.20 (m, 4 H, ArH), 7.19 (d, 2 H, ArH), 
6.56 (d, 2 H, ArH), 6.19 (m, 3J(H,H) = 7 Hz, 2 H, NCH), 
6.06 (m, 
3
J(H,H) = 7 Hz, 2 H, NCH), 5.80 (s, 4 H, NCH2Ph), 5.48 (s, 4 H, NCH2), 1.89 (d, 
3
J(H,H) = 7 Hz, 12 H, CH3), 1.67 (d, 
3




H} NMR (125.77 MHz, 
CDCl3): 178.8 (Ccarbene-benz), 170.7 (Ccarbene-imi), 136.8, 134.3, 134.2, 129.5, 128.9, 128.8, 124.8, 
122.7 (2 ), 120.8, 113.32, 113.30 (ArC), 55.3, 54.7, 54.5 (NCH, NCH2Ph), 51.4 (NCH2), 21.9, 
21.6 (CH3). Anal. Calcd for C48H58Br4N8Pd2: C, 45.06; H, 4.57; N, 8.76. Found: C, 44.79; H, 
4.48; N, 8.64. MS (ESI): m/z 1199 [M  Br]+. 
 
Dicarbene = G, (38).  Method 1, yield: 32 mg, 0.04 mmol, 18%; or 
Method 2 from complex IV (62 mg, 0.10 mmol), 1,3-
diisopropylbenzimidazolium salt (28 mg, 0.10 mmol), potassium 
carbonate (17 mg, 0.12 mmol) and KPF6 (200 mg, 1.00 mmol). Yield: 
76 mg, 0.09 mmol, 85%. 
1
H NMR (500 MHz, CD3CN): δ 7.78 (d, 1 
H, ArH), 7.61 (d, 1 H, ArH), 7.407.38 (m, 3 H, ArH), 7.31 (t, 1 H, ArH), 7.25 (t, 1 H, 
ArH), 7.217.19 (m, 3 H, ArH), 7.14 (d, 1 H, ArH), 7.11 (d, 1 H, ArH), 6.94 (t, 2 H, ArH), 
6.87 (d, 1 H, ArH), 6.74 (d, 1 H, ArH), 6.31 (d, 2 H, ArH), 6.01 (m, 3J(H,H) = 7 Hz, 1 H, 
NCH), 5.90 (d, 
2
J(H,H) = 15 Hz, 1 H, NCHHPh), 5.87 (m, 
3
J(H,H) = 7 Hz, 1 H, NCH), 5.28 (d, 
2
J(H,H) = 15 Hz, 1 H, NCHHPh), 5.13 (t, 
3
J(H,H) = 12 Hz, 1 H, NCH2), 5.08 (d, 
2
J(H,H) = 15 
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Hz, 1 H, NCHHPh), 4.94 (t, 
3
J(H,H) = 12 Hz, 1 H, NCH2), 4.66 (d, 
2
J(H,H) = 15 Hz, 1 H, 
NCHHPh), 4.604.56 (m, 1 H, NCH2), 4.464.42 (m, 1 H, NCH2), 2.48 (brs, 1 H, CH2), 2.10 
(brs, 1 H, CH2), 1.76 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.66 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.48 (d, 
3
J(H,H) = 7 Hz, 3 H, CH3), 1.44 (d, 
3




H} NMR (125.77 MHz, 
CD3CN): 181.1 (Ccarbene-probe), 168.9 (Ccarbene-trans), 162.3 (Ccarbene-cis), 137.3, 136.5, 134.5, 133.7, 
130.0 (2 ), 129.6, 129.3, 129.2, 128.8, 127.4, 126.2, 124.6, 123.9, 123.1, 122.9, 114.5, 114.4 
(ArC), 55.6, 55.5, 54.7, 54.2, 53.6, 53.2 (NCH2Ph, NCH2 and NCH), 30.3 (CH2), 21.9, 21.0, 




H} NMR (202.45 MHz, CD3CN): 143.1 (m, 
1




H} NMR (282.38 MHz, CDCl3): 3.4 (d, 
1
J(F,P) = 708 Hz, PF6). Anal. Calcd for 
C36H42BrF6N6PPd: C, 48.58; H, 4.76; N, 9.44. Found: C, 48.50; H, 4.67; N, 9.56. MS (ESI): m/z 




C-labeled complex was obtained though the same procedure starting from 
C2 
13




H} NMR (125.77 MHz, CDCl3): δ 




Propylene bridged dipalladium complex (40). Yield: 93 
mg, 0.07 mmol, 72%. 
1
H NMR (500 MHz, CDCl3): δ 
7.587.56 (m, 2 H, ArH), 7.537.52 (m, 6 H, ArH), 
7.40 (t, 4 H, ArH), 7.35 (t, 2 H, ArH), 7.217.17 (m, 4 
H, ArH), 7.15 (d, 2 H, ArH), 6.52 (d, 2 H, ArH), 6.23 
(m, 
3
J(H,H) = 7 Hz, 2 H, NCH), 6.07 (m, 
3
J(H,H) = 7 Hz, 
2 H, NCH), 5.76 (s, 4 H, NCH2Ph), 4.76 (t, 
3
J(H,H) = 7 Hz, 4 H, NCH2), 3.34 (m, 
3
J(H,H) = 7 Hz, 
2 H, CH2), 1.84 (d, 
3
J(H,H) = 7 Hz, 12 H, CH3), 1.68 (d, 
3





NMR (125.77 MHz, CDCl3): 179.1 (Ccarbene-benz), 170.4 (Ccarbene-imi), 136.9, 134.2, 129.5, 129.2, 
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128.8, 123.0, 122.7, 121.2, 113.2 (ArC), 55.3, 54.6, 54.5 (NCH, NCH2Ph), 49.7 (NCH2), 32.1 
(CH2), 21.8, 21.6 (CH3). Anal. Calcd for C49H60Br4N8Pd2: C, 45.50; H, 4.68; N, 8.66. Found: C, 
45.52; H, 4.36; N, 9.01. MS (ESI): m/z 1213 [M  Br]+. 
 
[PdBr2(C3OAc-bimy)]2 (41). Salt H (820 mg, 2 mmol), 
Pd(OAc)2 (449 mg, 2 mmol) and NaBr (823 mg, 8 mmol) were 
mixed in DMSO (10 mL) and stirred at 90 C for 24 h. The 
solvent of the mixture was removed by vacuum distillation, and 
CH2Cl2 (50 mL) was added. The suspension was filtered over Celite and the filtrate was 
concentrated to 2 mL, which was subjected to column chromatography using a mixture of ethyl 
acetate and hexane as eluent, giving the product as a red solid (437 mg, 0.38 mmol, 38%). 
1
H 
NMR (300 MHz, CDCl3): δ 7.51 (ps–d, 4 H, Ar–H), 7.42–7.30 (m, 10 H, Ar–H), 7.15 (t, 2 H, 
Ar–H), 7.08 (ps–d, 2 H, Ar–H), 6.19 (s, 4 H, NCH2Ph), 5.00 (t, 
3
J(H,H) = 7.2 Hz, 4 H, NCH2), 





NMR (75.48 MHz, CDCl3): δ 171.6 (CO), 160.6 (Ccarbene), 135.4, 134.9, 134.8, 129.7, 129.1, 
128.6, 124.5, 112.6, 110.0 (Ar–C, 1 × coincident), 62.2 (CH2OCOCH3), 54.4 (NCH2Ph), 46.5 
(NCH2), 29.3 (CH2OCOCH3), 21.7 (CH2CH2CH2). IR (KBr pellet) ~  = 1738 cm
-1 
(s, C=O). Anal. 
Calcd for C38H40Br4N4Pd2: C, 39.71; H, 3.51; N, 4.88. Found: C, 40.00; H, 3.45; N, 4.89. MS 




[PdBr2(C3Br-bimy)]2 (42). A mixture of Ag2O (232 mg, 1 
mmol) and salt H (820 mg, 2 mmol) was suspended in CH2Cl2 
(30 mL) and stirred at ambient temperature for 3 h shielded 
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from light. The resulting mixture was filtered into a solution of [PdBr2(CH3CN)2] (PdBr2, 533 mg, 
2 mmol) in CH3CN (30 mL). The reaction mixture was stirred for 20 h and filtered through a 
sintered funnel. The solvent of the filtrate was removed under vacuum to give a red brown 
residue, which was suspended and stirred in diethyl ether (100 mL) overnight. The resulting 
suspension was filtered through a sintered funnel and washed with diethyl ether (10 mL  3). 
Drying the residue in vacuo afforded the product as red brown powders (1.0 g, 0.86 mmol, 86%). 
1
H NMR (500 MHz, d6-DMSO): δ 7.77 (d, 2 H, Ar–H), 7.60 (d, 4 H, Ar–H), 7.38–7.29 (m, 8 H, 
Ar–H), 7.24 (m, 4 H, Ar–H), 6.07 (s, 4 H, NCH2Ph), 4.94 (t, 
3
J(H,H) = 7.4 Hz, 4 H, NCH2), 3.76 
(t, 
3
J(H,H) = 6.4 Hz, 4 H, CH2Br), 2.69 (m, 
3





(125.77 MHz, d6-DMSO): δ 135.0, 134.1, 133.3, 128.5, 128.0, 123.5, 123.4, 111.6, 110.9 (Ar–C, 
1 × coincident), 52.2 (NCH2Ph). 46.6 (NCH2), 31.7 (CH2Br), 31.5 (CH2CH2CH2), the Ccarbene 
signal could not be detected. Anal. Calcd for C34H34Br6N4Pd2: C, 34.29; H, 2.88; N, 4.70. Found: 




trans-[PdBr2(C3Br-bimy)(CH3CN)] (43). A suspension of complex 42 
(120 mg, 0.10 mmol) in CH3CN (20 mL) was stirred at 80 C overnight. 
The reaction mixture was filtered over Celite and removal of the solvent 
from the filtrate in vacuo afforded the product as a yellow powder (57 
mg, 0.09 mmol, 90%). 
1
H NMR (300 MHz, CD3CN): δ 7.61 (d, 1 H, Ar–H), 7.54–7.51 (m, 2 H, 
Ar–H), 7.34–7.30 (m, 4 H, Ar–H), 7.20–7.14 (m, 2 H, Ar–H), 6.06 (s, 2 H, NCH2Ph), 4.93 (t, 
3
J(H,H) = 7.4 Hz, 2 H, NCH2), 3.65 (t, 
3
J(H,H) = 6.4 Hz, 2 H, CH2Br), 2.76 (m, 
3
J(H,H) = 7.4 Hz, 
2 H, CH2CH2CH2), 1.95 (s, NCCH3, correct integration was not obtained due to ligand exchange 




H} NMR (75.48 MHz, CD3CN): δ 161.8 (Ccarbene), 136.0, 135.5, 134.7, 
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129.5, 129.05, 124.6, 124.5 (Ar–C, 1 × coincident), 118.3 (CN), 112.5, 111.7 (Ar–C), 53.8 
(NCH2Ph), 47.8 (NCH2), 32.8 (CH2Br), 31.8 (CH2CH2CH2). Anal. Calcd for C19H20Br3N3Pd: C, 
35.85; H, 3.17; N, 6.60. Found: C, 35.78; H, 2.98; N, 6.63. MS (ESI): m/z 558 [M – Br]+. 
 
trans-[PdBr2(C3Br-bimy)(Py)] (44). Pyridine (88.6 µL, 1.1 mmol) was 
added to the suspension of complex 42 (596 mg, 0.5 mmol) in CH2Cl2 
(25 mL) and stirred at ambient temperature for 2 h. The solvent was 
removed under reduced pressure, and the residue was washed with 
diethyl ether to give a yellow solid product (277 mg, 0.4 mmol, 82%). 
1
H NMR (500 MHz, 
CDCl3): δ 9.05 (d, 2 H, py–H), 7.76 (t, 1 H, py–H), 7.58 (ps–d, 2 H, py–H), 7.54 (d, 1 H, Ar–H), 
7.38–7.30 (m, 5 H, Ar–H), 7.25 (t, 1 H, Ar–H), 7.11 (t, 1 H, Ar–H), 7.05 (ps–d, 1 H, Ar–H), 6.17 
(s, 2 H, NCH2Ph), 5.07 (t, 
3
J(H,H) = 7.2 Hz, 2 H, NCH2), 3.67 (t, 
3
J(H,H) = 5.9 Hz, 2 H, CH2Br), 
2.93 (m, 
3




H} NMR (125.77 MHz, CDCl3): δ 164.6 
(Ccarbene), 153.3, 138.7, 135.8, 135.5, 135.0, 129.5, 128.9, 128.8, 125.3, 124.0, 123.9, 112.3, 111.0 
(Ar–C), 54.5 (NCH2Ph), 47.4 (NCH2), 32.7 (CH2Br), 31.8 (CH2CH2CH2). Anal. Calc for 
C22H22Br3N3Pd: C, 39.17; H, 3.29; N, 6.23. Found: C, 39.60; H, 3.43; N, 6.53. MS (ESI): m/z 594 
[M – Br]+. 
 
trans-[PdBr2(C3Br-bimy)2] (45). A mixture of Ag2O (232 mg, 1.00 
mmol) and salt H (410 mg, 2.00 mmol) were suspended in CH2Cl2 
(60 mL) and stirred at ambient temperature for 3 h shielded from 
light. A solution of [PdBr2(CH3CN)2] (PdBr2, 266 mg, 1.00 mmol) 
in CH3CN (200 mL) was added. The reaction mixture was stirred for 
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20 h, and the resulting suspension was filtered through a sintered funnel. Removal of the solvent 
under vacuum yielded the product as a pale-yellow powder. Yields and syn:anti ratios: 922 mg, 
1.00 mmol, >99%, 1:2.2. 
1
H NMR (300 MHz, CDCl3): δ 7.62 (d, 5 H, Ar–H), 7.56 (d, 2 H, Ar–
H), 7.49 (d, 3 H, Ar–H), 7.42–7.33 (m, 11 H, Ar–H), 7.23 (m, 8 H, Ar–H), 7.17–7.12 (m, 7 H, 
Ar–H), syn: 5.95 (s, 4 H, NCH2Ph), 5.05 (t, 
3
J(H,H) = 7.0 Hz, 4 H, NCH2), 3.63 (t, 
3
J(H,H) = 6.0 
Hz, 4 H, CH2Br), 2.96 (m, 
3
J(H,H) = 6.5 Hz, 4 H, CH2CH2CH2), anti: 6.18 (s, 4 H, NCH2Ph), 
4.92 (t, 
3
J(H,H) = 7.2 Hz, 4 H, NCH2), 3.25 (t, 
3
J(H,H) = 6.0 Hz, 4 H, CH2Br), 2.73 (m, 
3
J(H,H) 




H} NMR (75.47 MHz, CDCl3): δ 182.6, 182.5 (Ccarbene), 135.9, 
135.8, 135.6, 135.5, 135.1, 134.9, 129.6, 129.3, 128.8, 128.5, 128.3, 123.9, 123.8, 112.1, 112.0, 
111.1, 111.0 (Ar–C, 3 × coincident), 53.7, 53.3 (NCH2Ph), 47.1 (2  NCH2), 33.5, 33.2 (CH2Br), 
31.7, 31.2 (CH2CH2CH2). Anal. Calcd for C34H34Br4N4Pd: C, 44.16; H, 3.71; N, 6.06. Found: C, 
44.12; H, 3.60; N, 6.12. MS (ESI): m/z 843 [M – Br]+.  
 
trans-[PdBr2(C3OH-bimy)2] (46). Complex 45 was suspended in 
d6-DMSO (0.6 mL) and heated to 110C for one day before NMR. 
syn:anti ratios: 1:1.4. 
1
H NMR (400 MHz, d6-DMSO): δ 7.74 (d, 5 
H, Ar–H), 7.67 (d, 2 H, Ar–H), 7.60–7.58 (m, 4 H, Ar–H), 7.37–
7.29 (m, 14 H, Ar–H), 7.25–7.21 (m, 11 H, Ar–H), syn: 6.15 (s, 4 H, 
NCH2Ph), 4.82 (t, 
3
J(H,H) = 7.6 Hz, 4 H, NCH2), 3.34 (t, 
3
J(H,H) = 6.0 Hz, 4 H, CH2O), 2.23 (m, 
4 H, 
3
J(H,H) = 6.8 Hz, CH2CH2CH2), anti: 6.00 (s, 4 H, NCH2Ph), 4.93 (t, 
3
J(H,H) = 7.2 Hz, 4 H, 
NCH2), 3.64 (t, 
3
J(H,H) = 6.0 Hz, 4 H, CH2O), 2.36 (m, 
3
J(H,H) = 6.7 Hz, 4 H, CH2CH2CH2), the 
OH signals are found at 4.62 (t, 
3




H} NMR (100.62 MHz, d6-
DMSO): δ 181.2, 181.1 (Ccarbene), 135.84, 135.76, 134.3, 134.2, 133.5, 133.3, 128.5, 128.3, 128.0, 
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127.8, 127.7, 123.1, 123.00, 122.97, 111.5, 111.4, 111.0, 110.9 (Ar–C, 2 × coincident), 58.1, 57.8 
(CH2O), 51.7, 51.5 (NCH2Ph), 44.91, 44.86 (NCH2), 32.7, 32.5 (CH2CH2CH2). Anal. Calc. for 
C34H36Br2N4O2Pd: C, 51.12; H, 4.54; N, 7.01. Found: C, 51.38; H, 4.26; N, 6.95. MS (ESI): m/z 
719 [M – Br]+. 
 
trans-[PdBr2(C3X-bimy)2] (4748). Complex 44 (67 mg, 0.10 mmol) 
and KOAc (25 mg, 0.25 mmol) or NaN3 (85 mg, 0.13 mmol) were 
mixed in CH3CN (20 mL) and refluxed overnight. CH2Cl2 (30 mL) was 
added after the solvent was removed. The resulting suspension was 
filtered over Celite and the solvent removed under reduced pressure, giving the product as red 
brown (47) or yellow (48) powders.  
X = OAc, (47). Yield: 59 mg, 0.90 mmol, 90%. 
1
H NMR (300 MHz, CDCl3): δ 9.04 (dd, 
2 H, py–H), 7.76 (t, 1 H, py–H), 7.57 (ps–d, 2 H, py–H), 7.40 (d, 1 H, Ar–H), 7.38–7.31 (m, 5 H, 
Ar–H), 7.23 (t, 1 H, Ar–H), 7.10 (t, 1 H, Ar–H), 7.04 (ps–d, 1 H, Ar–H), 6.16 (s, 2 H, NCH2Ph), 
4.99 (t, 
3
J(H,H) = 7.6 Hz, 2 H, NCH2), 4.31 (t, 
3
J(H,H) = 5.9 Hz, 2 H, CH2OCOCH3), 2.68 (m, 
3




H} NMR (75.48 MHz, CDCl3): δ 
171.5 (C=O), 164.3 (Ccarbene), 153.2, 138.7, 135.6, 135.4, 134.9, 129.5, 128.8, 128.7, 125.2, 123.9. 
123.8, 112.3, 110.7 (Ar–C), 62.5 (CH2OCOCH3), 54.3 (NCH2Ph), 46.3 (NCH2), 29.0 
(CH2OCOCH3), 21.6 (CH2CH2CH2). Anal. Calcd for C24H25Br2N3O2Pd: C, 44.10; H, 3.85; N, 




C NMR spectra are 




X = N3, (48). Yield: 64 mg, 0.10 mmol, >99%. 
1
H NMR (500 MHz, CDCl3): δ 9.04 (d, 2 
H, py–H), 7.76 (t, 1 H, py–H), 7.58 (ps–d, 2 H, py–H), 7.46 (d, 1 H, Ar–H), 7.38–7.30 (m, 5 H, 
Ar–H), 7.25 (t, 1 H, Ar–H), 7.11 (t, 1 H, Ar–H), 7.05 (ps–d, 1 H, Ar–H), 6.17 (s, 2 H, NCH2Ph), 
4.98 (t, 
3
J(H,H) = 7.3 Hz, 2 H, NCH2), 3.60 (t, 
3
J(H,H) = 6.2 Hz, 2 H, CH2N3), 2.61 (m, 
3
J(H,H) 




H} NMR (125.77 MHz, CDCl3): δ 164.4 (Ccarbene), 153.2, 
138.7, 135.7, 135.4, 134.9, 129.5, 128.9, 128.7, 125.3, 124.0, 123.9, 112.3, 110.8 (Ar–C), 54.4 
(NCH2Ph), 49.3 (NCH2), 46.2 (CH2N3), 29.2 (CH2CH2CH2). Anal. Calcd for C22H22Br2N6Pd: C, 
41.50; H, 3.48; N, 13.20. Found: C, 41.76 ;H, 3.74; N, 13.52. MS (ESI): m/z 557 [M – Br]+. 
 
trans-[PdI2(C3I-bimy)(Py)] (49). NaI (1.5 g, 10 mmol) was added into 
the solution of complex 44 (675 mg, 1 mmol) in acetone and stirred at 
ambient temperature for 4 h. The solvent of the suspension was 
removed in vacuo before CH2Cl2 (20 mL) was added. The resulting red 
orange suspension was filtered over Celite, and the solvent of the filtrate was removed under 
reduced pressure to give the product as an orange powder (775 mg, 0.95 mmol, 95%). 
1
H NMR 
(500 MHz, CDCl3): δ 9.07 (d, 2 H, py–H), 7.74 (t, 1 H, py–H), 7.58 (ps–d, 2 H, py–H), 7.52 (d, 1 
H, Ar–H), 7.38–7.31 (m, 5 H, Ar–H), 7.23 (t, 1 H, Ar–H), 7.08 (t, 1 H, Ar–H), 6.95 (ps–d, 1 H, 
Ar–H), 6.05 (s, 2 H, NCH2Ph), 4.94 (t, 
3
J(H,H) = 7.5 Hz, 2 H, NCH2), 3.43 (t, 
3
J(H,H) = 6.2 Hz, 
2 H, CH2I), 2.86 (m, 
3




H} NMR (125.77 MHz, CDCl3): 
δ 163.3 (Ccarbene), 154.6, 138.4, 135.9, 135.3, 135.2, 129.4, 129.0, 128.9, 125.2, 123.8, 123.7, 
112.4, 111.0 (Ar–C), 55.4 (NCH2Ph), 50.3 (NCH2), 32.3 (CH2I), 4.0 (CH2CH2CH2). Anal. Calcd 





C NMR spectra are attached in the appendix.. MS (ESI): m/z 687 [M – I]+. 
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trans-[PdI2(C3X-bimy)(Py)] (5052). Complex 49 (159 mg, 0.20 
mmol) and NaN3 or KSCN or KSAc (13/19/24 mg, 0.20 mmol) were 
stirred in CH3CN (20 mL) overnight at 90 C. The suspension was 
filtered over Celite, and the solvent of the filtrate was removed under reduced pressure, affording 
a red-orange solid. After washing with H2O (3  5 mL), CH2Cl2 (50 mL) was added. The 
resulting suspension was filtered over Celite, and the filtrate was dried in vacuo giving the 
product as red-orange (50) or orange (51) or brown (52) solids.  
X = N3, (50). Yield: 144 mg, 0.20 mmol, 98%. 
1
H NMR (500 MHz, CDCl3): δ 9.05 (d, 2 
H, py–H), 7.73 (t, 1 H, py–H), 7.59 (ps–d, 2 H, py–H), 7.46 (d, 1 H, Ar–H), 7.39–7.31 (m, 5 H, 
Ar–H), 7.24 (t, 1 H, Ar–H), 7.08 (t, 1 H, Ar–H), 6.96 (ps–d, 1 H, Ar–H), 6.06 (s, 2 H, NCH2Ph), 
4.90 (t, 
3
J(H,H) = 7.5 Hz, 2 H, NCH2), 3.60 (t, 
3
J(H,H) = 6.1 Hz, 2 H, CH2N3), 2.63 (m, 
3
J(H,H) 




H} NMR (125.77 MHz, CDCl3): δ 163.0 (Ccarbene), 154.4, 
138.4, 135.8, 135.2, 135.1, 129.4, 128.9, 128.8, 125.2, 123.8, 123.7, 112.4, 110.7 (Ar–C), 55.3 
(NCH2Ph), 49.4 (NCH2), 47.0 (CH2N3), 28.5 (CH2CH2CH2). Anal. Calcd for C22H22I2N6Pd: C, 




X = SCN, (51). Yield: 135 mg, 0.18 mmol, 90%. 
1
H NMR (500 MHz, CDCl3): δ 9.04 (d, 
2 H, py–H), 7.76 (t, 1 H, py–H), 7.56 (ps–d, 2 H, py–H), 7.45 (d, 1 H, Ar–H), 7.38–7.34 (m, 5 H, 
Ar–H), 7.26 (t, 1 H, Ar–H), 7.11 (t, 1H, Ar–H), 6.98 (d, 1 H, Ar–H), 6.06 (s, 2 H, NCH2Ph), 5.01 
(t, 
3
J(H,H) = 6.8 Hz, 2 H, NCH2), 3.28 (t, 
3
J(H,H) = 6.5 Hz, 2 H, CH2SCN), 2.89 (m, 
3
J(H,H) = 




H} NMR (125.77 MHz, CDCl3): δ 163.9 (Ccarbene), 154.6, 138.5, 
135.7, 135.5, 135.1, 129.5, 129.0, 125.3, 124.1, 124.0, 112.7 (Ar–C, 1 × coincident), 112.4 
(SCN), 110.7 (Ar–C), 55.6 (NCH2Ph). 47.7 (NCH2), 32.5 (CH2SCN), 28.9 (CH2CH2CH2). Anal. 
Chapter 6 
140 
Calcd for C23H22I2N4PdS: C, 36.99; H, 2.97; N, 7.50. Found: C, 36.77; H, 3.26; N, 7.96. MS 
(ESI): m/z 719 [M – SCN + MeOH]+. 
 
X = SAc, (52). Yield: 99 mg, 0.13 mmol, 65%. 
1
H NMR (500 MHz, CDCl3): δ 9.06 (d, 2 
H, py–H), 7.74 (t, 1 H, py–H), 7.56 (ps–d, 2 H, py–H), 7.48 (d, 1 H, Ar–H), 7.37–7.34 (m, 5 H, 
Ar–H), 7.22 (t, 1 H, Ar–H), 7.06 ( t, 1 H, Ar–H), 6.93 (ps–d, 1 H, Ar–H), 6.03 (s, 2 H, NCH2Ph), 
4.85 (t, 
3
J(H,H) = 7.8 Hz, 2 H, NCH2), 3.14 (t, 
3
J(H,H) = 6.9 Hz, 2 H, CH2SCOCH3), 2.62 (m, 
3




H} NMR (125.77 MHz, 
CDCl3): δ 196.0 (C=O), 162.9 (Ccarbene), 154.5, 138.4, 135.7, 135.2, 129.4, 128.9, 128.8, 125.2, 
123.7, 123.6, 112.4, 110.8 (Ar–C, 1 × coincident), 55.2 (NCH2Ph), 48.7 (NCH2), 31.4 (SCH2), 
28.9 (SCOCH3), 27.3 (CH2CH2CH2). Anal. Calcd for C24H25I2N3OPdS: C, 37.74; H, 3.30; N, 
5.50. Found: C, 37.49; H, 3.28; N, 5.26. MS (ESI): m/z763 [M – I]+. 
 
 Propyl thiolato bridged complex (53). Sodium hydroxide (10 
mg, 0.25 mmol) in methanol (6 mL) was added to the solution of 
complex 52 (140 mg, 0.17 mmol) in CH2Cl2 (10 mL) and stirred 
overnight. The solvent of the mixture was removed, and CH2Cl2 
(20 mL) was added. The resulting suspension was filtered through Celite, and removal of the 
solvent of the filtrate gave the product as an orange powder (73 mg, 0.07 mmol, 82%). 
1
H NMR 
(500 MHz, CDCl3): δ 7.49 (ps–d, 3 H, Ar–H), 7.39 (ps–d, 3 H, Ar–H), 7.33 (t, 4 H, Ar–H), 7.30–
7.24 (m, 6 H, Ar–H), 7.18 ( t, 2 H, Ar–H), 6.37 (d, 2J(H, H) = 15.8 Hz, 2 H, NCHHPh), 6.25 (m, 
2 H, NCHH), 5.32 (d, 
2
J(H, H) = 15.8 Hz, 2 H, NCHHPh), 4.65 (m, 2 H, NCHH), 3.10–3.00 (m, 




H} NMR (125.77 
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MHz, CDCl3): δ 174.8 (Ccarbene), 136.0, 135.5, 134.0, 129.5, 128.9, 128.5, 124.3, 124.1, 112.4, 
110.7 (Ar–C), 54.0 (NCH2Ph). 43.9(NCH2), 27.1 (SCH2), 27.0 (CH2CH2CH2). Anal. Calcd for 
C34H34I2N4Pd2S2: C, 39.67; H, 3.33; N, 5.44. Found: C, 39.98; H, 3.56; N, 5.22. MS (ESI): m/z 
903 [M – I]+. 
 
trans-[PdI2(C3SO3-bimy)(CH3CN)](NMe4) (54). Complex 53 (103 mg, 
0.10 mmol), Oxone (20 mg, 0.30 mmol) and NMe4I (101 mg, 0.50 mmol) 
in DMF (10 mL) and H2O (4 mL) were stirred at ambient temperature 
overnight. After the solvent was removed, the resulting solid was 
triturated with CH3CN (3 × 10 mL) and the suspension filtered. The solvent of the filtrate was 
removed and the residue was washed with H2O (3 × 3 mL) and redissolved in CH3CN (20 mL). 
Removal of the solvent gave the product as a yellow powder. A second batch was obtained by 
removing the solvent of the aqueous solution, washing the residue with little H2O (3 × 1 mL), and 
recrystallization in CH3CN (5 mL) (137 mg, 0.17 mmol, 85%). 
1
H NMR (500 MHz, CD3CN): δ 
7.68 (d, 1 H, Ar–H), 7.49 (brs, 2 H, Ar–H), 7.31 (brs, 3 H, Ar–H), 7.23 (t, 1 H, Ar–H), 7.08 (t, 
1 H, Ar–H), 6.99 (d, 1 H, Ar–H), 5.90 (s, 2 H, NCH2Ph), 4.84 (brs, 2 H, NCH2), 3.08 (s, 12 H, 
NMe4), 2.65 (brs, 2 H, CH2SO3), 2.56 (brs, 2 H, CH2CH2CH2), 1.96 (s, CH3CN, correct 




H} NMR (125.77 MHz, 
CD3CN): 159.9 (NCN), 135.7, 135.6, 135.1, 129.4, 129.1, 129.0, 124.5, 124.2 (Ar–C), 118.1 
(CN), 112.4, 112.0 (Ar–C), 56.2 (t, 1J(C,N) = 3.7 Hz, NMe4), 54.6 (NCH2Ph), 49.4 (CH2SO3), 
48.9 (NCH2), 24.6 (CH2CH2CH2), 1.32 (m, CH3CN, assignment is tentative due to overlap with 
solvent signals). Anal. Calcd for C23H32I2N4O3PdS: C, 34.32; H, 4.01; N, 6.96. Found: C, 33.99; 
H, 3.83; N, 7.12. MS (ESI): m/z 74 [NMe4]
+





Salt I. α,α’-dibromo-o-xylene (5.3 g, 20 mmol) and 1-benzylbenzimidazole 
(208 mg, 1 mmol) were dissolved in toluene (50 mL) and stirred at 50 ºC 
overnight, resulting in a suspension. The white solid was collected by 
centrifuging and washed with toluene (3 × 10 mL) and diethyl ether (3 × 10 
mL). The solid was redissolved in CH2Cl2 and filtered. Slow evaporation of the filtrate gives the 
product as a white crystalline solid (179 mg, 0.38 mmol, 38%). 
1
H NMR (500 MHz, CDCl3): δ 
11.44 (s, 1 H, NCHN), 7.58 (d, 1 H, Ar–H), 7.54–7.42 (m, 5 H, Ar–H), 7.35–7.28 (m, 6 H, Ar–H), 





NMR (125.77 MHz, CDCl3): 144.0 (NCHN), 136.9, 133.1, 132.33, 132.25, 131.9, 131.7, 130.4, 
129.9, 129.83, 129.76, 129.0, 128.9, 127.83, 127.82, 114.6, 114.5 (Ar–C), 52.4, 49.6 (NCH2Ph), 




Salt J. A mixture of salt I (63 mg, 0.13 mmol) and KSAc (18 mg, 0.16 
mmol) in CH3CN (20 mL) was stirred overnight. The solvent of the mixture 
was removed in vacuo before CH2Cl2 (30 mL) was added. The resulting 
suspension was filtered and dried under reduced pressure to afford the 
product as off-white oil (50 mg, 0.11 mmol, 83%). 
1
H NMR (300 MHz, CDCl3): δ 11.15 (s, 1 H, 
NCHN), 7.64–7.61 (m, 1 H, Ar–H), 7.50–7.39 (m, 5 H, Ar–H), 7.32–7.11 (m, 7 H, Ar–H), 5.92 





(75.47 MHz, CDCl3): 195.1 (CO), 143.6 (NCHN), 136.3, 133.2, 132.0, 131.81, 131.79, 131.0, 
130.1, 129.7, 129.6, 129.4, 129.1, 129.0, 127.8, 127.7, 114.5, 114.3 (Ar–C), 52.1, 49.5 (NCH2Ph), 






Xylenyl-thiolato-bridged complex (55). A mixture of salt J 
(472 mg, 1.0 mmol) and Pd(OAc)2 (224 mg, 1.0 mmol) in 
DMSO (5 mL) was stirred at 80 ºC overnight. The resulting 
suspension was filtered, and the yellow solid was washed with 
H2O (3 × 20 mL) and dried to give the products (403 mg, 0.38 
mmol, 76%). 
1
H NMR (500 MHz, CDCl3): δ 7.59 (d, 2 H, Ar–
H), 7.43–7.39 (m, 4 H, Ar–H), 7.35–7.32 (m, 8 H, Ar–H), 7.22–7.09 (m, 12 H, Ar–H and 
NCHHPh), 7.07–7.06 (m, 2 H, Ar–H), 6.96–6.88 (m, 2 H, NCHH), 5.32 (d, 2 H, NCHHPh), 
4.91–4.81 (m, 2 H, NCHH), 4.39 (d, 2J(H,H) = 15.1 Hz, 1 H, NCHHS), 4.22 (d, 2J(H,H) = 15.1 
Hz, 1 H, NCHHS), 2.63 (d, 
2
J(H,H) = 15.1 Hz, 2 H, NCHHS). Anal. Calcd for 
C44H38Br2N4Pd2S2·H2O: C, 49.04; H, 3.74; N, 5.20. Found: C, 48.72; H, 3.48; N, 5.05. MS (ESI): 
m/z 979 [M – Br]+. The 13C NMR spectrum could not be obtained due to poor solubility. 
 
Xylenyl-sulfonate complex (56). This complex was prepared in 
analogy to complex 54 from complex 55 (212 mg, 0.2 mmol), Oxone 
(39 mg, 0.6 mmol) and NMe4Br (154 mg, 1.0 mmol). Yield: 207 mg, 
0.3 mmol, 74%. 
1
H NMR (500 MHz, CD3CN): δ 7.59 (d, 2 H, Ar–H), 
7.41–7.33 (m, 4 H, Ar–H), 7.22 (t, 1 H, Ar–H), 7.17–7.11 (m, 4 H, Ar–H), 7.04 (t, 1 H, Ar–H), 
6.86 (d, 1 H, Ar–H), 6.41 (s, 2 H, NCH2Ph), 6.13 (s, 2 H, NCH2Ph), 4.17 (s, 2 H, CH2SO3), 3.06 





H} NMR (125.77 MHz, CD3CN): 162.6 (NCN), 136.1, 135.4, 135.2, 134.9, 
133.5, 133.2, 129.6, 129.03, 128.96, 128.2, 128.0, 127.8, 124.5, 124.4 (Ar–C), 118.1 (CN), 113.1, 
112.4 (Ar–C), 56.1 (t, 1J(C,N) = 3.7 Hz, NMe4), 55.5, 53.8 (NCH2Ph), 51.0 (CH2SO3), 1.32 (m, 
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CH3CN, assignment is tentative due to overlap with solvent signals). Anal. Calcd for 
C28H34Br2N4O3PdS: C, 43.51; H, 4.43; N, 7.25. Found: C, 43.23; H, 4.49; N, 7.24. MS (ESI): m/z 
74 [NMe4]
+




trans-[PdBr2(C3X-bimy)2] (5759). A mixture of 45 (93 mg, 0.10 
mmol) and KOAc or NaN3 (98/65 mg, 1.00 mmol) was suspended in 
CH3CN (20 mL) and heated to reflux at 85C for one day. The 
resulting product was dried under reduced pressure followed by 
addition of CH2Cl2 (30 mL). The resulting yellow suspension was 
filtered over Celite and the solvent of the filtrate was removed in vacuo, affording complexes 57 
and 59 as yellow solids. Complex 58 was obtained via the reaction complex 45 (186 mg, 0.20 
mmol) and diethylamine (0.20 mL, 2.00 mmol), which were dissolved in CHCl3 (15 mL) and 
reflux at 70C for one day. The resulting orange liquid was dried under reduced pressure and 
washed with H2O (3  5 mL) to give a brown solid. 
X = OAC, (57). Yield and syn:anti ratio: 79 mg, 0.09 mmol, 90%, 1:1.5. 
1
H NMR (500 
MHz, CDCl3): δ 7.66 (d, 5 H, Ar–H), 7.42–7.31 (m, 15 H, Ar–H), 7.22 (m, 9 H, Ar–H), 7.12–
7.11 (m, 7 H, Ar–H), syn: 5.95 (s, 4 H, NCH2Ph), 4.98 (t, 
3
J(H,H) = 7.3 Hz, 4 H, NCH2), 4.31 (t, 
3
J(H,H) = 6.0 Hz, 4 H, CH2O), 2.74 (m, 4 H, 
3
J(H,H) = 6.5 Hz, CH2CH2CH2), 2.12 (s, 6 H, CH3), 
anti: 6.17 (s, 4 H, NCH2Ph), 4.85 (t, 
3
J(H,H) = 7.5 Hz, 4 H, NCH2), 3.99 (t, 
3
J(H,H) = 6.0 Hz, 4 
H, CH2O), 2.53 (m, 
3





(125.77 MHz, CDCl3): δ 182.6, 182.5 (Ccarbene), 171.5, 171.4 (CO), 135.9, 135.8, 135.54, 135.49, 
135.0, 134.8, 129.5, 129.3, 128.8, 128.42, 128.35, 126.2, 126.1, 123.72, 123.71, 123.69, 112.2, 
112.0, 110.74, 110.69 (Ar–C), 62.6, 62.4 (CH2O), 53.6, 53.3 (NCH2Ph), 45.8 (2 × NCH2), 29.7, 
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29.5 (CH2CH2CH2), 21.6, 21.4 (CH3). Anal. Calcd for C38H40Br2N4O4Pd: C, 51.69; H, 4.57; N, 
6.35. Found: C, 51.76; H, 4.18; N, 6.15. MS (ESI): m/z 803 [M – Br]+. 
 
X = NEt2, (58). Yield and syn:anti ratio: 182 mg, 0.20 mmol, >99%, 1:1.9. 
1
H NMR (500 
MHz, CDCl3): δ 7.66 (d, 5 H, Ar–H), 7.50 (d, 1 H, Ar–H), 7.42 (d, 5 H, Ar–H), 7.37 (t, 6 H, Ar–
H), 7.31 (t, 3 H, Ar–H), 7.21–7.20 (m, 8 H, Ar–H), 7.10–7.06 (m, 8 H, Ar–H), syn: 5.96 (s, 4 H, 
NCH2Ph), 4.94 (t, 
3
J(H,H) = 7.4 Hz, 4 H, NCH2CH2), 2.69 (t, 
3
J(H,H) = 6.9 Hz, 4 H, 
CH2NCH2CH3), 2.62 (m, 
3
J(H,H) = 7.1 Hz, 8 H, CH2NCH2CH3), 2.50 (m, 
3
J(H,H) = 7.2 Hz, 4 H, 
CH2CH2CH2), 1.07 (t, 
3
J(H,H) = 7.1 Hz, 12 H, CH3), anti: 6.18 (s, 4 H, NCH2Ph), 4.82 (t, 
3
J(H,H) 
= 7.6 Hz, 4 H, NCH2CH2), 2.41–2.39 (m, 12 H, CH2NCH2CH3 and CH2NCH2CH3), 2.31 (m, 
3
J(H,H) = 7.2 Hz, 4 H, CH2CH2CH2), 0.91 (t, 
3





(125.77 MHz, CDCl3): δ 182.53, 182.49 (Ccarbene), 136.17, 136.15, 135.7, 135.6, 135.1, 134.9, 
129.5, 129.4, 129.2, 128.7, 128.6, 128.5, 128.38, 123.37, 123.5, 123.4, 112.1, 111.9, 111.4, 111.2 
(Ar–C), 53.8, 53.3 (NCH2Ph), 51.2, 50.9, 47.4, 47.3, 47.2 (2 ) (NCH2), 28.3, 28.1 
(CH2CH2CH2), 12.2, 12.1 (CH3). Anal. Calcd for C42H54Br2N6Pd: C, 55.49; H, 5.99; N, 9.24. 




X = N3, (59). Yield and syn:anti ratio: 85 mg, 0.10 mmol, >99%, 1:2.1. 
1
H NMR (500 
MHz, CDCl3): δ 7.64 (d, 4 H, Ar–H), 7.47 (d, 2 H, Ar–H), 7.40 (ps–t, 10 H, Ar–H), 7.34 (ps–t, 3 
H, Ar–H), 7.28–7.21 (m, 9 H, Ar–H), 7.13–7.12 (m, 8 H, Ar–H), syn: 5.95 (s, 4 H, NCH2Ph), 
4.98 (t, 
3
J(H,H) = 7.1 Hz, 4 H, NCH2), 3.60 (t, 
3
J(H,H) = 6.0 Hz, 4 H, CH2N3), 2.62 (m, 
3
J(H,H) 
= 6.4 Hz, 4 H, CH2CH2CH2), anti: 6.19 (s, 4 H, NCH2Ph), 4.83 (t, 
3
J(H,H) = 7.3 Hz, 4 H, NCH2), 
3.23 (t, 
3
J(H,H) = 6.1 Hz, 4 H, CH2N3), 2.40 (m, 
3







NMR (125.77 MHz, CDCl3): δ 182.62, 182.58 (Ccarbene), 136.0, 135.9, 135.53, 135.46, 135.1, 
134.9, 129.6, 129.3, 128.8, 128.5, 128.35, 128.33, 123.89, 123.88, 123.80, 112.2, 112.1, 111.0, 
110.9 (Ar–C, 2 × coincident), 53.7, 53.3 (NCH2Ph), 49.5, 49.3 (CH2N3), 46.0, 45.9 (NCH2), 29.9, 
29.7 (CH2CH2CH2). Anal. Calcd for C34H34Br2N10Pd: C, 48.10; H, 4.04; N, 16.50. Found: C, 




C NMR spectra are attached in the 
appendix. MS (ESI): m/z 769 [M – Br]+. 
 
trans-[PdI2(C3I-bimy)2] (60). A solution of NaI (0.30 g, 2.00 mmol) 
in acetone (50 mL) was added to a suspension of complex 45 (93 mg, 
0.10 mmol) in CH2Cl2 (20 mL) and stirred overnight. The solvent of 
the suspension was removed in vacuo, and 100 mL of CH2Cl2 was 
added. The resulting yellow suspension was filtered over Celite, and 
the solvent removed under reduced pressure to give the products as 
yellow powders. Yield and syn:anti ratio: 106 mg, 0.10 mmol, 95%, 1:1.2. 
1
H NMR (500 MHz, 
CDCl3): δ 7.59–7.55 (m, 6 H, Ar–H), 7.48 (d, 2 H, Ar–H), 7.38 (t, 8 H, Ar–H), 7.34 (d, 2 H, Ar–
H), 7.24 (m, 10 H, Ar–H), 7.14–7.09 (m, 4 H, Ar–H), 7.03 (t, 4 H, Ar–H), syn: 5.85 (s, 4 H, 
NCH2Ph), 4.89 (t, 
3
J(H,H) = 7.3 Hz, 4 H, NCH2), 3.38 (t, 
3
J(H,H) = 6.4 Hz, 4 H, CH2I), 2.89 (m, 
3
J(H,H) = 7.2 Hz, 4 H, CH2CH2CH2), anti: 6.06 (s, 4 H, NCH2Ph), 4.78 (t, 
3
J(H,H) = 7.5 Hz, 4 H, 
NCH2), 3.03 (t, 
3
J(H,H) = 6.3 Hz, 4 H, CH2I), 2.68 (m, 
3




H} NMR (125.77 MHz, CDCl3): δ 181.8, 181.7 (Ccarbene), 136.0, 135.9, 135.57, 135.56, 
135.4, 129.6, 129.3, 128.8, 128.58, 128.56, 128.54, 123.72, 123.68, 112.3, 112.2, 111.1, 111.0 
(Ar–C, 3 × coincident), 54.7, 54.2 (NCH2Ph), 49.9 (2  CH2I), 33.2, 32.8 (NCH2), 3.84, 3.20 
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(CH2CH2CH2). Anal. Calcd for C34H34I4N4Pd: C, 36.70; H, 3.08; N, 5.04. Found: C, 36.49; H, 
3.43; N, 4.98. MS (ESI): m/z 985 [M – I]+. 
 
trans-[Pd(SPh)2(C3SPh-bimy)2] (61). Complex 45 (93 mg, 0.10 
mmol) and freshly made NaSPh (132 mg, 1.00 mmol) were 
suspended in degassed THF (30 mL) and stirred overnight. The 
suspension was dried under reduced pressure and CH2Cl2 (50 mL) 
was added. The liquid was collected by filtration, concentrated to 5 
mL, and subjected to colum chromatography (SiO2, ethyl acetate:hexane = 1:8). The products 
were collected as bright yellow solids. Yield and syn:anti ratio: 81 mg, 0.08 mmol, 78%, 1:1.5. 
1
H NMR (500 MHz, CDCl3): δ 7.77 (d, 4 H, Ar–H), 7.59 (d, 3 H, Ar–H), 7.52 (t, 1 H, Ar–H), 
7.47 (d, 2 H, Ar–H), 7.43–7.38 (m, 5 H, Ar–H), 7.33–7.26 (m, 22 H, Ar–H), 7.19 (t, 6 H, Ar–H), 
7.11–7.06 (m, 7 H, Ar–H), 7.01 (t, 4 H, Ar–H), 6.96 (d, 4 H, Ar–H), 6.91 (d, 5 H, Ar–H), 6.86 (d, 
2 H, Ar–H), 6.60–6.53 (m, 4 H, Ar–H), 6.46–6.42 (m, 7 H, Ar–H), syn: 5.72 (s, 4 H, NCH2Ph), 
4.93 (t, 
3
J(H,H) = 7.5 Hz, 4 H, NCH2), 3.25 (t, 
3
J(H,H) = 6.6 Hz, 4 H, CH2S), 2.69 (m, 
3
J(H,H) = 
7.2 Hz, 4 H, CH2CH2CH2), anti: 5.98 (s, 4 H, NCH2Ph), 4.71 (t, 
3
J(H,H) = 7.7 Hz, 4 H, NCH2), 
3.02 (t, 
3
J(H,H) = 6.6 Hz, 4 H, CH2S), 2.56 (m, 
3





NMR (125.77 MHz, CDCl3): δ 191.1, 191.0 (Ccarbene), 145.1, 145.0, 136.9, 136.8, 136.5, 135.8, 
135.5, 135.4, 135.1, 135.02, 134.96, 130.0, 129.9, 129.7, 129.6, 129.4, 129.3, 129.0, 128.9, 128.7, 
128.6, 128.5, 127.5, 127.4, 126.8, 126.7, 124.02, 123.96, 123.03, 122.98, 122.95, 111.8, 111.7, 
110.6 (Ar−C, 2 × coincident), 53.8, 53.4 (NCH2Ph), 47.8 (2  NCH2), 32.2, 31.9 (CH2S), 29.5, 
29.4 (CH2CH2CH2). Anal. Calcd for C58H54N4PdS4: C, 66.87; H, 5.23; N, 5.38. Found: C, 66.50; 
H, 5.09; N, 5.32. MS (ESI): m/z 931 [M – SPh]+. 
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trans-[Pd(SCN)2(C3SCN-bimy)2] (62). Complex 45 (93 mg, 0.10 
mmol) and KSCN (98 mg, 1.00 mmol) were suspended in CH3CN 
(30 mL) and refluxed overnight. The resulting yellow suspension 
was dried in vacuo before CH2Cl2 (20 mL) was added. The 
suspension was then filtered and dried to give the pure products as 
pale yellow solids. Yield and syn:anti ratio: 82 mg, 0.10 mmol, 98%, 1:1.9. 
1
H NMR (500 MHz, 
CDCl3): δ 7.54 (d, 2 H, Ar–H), 7.50 (d, 2 H, Ar–H), 7.47–7.40 (m, 12 H, Ar–H), 7.35–7.31 (m, 4 
H, Ar–H), 7.29–7.28 (m, 6 H, Ar–H), 7.23–7.17 (m, 10 H, Ar–H), syn: 5.89 (s, 4 H, NCH2Ph), 
5.03 (t, 
3
J(H,H) = 6.9 Hz, 4 H, NCH2), 3.19 (t, 
3
J(H,H) = 6.8 Hz, 4 H, CH2SCN), 2.88 (m, 
3
J(H,H) 
= 6.9 Hz, 4 H, CH2CH2CH2), anti: 6.21 (s, 4 H, NCH2Ph), 4.90 (t, 
3
J(H,H) = 6.9 Hz, 4 H, NCH2), 
2.79 (t, 4 H, 
3
J(H,H) = 6.7 Hz, CH2SCN), 2.60 (m, 
3





NMR (125.77 MHz, CDCl3): δ 180.8, 180.7 (Ccarbene), 136.0, 135.90, 135.88, 135.8, 135.1, 135.0, 
130.0, 129.63, 129.60, 129.2, 128.9, 127.5, 127.4, 124.99, 124.95 124.91 (Ar–C), 120.5, 120.4 
(PdSCN), 112.7, 112.5 (Ar–C), 112.4, 112.3 (CH2SCN), 112.1, 111.2 (Ar–C), 53.4, 53.1 
(NCH2Ph), 47.0, 46.7 (NCH2), 31.8, 31.3 (CH2SCN), 30.6, 30.0 (CH2CH2CH2). Anal. Calcd for 










trans-[Pd(SCN)2(C3Br-bimy)2] (63). Complex 45 (93 mg, 0.10 
mmol) and KSCN (98 mg, 1.00 mmol) were suspended in THF (30 
mL) and stirred overnight. The resulting yellow suspension was 
filtered before the filtrate was dried in vacuo and CH2Cl2 (20 mL) 
Chapter 6 
149 
was added. The CH2Cl2 layer was collected by filtration and left slow evaporation to afford the 
products as yellow crystals. Yield and syn:anti ratio: 67 mg, 0.08 mmol, 76%, 1:2.6. 
1
H NMR 
(500 MHz, CDCl3): δ 7.63 (d, 1 H, Ar–H), 7.55 (d, 3 H, Ar–H), 7.47–7.41 (m, 12 H, Ar–H), 
7.39–7.37 (m, 4 H, Ar–H), 7.32–7.28 (m, 8 H, Ar–H), 7.17 (t, 5 H, Ar–H), 7.13 (d, 3 H, Ar–H), 
syn: 5.88 (s, 4 H, NCH2Ph), 5.02 (t, 
3
J(H,H) = 7.2 Hz, 4 H, NCH2), 3.66 (t, 4 H, 
3
J(H,H) = 5.9 Hz, 
CH2Br), 2.88 (m, 
3
J(H,H) = 6.5 Hz, 4 H, CH2CH2CH2), anti: 6.19 (s, 4 H, NCH2Ph), 4.89 (t, 
3
J(H,H) = 7.4 Hz, 4 H, NCH2), 3.35 (t, 
3
J(H,H) = 5.8 Hz, 4 H, CH2Br), 2.67 (m, 
3
J(H,H) = 6.7 Hz, 




H} NMR (125.77 MHz, CDCl3): δ 181.0 (2  Ccarbene), 136.4, 136.3, 
136.0, 135.8, 135.3, 135.2, 129.8, 129.71, 129.65, 129.1, 128.9, 128.1, 127.8, 127.7, 124.69, 
124.67 (Ar–C), 120.64, 120.61 (PdSCN), 112.7, 112.3, 111.5, 111.3 (Ar–C), 53.7, 53.1 
(NCH2Ph), 47.5 (2  NCH2), 33.5, 33.1 (CH2Br), 31.4, 30.9 (CH2CH2CH2). Anal. Calcd for 
C36H34Br2N6PdS2: C, 49.08; H, 3.89; N, 9.54. Found: C, 49.06; H, 4.17; N, 9.47. MS (ESI): m/z 
822 [M – SCN]+. 
 
trans-[PdI2(C3X-bimy)2] (6467). Complex 60 (56 mg, 0.05 mmol) 
and NaN3 (33 mg, 0.50 mmol) or NaSPh (18 mg, 0.14 mmol) or 
KSAc (21 mg, 0.19 mmol) or KSCN (15 mg, 0.15 mmol) were 
suspended in CH3CN (20 mL) and stirred overnight. The solvent of 
the suspension was removed in vacuo, and CH2Cl2 (50 mL) of was 
added. The resulting yellow suspension was filtered over Celite and the solvent removed under 
reduced pressure to give the products as yellow powders. 
X = N3, (64). Yield and syn:anti ratio: 42 mg, 0.05 mmol, 99%, 1:1.7. 
1
H NMR (500 MHz, 
CDCl3): δ 7.62 (d, 4 H, Ar–H), 7.47 (d, 2 H, Ar–H), 7.42–7.38 (m, 10 H, Ar–H), 7.36–7.33 (m, 2 
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H, Ar–H), 7.28–7.22 (m, 9 H, Ar–H), 7.14–7.09 (m, 4 H, Ar–H), 7.04 (t, 4 H, Ar–H), 6.99 (s, 1 H, 
Ar–H), syn: 5.87 (s, 4 H, NCH2Ph), 4.89 (t, 
3
J(H,H) = 7.3 Hz, 4 H, NCH2), 3.59 (t, 
3
J(H,H) = 6.1 
Hz, 4 H, CH2N3), 2.61 (m, 
3
J(H,H) = 7.2 Hz, 4 H, CH2CH2CH2), anti: 6.09 (s, 4 H, NCH2Ph), 
4.77 (t, 
3
J(H,H) = 7.5 Hz, 4 H, NCH2), 3.28 (t, 
3
J(H,H) = 6.2 Hz, 4 H, CH2N3), 2.42 (m, 
3
J(H,H) 




H} NMR (125.77 MHz, CDCl3): δ 181.9, 181.8 (Ccarbene), 
135.95, 135.87, 135.64, 135.59, 135.5, 135.3, 129.5, 129.3, 128.8, 128.6, 128.5, 126.2, 123.7, 
123.64, 123.60, 112.3, 112.2 110.9, 110.8 (Ar–C, 2 × coincident), 54.5, 54.2 (NCH2Ph), 49.6, 
49.3 (CH2N3), 46.6, 46.4 (NCH2), 29.2, 29.0 (CH2CH2CH2). Anal. Calcd for C34H34I2N10Pd: C, 





NMR spectra are attached in the appendix. MS (ESI): m/z 815 [M – I]+. 
 
X = SPh, (65). Yield and syn:anti ratio: 48 mg, 0.44 mmol, 89%, 1:1.3. 
1
H NMR (500 
MHz, CDCl3): δ 7.60 (d, 4 H, Ar–H), 7.51 (d, 1 H, Ar–H), 7.42–7.29 (m, 22 H, Ar–H), 7.26–7.21 
(m, 15 H, Ar–H), 7.20–7.15 (m, 6 H, Ar–H), 7.10–7.06 (m, 4 H, Ar–H), 7.02–7.00 (m, 4 H, Ar–
H), syn: 5.86 (s, 4 H, NCH2Ph), 4.93 (t, 
3
J(H,H) = 7.4 Hz, 4 H, NCH2), 3.12 (t, 4 H, 
3
J(H,H) = 
6.6 Hz, CH2S), 2.65 (m, 
3
J(H,H) = 7.2 Hz, 4 H, CH2CH2CH2), anti: 6.08 (s, 4 H, NCH2Ph), 4.83 
(t, 
3
J(H,H) = 7.5 Hz, 4 H, NCH2), 2.85 (t, 
3
J(H,H) = 6.5 Hz, 4 H, CH2S), 2.49 (m, 
3
J(H,H) = 7.3 




H} NMR (125.77 MHz, CDCl3): δ 181.71, 181.66 (Ccarbene), 136.4, 
136.3, 135.9, 135.8, 135.7, 135.5, 135.3, 130.4, 130.1, 129.8, 129.7, 129.6, 129.5, 129.3, 128.7, 
128.59, 128.57, 128.5, 128.1, 127.0, 126.8, 123.52, 123.47, 123.45, 112.2, 112.0, 111.04, 110.96 
(Ar–C), 54.6, 54.1 (NCH2Ph), 48.0, 47.9 (NCH2), 32.0, 31.5 (CH2S), 28.8, 28.5 (CH2CH2CH2). 
Anal. Calcd for C46H44I2N4PdS2: C, 51.29; H, 4.12; N, 5.20. Found: C, 51.68; H, 4.58; N, 4.66 
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C NMR spectra are attached in the appendix. MS (ESI): m/z 951 
[M – I]+. 
 
X = SAc, (66). Yield and syn:anti ratio: 10 mg, 0.01 mmol, 20%, 1:1.1. 
1
H NMR (500 
MHz, CDCl3): δ 7.63 (d, 4 H, Ar–H), 7.44 (d, 2 H, Ar–H), 7.39–7.36 (m, 12 H, Ar–H), 7.33 (d, 2 
H, Ar–H), 7.24–7.20 (m, 8 H, Ar–H), 7.12–7.07 (m, 4 H, Ar–H), 7.01 (t, 4 H, Ar–H), syn: 5.85 (s, 
4 H, NCH2Ph), 4.86 (t, 
3
J(H,H) = 7.5 Hz, 4 H, NCH2), 3.12 (t, 
3
J(H,H) = 7.1 Hz, 4 H, CH2S), 
2.64, (m, 
3
J(H,H) = 7.4 Hz, 4 H, CH2CH2CH2), 2.40 (s, 6 H, CH3), anti: 6.09 (s, 4 H, NCH2Ph), 
4.72 (t, 
3
J(H,H) = 7.7 Hz, 4 H, NCH2), 2.81 (t, 
3
J(H,H) = 6.9 Hz, 4 H, CH2S), 2.44 (m, 
3
J(H,H) = 




H} NMR (125.77 MHz, CDCl3): δ 196.2, 
196.1 (CO), 181.7, 181.6 (Ccarbene), 135.9, 135.8, 135.7, 135.6, 135.4, 129.5, 129.3, 128.79, 
128.77, 128.63, 128.61, 128.5, 123.61, 123.56, 123.5, 112.4, 112.3, 112.2, 111.0, 110.9 (Ar–C), 
54.7, 54.2 (NCH2Ph), 48.3, 48.2 (NCH2), 31.4, 31.1 (CH2S), 29.8, 29.4 (CH2CH2CH2), 27.4, 27.1 
(CH3). Anal. Calcd for C38H40I2N4O2PdS2: C, 45.23; H, 4.00; N, 5.35. Found: C, 45.48; H, 3.87; 
N, 5.59. MS (ESI): m/z 881 [M – I]+. 
 
X = SCN, (67). Yield and syn:anti ratio: 36 mg, 0.04 mmol, 74%, 1:1.8. 
1
H NMR (500 
MHz, CDCl3): δ 7.52 (d, 5 H, Ar–H), 7.48 (d, 2 H, Ar–H), 7.44–7.35 (m, 8 H, Ar–H), 7.32–7.22 
(m, 12 H, Ar–H), 7.15 (t, 5 H, Ar–H), 7.06 (ps–d, 4 H, Ar–H), syn: 5.84 (s, 4 H, NCH2Ph), 4.97 
(t, 
3
J(H,H) = 6.8 Hz, 4 H, NCH2), 3.19 (t, 
3
J(H,H) = 6.8 Hz, 4 H, CH2SCN), 2.91 (m, 
3
J(H,H) = 
6.8 Hz, 4 H, CH2CH2CH2), anti: 6.10 (s, 4 H, NCH2Ph), 4.86 (t, 
3
J(H,H) = 6.8 Hz, 4 H, NCH2), 
2.77 (t, 
3
J(H,H) = 6.6 Hz, 4 H, CH2SCN), 2.63 (m, 
3





NMR (125.77 MHz, CDCl3): δ 181.6, 181.5 (Ccarbene), 135.7, 135.54, 135.48, 135.3, 129.7, 129.3, 
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129.0, 128.6, 128.4, 128.1, 124.10, 124.06, 124.0, 112.5 (Ar–C), 112.40, 112.38 (SCN), 110.9 
(Ar–C, 5 × coincident), 54.5, 54.1 (NCH2Ph), 47.2, 47.1 (NCH2), 32.1, 31.6 (CH2SCN), 29.6, 
29.0 (CH2CH2CH2). Anal. Calcd for C36H34I2N6PdS2: C, 44.35; H, 3.51; N, 8.62. Found: C, 44.59, 
H, 3.63; N, 8.32. MS (ESI): m/z 847 [M – I]+. 
 
trans-[PdBr2(C3NEt3-bimy)2]Br2 (68). Complex 58 (1.20 g, 1.30 
mmol) was dissolved in ethyl bromide (15 mL, 200 mmol) in a 
sealed Schlenk tube and stirred overnight at 70 °C. The precipitate 
was collected by filtration and washed with CH3CN (3  5 mL) to 
give the product as off-white solid (1.20 g, 1.10 mmol, 86%) in a 
syn:anti ratio of 1:4.5. 
1
H NMR (500 MHz, d6-DMSO): δ 7.98 (d, 1 
H, Ar–H), 7.91 (d, 3 H, Ar–H), 7.60 (d, 6 H, Ar–H), 7.55 (d, 2 H, 
Ar–H),7.42–7.32 (m, 15 H, Ar–H), 7.26 (ps–d, 7 H, Ar–H), 7.21 (ps–d, 2 H, Ar–H), syn: 6.05 (s, 
4 H, NCH2Ph), 5.02 (t, 
3
J(H,H) = 6.7 Hz, 4 H, NCH2CH2), 3.53 (t, 
3
J(H,H) = 7.3 Hz, 4 H, 
CH2CH2N
+
), 3.30 (m, 
3
J(H,H) = 6.7 Hz, 12 H, N
+
CH2CH3), 2.62 (br–m, 4 H, CH2CH2CH2), 1.15 
(t, 
3
J(H,H) = 7.1 Hz, 18 H, CH3), anti: 6.25 (s, 4 H, NCH2Ph), 4.97 (t, 
3
J(H,H) = 6.7 Hz, 4 H, 
NCH2CH2), 3.20 (t, 
3
J(H,H) = 7.5 Hz, 4 H, CH2CH2N
+
), 3.00 (m, 
3
J(H,H) = 7.0 Hz, 12 H, 
N
+
CH2CH3), 2.36 (br–m, 4 H, CH2CH2CH2), 0.96 (t, 
3





NMR (125.77 MHz, d6-DMSO): δ 180.7, 180.5 (Ccarbene), 135.7, 135.4, 134.0, 133.9, 133.7, 
133.3, 128.5, 128.3, 127.90, 127.87, 127.7, 123.6, 123.5, 111.9, 111.7, 111.6, 111.4 (Ar–C, 3 × 
coincident), 53.7 (2  NCH2Ph), 52.3, 52.1 (2 ), 51.8 (N
+
CH2), 44.7 (2  NCH2), 21.7 (2  
CH2CH2CH2), 7.3, 7.0 (CH3). Anal. Calcd for C46H64Br4N6Pd: C, 49.02; H, 5.72; N, 7.46. Found: 
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C NMR spectra are attached in the 
appendix. MS (ESI): m/z 483 [M – 2Br]2+, 1047 [M – Br]+.  
 
General procedure for the Mizoroki-Heck cross-couplings. In a typical run, a reaction 
tube was charged with a mixture of aryl halide (1 mmol for monohalides. 0.5 mmol for dihalides, 
0.33 mmol for trihalides and 0.25 mmol for tetrahalides), NaOAc (1.5 equiv per halide present), 
tert-butyl acrylate (1.5 equiv per halide present), catalyst (1 mol% per halide present) and DMF 
(3 mL). The reaction was stirred and heated at 130 °C for 20 h. After the mixture was cooled to 
ambient temperature, dichloromethane (5 mL) was added. The organic layer was then washed 
with water (5 × 10 mL) and dried over Na2SO4. The solvent was reduced and the residue was 





H NMR (500 MHz, 
CDCl3): δ 7.86 (d, 
3
J(H,H) = 15.8 Hz, 4 H, CH), 7.70 (s, 2 H, 




H} NMR (125.77 MHz, 
CDCl3): δ 166.0 (CO), 139.8, 136.1, 127.3, 125.5 (Ar–C and CH=CH), 81.7 (C(CH3)3), 28.9 
(CH3). Anal. Calcd for C34H46O8: C, 70.08; H, 7.96. Found: C,70.00, H, 8.11. MS (ESI): m/z 663 




trans-[PdBr2(C3NEt3-bimy)2](HCO2)2 (70). Complex 68 (48 mg, 
0.04 mmol) and silver formate (13 mg, 0.09 mmol) were mixed in 
CH2Cl2/MeOH (10/5 mL). The mixture was stirred for 2 h before the 
precipitate was filtered off through Celite. Removal of the solvent 
gave an off-white solid which was dissolved in CD3CN for NMR. 
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The syn:anti ratio is 1:2.9. 
1
H NMR (300 MHz, CD3CN): δ 8.60 (s, 2 H, HCOO

), 7.81 (d, 1 H, 
Ar–H), 7.74 (d, 3 H, Ar–H), 7.55–7.53 (m, 6 H, Ar–H), 7.48–7.45 (m, 2 H, Ar–H), 7.39–7.30 (m, 
15 H, Ar–H), 7.24–7.18 (m, 9 H, Ar–H), syn: 6.02 (s, 4 H, NCH2Ph), 5.08 (t, 
3
J(H,H) = 6.7 Hz, 4 
H, NCH2CH2), 3.58 (m, 4 H, CH2CH2N
+
), 1.14 (t, 
3
J(H,H) = 7.2 Hz, 18 H, CH3), the N
+
CH2CH3 
protons are overlapped with CH2CH2N
+
 protons of the anti-isomer at 3.26–3.16 (m, 20 H), the 
CH2CH2CH2 protons are overlapped with the water signal at 2.69 ppm, anti: 6.25 (s, 4 H, 
NCH2Ph), 4.98 (t, 
3
J(H,H) = 6.3 Hz, 4 H, NCH2CH2), 2.93 (m, 
3
J(H,H) = 7.5 Hz, 12 H, 
N
+
CH2CH3), 2.37 (m, 4 H, CH2CH2CH2), 0.94 (t, 
3





(75.48 MHz, CD3CN): δ 182.4, 182.2 (Ccarbene), 167.7 (HCOO

), 137.3, 136.7, 135.4, 134.8, 
129.7, 129.6, 129.5, 129.1, 128.9, 128.8, 128.6, 128.5, 124.8, 124.6, 124.2, 124.1, 112.7, 112.24, 
112.15, 111.9 (Ar–C), 55.34, 55.25 (NCH2Ph), 53.6 (2 ), 53.34, 53.27 (N
+
CH2), 46.1, 45.8 






(C3NEt3-bimy)2]X2 (71, X = Br and HCO2). Complex 70 was 
left in CD3CN for 2 h to convert to this complex. 
1
H NMR (500 
MHz, CD3CN): δ 8.62 (s, 1 H, HCOO

), 7.76 (d, 2 H, Ar–H), 7.53 
(br–s, 4 H, Ar–H), 7.34–7.33 (m, 7 H, Ar–H), 7.28–7.22 (m, 5 H, 
Ar–H), 6.05 (s, 4 H, NCH2Ph), 5.84 (br–s, 4 H, NCH2CH2), 3.32 
(br–s, 4 H, CH2CH2N
+
), 3.03 (m, 
3
J(H,H) = 7.0 Hz, 12 H, 
N
+
CH2CH3), 2.41 (br–s, 4 H, CH2CH2CH2), 0.94 (t, 
3





NMR (125.77 MHz, CD3CN): δ 193.4 (Ccarbene), 167.7 (HCOO

), 137.4, 135.4, 135.1, 129.6, 
128.9, 128.6, 124.2, 124.1, 112.2, 111.9 (Ar–C), 55.3 (NCH2Ph), 53.7, 53.3 (N
+
CH2), 46.2 





Compound K. A mixture of 2-chloropropylamine hydrochloride (780 
mg, 6 mmol) and NEt3 (1.35 mL) in dry CH2Cl2 (30 mL) was stirred for 
1 h to give the free amine. Compound pyridine 2,6-dicarboxylic acid 
chloride (600 mg, 2.9 mmol) was added to this solution, and the reaction 
mixture was stirred at room temperature for 8 h. The solvent was evaporated before H2O was 
added. The aqueous layer was extracted with CHCl3 (3 × 50 mL), and the combined organic 
phases was dried over anhydrous Na2SO4 and concentrated in vacuo. The resulting crude solid 
was purified by column chromatography (SiO2, hexane/ethyl acetate: 1/1) to give K as a white 
solid (590 mg, 1.9 mmol, 64%). 
1
H NMR (500 MHz, CDCl3): δ 8.36–8.34 (ps–d, 2 H, Py–H), 
8.17 (brs, 2 H, CONH), 8.06–8.01 (ps–t, 1 H, Py–H), 3.66 (m, 8 H, NHCH2 and CH2Cl), 2.13 




H} NMR (125.77 MHz, CDCl3): δ 164.5 (CO), 149.3, 139.8, 125.7 (Py–C), 
43.7 (CH2Cl), 38.1 (NHCH2), 32.6 (CH2). Anal. Calcd for C13H17Cl2N3O2: C, 49.07; H, 5.38; N, 




Salt LBn. To the solution of compound K (159 mg, 0.5 
mmol) in CH3CN (30 mL), 1-benzylbenzimidazole (260 
mg, 1.25 mmol) and NaI (750 mg, 5 mmol) was added. 
After the mixture was applied with microwave for 3 h at 
150 C, the solvent was removed under reduced pressure 
and CH2Cl2 (100 mL) was added. The resulting suspension was filtered through Celite. Solvent 
of the filtrate was dried off in vacuo. Ethyl acetate (3 × 20 mL) was added to wash the residue, 
giving the product as a pale yellow powder (450 mg, 0.49 mmol, 98%). 
1
H NMR (500 MHz, 
DMSO-d6): δ 9.99 (s, 2 H, NCHN), 9.40 (t, 
3
J(H,H) = 6.1 Hz, 2 H, NH), 8.19 (pss, 3 H, Py–H), 
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8.11 (d, 2 H, Ar–H), 7.92 (d, 2 H, Ar–H), 7.67–7.60 (m, 4 H, Ar–H), 7.52 (ps–d, 4 H, Ar–H), 
7.43–7.36 (m, 6 H, Ar–H), 5.76 (s, 4 H, NCH2Ph), 4.62 (t, 
3
J(H,H) = 7.0 Hz, 4 H, NCH2), 3.51 
(m, 
3
J(H,H) = 6.4 Hz, 4 H, NHCH2), 2.31 (m, 
3





NMR (125.77 MHz, DMSO-d6): δ 163.4 (CO), 148.4 (C2/6), 142.6 (NCHN), 139.5 (C4), 133.9, 
131.2, 130.9, 129.0, 128.7, 128.3, 126.7, 126.6 (Ar–C), 124.3 (C3/5), 113.9, 113.8 (Ar–C), 49.9 
(NCH2Ph), 45.0 (NCH2), 35.9 (NHCH2), 28.9 (CH2CH2CH2). Anal. Calcd for C41H41I2N7O2: C, 
53.66; H, 4.50; N, 10.68. Found: C, 53.68; H, 4.88; N. 10.59 MS (ESI): m/z 332 [M – 2 I]2+, 790 
[M –I]+.  
Salt LMe. This salt was prepared in analogy to LBn from 0.5 mmol of compound K with 1-
methylbenzimidazole (165 mg, 1.25 mmol) and NaI (750 mg, 5 mmol). Yield: 341 mg, 0.45 
mmol, 89%. 
1
H NMR (500 MHz, DMSO-d6): δ 9.77 (s, 2 H, NCHN), 9.29 (t, 
3
J(H,H) = 5.9 Hz, 2 
H, NH), 8.17 (br–s, 3 H, Py–H), 8.09 (ps–t, 2 H, Ar–H), 7.97 (ps–t, 2 H, Ar–H), 7.66 (ps–t, 4 H, 
Ar–H), 4.60 (t, 3J(H,H) = 6.5 Hz, 4 H, NCH2), 4.06 (s, 6 H, NCH3), 3.50 (m, 
3
J(H,H) = 6.0 Hz, 4 




H} NMR (125.77 MHz, DMSO-d6): δ 163.3 
(CO), 148.3 (C2/6), 142.8 (NCHN), 139.5 (C4), 131.8, 130.8, 126.4 (Ar–C, two are coincident), 
124.2 (C3/5), 113.53, 113.47 (Ar–C), 44.8 (NCH2), 36.0 (NCH3), 33.2 (NHCH2), 28.8 
(CH2CH2CH2). Anal. Calcd for C29H33I2N7O2: C, 45.51; H, 4.35; N, 12.81. Found: C, 45.82; H, 
4.37; N, 12.45. MS (ESI): m/z 256 [M – 2 I]2+, 638 [M – I]+. 
Salt MBn. Salt LBn (890 mg, 0.97 mmol) was mixed with AgBF4 (380 mg, 1.95 mmol) in 
CH3CN and stirred for 3 h. The precipitation was removed by filtering through Celite. The filtrate 
was dried in vacuo to afford the product as white powders (747 mg, 0.89 mmol, 92%). 
1
H NMR 
(300 MHz, CD3CN): δ 9.35 (s, 2 H, NCHN), 8.75 (t, 
3
J(H,H) = 5.9 Hz, 2 H, NH), 8.20 (ps–d, 2 H, 
C3/5H), 8.08 (ps–t, 1 H, C4–H), 7.90 (d, 2 H, Ar–H), 7.69–7.53 (m, 6 H, Ar–H), 7.46–7.39 (m, 
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10 H, Ar–H), 5.60 (s, 4 H, NCH2Ph), 4.54 (t, 
3
J(H,H) = 6.8 Hz, 4 H, NCH2), 3.56 (m, 
3
J(H,H) = 
6.3 Hz, 4 H, NHCH2), 2.36 (m, 
3




H} NMR (75.48 MHz, 
CD3CN): δ 164.9 (CO), 149.7 (C2/6), 142.7 (NCHN), 140.2 (C4), 140.0, 132.7, 132.4, 130.2, 
130.1, 129.5, 128.0 (Ar–C, two are coincident), 125.4 (C3/5), 114.7, 114.6 (Ar–C), 51.7 
(NCH2Ph), 46.3 (NCH2), 36.8 (NHCH2), 29.4 (CH2CH2CH2). 
19
F NMR (282.38 MHz, CD3CN): 
δ -74.82, -74.87 (s, BF4). Anal. Calcd for C41H41B2F8N7O2: C, 58.80; H, 4.93; N, 11.71. Found: C, 
58.36; H, 4.64; N, 11.68. MS (ESI): m/z 332 [M – 2 BF4]
2+
, 750 [M – BF4]
+
.  
Salt MMe. This salt was prepared in analogy to MBn from LMe (742 mg, 0.97 mmol) and 
AgBF4 (380 mg, 1.95 mmol). Yield: 645 mg, 0.94 mmol, 97%. 
1
H NMR (500 MHz, CD3CN): 
9.14 (s, 2 H, NCHN), 8.54 (t, 
3
J(H,H) = 5.6 Hz, 2 H, NH), 8.16 (psd, 2 H, C3/5H), 8.05 (pst, 
1 H, C4H), 7.877.85 (m, 2 H, ArH), 7.747.73 (m, 2 H, ArH), 7.617.58 (m, 4 H, ArH), 
4.52 (t, 
3
J(H,H) = 6.8 Hz, 4 H, NCH2), 4.00 (s, 6 H, NCH3), 3.54 (m, 
3
J(H,H) = 6.3 Hz, 4 H, 
NHCH2), 2.33 (m, 
3




H} NMR (125.77 MHz, CD3CN): 
δ 164.8 (CO), 149.5 (C2/6), 142.9 (NCHN), 140.3 (C4), 133.2, 132.2, 127.83, 127.79 (ArC), 
125.4 (C3/5), 114.3, 114.1 (ArC), 46.2 (NCH2), 37.0 (NCH3), 34.1 (NHCH2), 29.4 
(CH2CH2CH2). 
19
F NMR (282.38 MHz, CD3CN): δ -74.87, -74.93 (s, BF4). Anal. Calcd for 
C29H33B2F8N7O2: C, 50.83; H, 4.85; N, 14.31. Found: C, 50.97; H, 4.78; N, 14.28. MS (ESI): m/z 
256 [M – 2 BF4]
2+




Silver(I) dicarbene complex 72Bn. A mixture of salt MBn (84 mg, 
0.10 mmol) was dissolved in CH3CN (20 mL) before Ag2O (28 
mg, 0.12 mmol) was added. The mixture was heated at 60 C 
with stirring for 5 h. The resulting suspension was dried in vacuo 
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before 100 mL of CH2Cl2 was added and filtered. The filtrate was consequently extracted with 
water (5 × 100 mL) and fried over Na2SO4. After the solvent was removed under reduced 
pressure, the white solid obtained was the product (86 mg, 0.10 mmol, 99%). 
1
H NMR (500 MHz, 
CD3CN): δ 8.57 (brs, 2 H, NH), 7.73 (brs, 2 H, C3/5), 7.60 (brs, 3 H, C4H and ArH), 7.40 
(pst, 4 H, ArH), 7.34 (pst, 2 H, ArH), 7.227.19 (m, 6 H, ArH), 7.15 (m, 4 H, ArH), 5.30 
(brs, 4 H, NCH2Ph), 4.45 (brs, 4 H, NCH2), 3.47 (brs, 4 H, NHCH2), 2.20 (m, CH2CH2CH2, 




H} NMR (75.48 
MHz, CD3CN): δ 164.4 (CO), 149.5 (C2/6), 139.8 (C4), 136.9, 134.7, 134.5, 129.9, 129.2, 128.4, 
125.29, 125.26 (ArC), 124.8 (C3/5), 113.0 (ArC, two are coincident), 53.0 (NCH2Ph), 48.6 
(NCH2), 37.7 (NHCH2), 30.3 (brs, CH2CH2CH2), the carbene signal was not obtained despite 
prolonged measuring. 
19
F NMR (282.38 MHz, CD3CN): δ -74.83, -74.89 (s, BF4). Anal. Calcd 
for C41H39AgBF4N7O2: C, 57.50; H, 4.59; N, 11.45. Found: C, 57.67; H, 4.35; N, 11.38. MS 
(ESI): m/z 768 [M  BF4]
+
.  
Silver(I) dicarbene complex 72Me. This complex was obtained in analogy to 72Bn from 
MMe (69 mg, 0.10 mmol) and Ag2O (28 mg, 0.12 mmol). Yield: 67 mg, 0.10 mmol, 95%. 
1
H 
NMR (500 MHz, DMSO-d6): δ 9.02 (brs, 2 H, NH), 8.04 (t, 1 H, C4H), 7.90 (d, 2 H, C3/5H), 
7.83 (d, 2 H, ArH), 7.53 (d, 2 H, ArH), 7.48–7.41 (m, 4 H, ArH), 4.75 (brs, 4 H, NCH2), 





(125.77 MHz, DMSO-d6): δ 162.3 (CO), 148.0 (C2/6), 139.3 (C4), 133.8, 133.2, 123.95, 123.92 
(ArC), 123.4 (C3/5), 112.3, 111.6 (ArC), 47.2 (NCH2), 36.8 (NCH3), 35.1 (NHCH2), 27.3 
(CH2CH2CH2), the carbene signal was not obtained despite prolonged measuring. 
19
F NMR 
(282.38 MHz, DMSO-d6): δ -72.25, -72.30 (s, BF4). Anal. Calcd for C29H31AgBF4N7O2: C, 49.46; 





Monogold(I) dicarbene complex 73Bn. A solution of 
[AuCl(THT)] (40 mg, 0.12 mmol) in CH2Cl2 (10 mL) was slowly 
added to the solution of complex 72Bn (106 mg, 0.12 mmol) in 
CH2Cl2 (20 mL). The mixture was kept stirring for 4 h before the 
precipitation was removed by centrifuging. The liquid was 
concentrated to 3 mL and subjected to column chromatography (SiO2, CH3CN/CHCl3, 2:7). Yield 
of mononuclear complex 73Bn: 42 mg, 0.04 mmol, 36%. 
1
H NMR (500 MHz, CDCl3): δ 8.89 (t, 
3
J(H,H) = 5.2 Hz, 2 H, NH), 7.99 (psd, 2 H, C3/5H), 7.90 (pst, 2 H, C4H), 7.60 (d, 2 H, 
ArH), 7.43 (t, 2 H, ArH), 7.31 (t, 2 H, ArH), 7.227.21 (m, 6 H, ArH), 7.127.10 (m, 6 H, 
ArH), 5.24 (s, 4 H, NCH2Ph), 4.74 (t, 
3
J(H,H) = 6.6 Hz, 4 H, NCH2), 3.69 (brs, 4 H, NHCH2), 
2.63 (m, 
3




H} NMR (125.77 MHz, CDCl3): δ 191.7 
(Ccarbene), 164.0 (CO), 149.4 (C2/6), 139.1 (C4), 135.5, 134.2, 133.9, 129.7, 129.1, 127.5, 125.7 
(ArC, two are coincident), 124.5 (C3/5), 113.0, 112.5 (ArC), 52.6 (NCH2Ph), 48.2 (NCH2), 
37.6 (NHCH2), 28.1 (CH2CH2CH2). 
19
F NMR (282.38 MHz, CDCl3): δ -74.50, -74.56 (s, BF4). 
Anal. Calcd for C41H39AuBF4N7O2: C, 52.08; H, 4.16; N, 10.37. Found: C, 52.02; H, 3.84; N, 




Digold(I) tetracarbene complex 74Bn. This 
complex was isolated in the yield of 46 mg, 
0.02 mmol, 39%. 
1
H NMR (500 MHz, CDCl3): 
δ 9.34 (brs, 4 H, NH), 7.80 (psd, 4 H, 
C3/5H), 7.47 (psd, 4 H, C4H and ArH), 
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7.39 (m, 4 H, ArH), 7.34 (m, 10 H, ArH), 7.22 (m, 12 H, ArH), 7.15 (m, 8 H, ArH), 5.49 (s, 
8 H, NCH2Ph), 4.63 (t, 
3
J(H,H) = 7.1 Hz, 8 H, NCH2), 3.65 (m, 
3
J(H,H) = 5.6 Hz, 8 H, NHCH2), 
2.34 (m, 
3




H} NMR (125.77 MHz, CDCl3): δ 191.1 
(Ccarbene), 164.9 (CO), 149.3 (C2/6), 138.3 (C4), 135.6, 133.9, 133.7, 129.7, 129.1, 127.5, 125.8, 
125.7 (ArC), 124.5 (C3/5), 112.7, 112.6 (ArC), 52.7 (NCH2Ph), 47.8 (NCH2), 37.7 (NHCH2), 
30.5 (CH2CH2CH2). 
19
F NMR (282.38 MHz, CD3CN): δ -74.96, -74.98 (s, BF4). Anal. Calcd for 
C82H78Au2B2F8N14O4: C, 52.08; H, 4.16; N, 10.37. Found: C, 52.24; H, 4.25; N, 10.55. MS (ESI): 




Monogold(I) dicarbene complexes 73Me. Complexes 73Me and 74Me were synthesized in 
analogy to the previous complexes but purified by column chromatography (SiO2, CH2Cl2/MeOH, 
30:1). They were further separated by washing with CH3CN. Complex 73Me was collected from 
the CH3CN phase and dried as a white powder (35 mg, 0.04 mmol, 35%). 
1
H NMR (500 MHz, 
CD3CN): δ 8.20 (t, 
3
J(H,H) = 5.4 Hz, 2 H, NH), 7.95 (t , 1 H, C3/5H), 7.82 (psd, 2 H, C4H), 
7.71 (d, 2 H, ArH), 7.477.41 (m, 4 H, ArH), 7.38 (psd, 2 H, ArH), 4.75 (t, 3J(H,H) = 6.2 
Hz, 4 H, NCH2), 3.65 (s, 6 H, NCH3), 3.39 (m, 
3
J(H,H) = 5.5 Hz, 4 H, NHCH2), 2.54 (m, 
3
J(H,H) 




H} NMR (125.77 MHz, CDCl 3): δ 191.9 (Ccarbene), 163.5 
(CO), 149.2 (C2/6), 140.4 (C4), 134.9, 134.1, 125.71, 125.68 (ArC), 124.7 (C3/5), 113.3, 112.7 
(ArC), 48.1 (NCH2), 37.9 (NCH3), 35.4 (NHCH2), 27.4 (CH2CH2CH2). 
19
F NMR (282.38 MHz, 
CD3CN): δ -75.40, -75.41 (BF4). Anal. Calcd for C29H31AuBF4N7O2: C, 43.90; H, 3.94; N, 12.36. 






Digold(I) tetracarbene complex 74Me. This dinuclear complex was collected from the 
solid phase as a white powder (49 mg, 0.03 mmol, 50%). 
1
H NMR (500 MHz, CD2Cl2): δ 9.02 
(brs, 4 H, NH), 7.79 (d, 4 H, C3/5H), 7.477.44 (m, 14 H, C4H and ArH), 7.37 (t, 4 H, 
ArH), 4.57 (t, 3J(H,H) = 7.6 Hz, 8 H, NCH2), 4.02 (s, 12 H, NCH3), 3.57 (m, 
3
J(H,H) = 6.1 Hz, 
8 H, NHCH2), 2.27 (m, 
3




H} NMR (125.77 MHz, 
CD2Cl2): δ 190.8 (Ccarbene), 164.2 (CO), 148.9 (C2/6), 138.3 (C4), 134.2, 133.2, 125.25, 125.22 
(ArC), 124.2 (C3/5), 111.9, 111.8 (ArC), 47.0 (NCH2), 37.3 (NCH3), 35.3 (NHCH2), 30.3 
(CH2CH2CH2). 
19
F NMR (282.38 MHz, CD2Cl2): δ -75.34, -75.40 (BF4). Anal. Calcd for 
C58H62Au2B2F8N14O4: C, 43.90; H, 3.94; N, 12.36. Found: C, 44.24; H, 4.25; N, 12.55. MS (ESI): 




Monogold(III) dicarbene complexes 75Bn. Complex 73Bn (95 
mg 0.10 mmol) and PhICl2 (33 mg, 0.12 mmol) were dissolved in 
CH2Cl2 (10 mL) and stirred for 24 h shielded from light. The 
solvent was then removed under vaccum, and the residue was 
washed with diethyl ether to give the product as pale yellow solid 
(90 mg, 0.09 mmol, 89%). 
1
H NMR (300 MHz, CDCl3): δ 9.35 (brs, 2 H, NH), 8.25 (psd, 2 H, 
C3/5H), 7.96 (t, 1 H, C4H), 7.72 (psd, 2 H, ArH), 7.49 (t, 2 H, ArH), 7.35 (t, 2 H, ArH), 
7.20 (m, 8 H, ArH), 6.93 (psd, 4 H, ArH), 5.46 (s, 4 H, NCH2Ph), 4.99 (brs, 4 H, NCH2), 




H} NMR (75.48 MHz, CDCl3): δ 
165.4 (CO), 163.4 (Ccarbene), 149.6 (C2/6), 139.2 (C4), 134.8, 134.3, 133.4, 129.9, 129.4, 126.9, 
126.7 (ArC, two are coincident), 125.1 (C3/5), 114.1, 113.4 (ArC), 52.0 (NCH2Ph), 49.1 
(NCH2), 37.0 (NHCH2), 28.8 (CH2CH2CH2). 
19
F NMR (282.38 MHz, CDCl3): δ -73.58, -73.63 
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(BF4). Anal. Calcd for C41H39AuBCl2F4N7O2: C, 48.45; H, 3.87; N, 9.65. Found: C, 48.22; H, 
3.84; N, 10.03. MS (ESI): m/z 928 [M  BF4]
+
.  
Monogold(III) dicarbene complexes 75Me. This complex was prepared in analogy to 
complex 75Bn from complex 73Me (79 mg 0.10 mmol) and PhICl2 (33 mg, 0.12 mmol). Yield: 67 
mg, 0.08 mmol, 78%. 
1
H NMR (500 MHz, CDCl3 with several drops of MeOD): δ 10.4 (brs, the 
integral was not correct due to fast exchange with the MeOD solvent, NH), 8.21 (psd, 2 H, 
C3/5H), 7.94 (t, 1 H, C4H), 7.74 (psd, 2 H, ArH), 7.59 (brs, 1 H, ArH), 7.53 (m, 5 H, 





H} NMR (125.77 MHz, CDCl3 and several drops of MeOD): δ 165.8 (CO), 
162.4 (Ccarbene), 149.6 (C2/6), 139.2 (C4), 135.3, 133.9, 126.6 (ArC, two are coincident), 125.2 
(C3/5), 113.8, 112.3 (ArC), 49.1 (NCH2), 37.0 (NCH3), 35.0 (NHCH2), 28.8 (CH2CH2CH2). 
19
F 
NMR (282.38 MHz, CDCl3 several drops of MeOD): δ -74.67, -74.73 (BF4). Anal. Calcd for 
C29H31AuBCl2F4N7O2: C, 40.30; H, 3.62; N, 11.34. Found: C, 40.12; H, 3.84; N, 11.43. MS 




Gold(I), Gold(I) and Cobalt(III) 
trinuclear tetracarbene complexes 
76. Co(II)Cl2·6H2O (71 mg, 0.30 
mmol) and 30 equivalents of NaH (360 
mg, 9.00 mmol,  60% dispersion in 
mineral oil) were stirred in dry THF 
for 0.5 h before addition of complex 74Bn (567 mg, 0.30 mmol) in dry CH2Cl2 solution. After 
stirring the reaction mixture for 3 h under N2, the mixture was stirring in air for 0.5 h. The 
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volatile was removed in vacuo before CH2Cl2 was added to dissolve the product. The CH2Cl2 
phase was extracted with H2O (5  10 mL) and dried over Na2SO4 to give the crude product. The 
residue was washed with hexane (5  10 mL) and dissolved in CH2Cl2 and toluene. Slow 
evaporation afforded the product as yellow solids (474 mg, 0.25 mmol, 85%). 
1
H NMR (500 




H} NMR (100.82 MHz, 
CDCl3): δ 190.1 (Ccarbene), 169.5 (CO), 157.2 (C2/6), 138.5 (C4), 135.5, 133.9, 133.7, 129.8, 
129.7, 128.9, 127.9, 126.0 (ArC), 123.2 (C3/5), 113.4, 112.2 (ArC), 52.9 (NCH2Ph), 49.3 
(NCH2), 43.4 (CONCH2), 31.7 (CH2CH2CH2). 
19
F NMR (282.38 MHz, CDCl3): δ -74.89, -74.95 
(s, BF4). Anal. Calcd for C82H74Au2BCoF4N14O4: C, 52.97; H, 4.01; N, 10.55. Found: C, 52.67; 
H, 4.34; N, 10.39. HRMS (ESI): m/z 1771.4702 (calcd for [M  BF4]
+
 1771.4675).  
 
Palladium(II) dicarbene complex 77Bn. A solution of 
[PdCl2(CH3CN)2] (PdCl2: 18 mg, 0.10 mmol) in CH3CN (20 mL) 
and tetramethylammonium chloride (15 mg, 0.14 mmol) in 
MeOH (2 mL) was slowly added to a solution of complex 72Bn 
(86 mg, 0.10 mmol) in CH2Cl2 (10 mL). The mixture was kept 
stirring overnight before the precipitation was filtered off through Celite. The filtrate was 
concentrated to 3 mL, which was subjected to column chromatography (SiO2, hexane/ethyl 
acetate: 1/5) to obtain the product as a pale yellow solid (53 mg, 0.06 mmol, 63%). 
1
H NMR (500 
MHz, CDCl3): δ 9.20 (t, 
3
J(H,H) = 5.3 Hz, 2 H, CONH), 8.06 (d, 2 H, C3/5–H), 7.89 (t, 1 H, C4–
H), 7.48 (d, 2 H, Ar–H), 7.37 (t, 4 H, Ar–H), 7.27–7.21 (m, 9 H, Ar–H), 7.02 (t, 2 H, Ar–H), 6.67 
(d, 1 H, Ar–H), 6.44 (d, 2J(H, H) = 15.1 Hz, 2 H, NCHHPh), 5.77 (m, 2 H, NCH2), 5.19 (d, 
2
J(H, 
H) = 15.1 Hz, 2 H, NCHHPh), 4.57 (m, 2 H, NCH2), 3.73 (m, 2 H, NHCH2), 3.60 (m, 2 H, 
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H} NMR (125.77 MHz, 
CDCl3): δ 180.3 (Ccarbene), 164.3 (CO), 149.8 (C2/6), 139.0 (C4), 135.7, 134.9, 134.8, 129.3, 
128.71, 128.68 (Ar–C), 125.0 (C3/5), 124.8, 123.8, 112.5, 112.2 (Ar–C), 53.6 (NCH2Ph), 47.8 
(NCH2), 38.5 (NHCH2), 26.3 (CH2CH2CH2). Anal. Calcd for C41H39Cl2N7O2Pd: C, 58.69; H, 
4.68; N, 11.68. Found: C, 58.70; H, 5.01; N, 11.86. MS (ESI): m/z 803 [M –Cl]+.  
Palladium(II) dicarbene complex 77Me. This complex was prepared in analogy to 77Bn 
from PdCl2 (18 mg, 0.10 mmol), tetramethylammonium chloride (15 mg, 0.14 mmol) and 
complex 72Me (70 mg, 0.10 mmol). It was purified by column chromatography (SiO2, 
CH2Cl2/MeOH: 40/1). Yield: 36 mg, 0.05 mmol, 52%. 
1
H NMR (500 MHz, CDCl3): δ 9.12 (t, 
3
J(H,H) = 5.8 Hz, 2 H, CONH), 7.95 (d, 2 H, C3/5–H), 7.82 (t, 1 H, C4–H), 7.49 (d, 2 H, Ar–H), 
7.30–7.27 (m, 2 H, Ar–H), 7.23 (t, 2 H, Ar–H), 7.06 (d, 2 H, Ar–H), 5.81–5.75 (m, 2 H, NCH2), 
4.61–4.56 (m, 2 H, NCH2), 3.97 (s, 6 H, NCH3), 3.77–3.70 (m, 2 H, NHCH2), 3.51–3.48 (m, 2 H, 





(125.77 MHz, CDCl3): δ 179.4 (Ccarbene), 164.1 (CO), 149.3 (C2/6), 138.9 (C4), 135.6, 134.1, 
(Ar–C), 124.6 (C3/5), 123.9, 112.7, 112.6 (Ar–C, two are coincident), 47.3 (NCH2), 38.1 
(NHCH2), 34.9 (NCH3), 26.0 (CH2CH2CH2). Anal. Calcd for C29H31Cl2N7O2Pd: C, 50.71; H, 
4.55; N, 14.27. Found: C, 50.34; H, 4.17; N, 13.95. MS (ESI): m/z 650 [M – Cl] +. 
 
Palladium(II) (N’,N,N’)-pincer complex 78Bn. Salt 
precusor MBn (84 mg, 0.10 mmol) was mixed with NEt3 
(30 µL, 0.22 mmol) in CH3CN (10 mL) and stirred for 15 
min at 70 C. [PdCl2(CH3CN)2] (PdCl2: 18 mg, 0.10 mmol) 
was added, and the mixture was kept stirring for 2 h at 70 
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C. The resulting mixture was filtered and dried in vacuo. The residue was dissolved in CH2Cl2 
(20 mL) and extracted with H2O (5 × 20 mL). The organic layer was collected and dried over 
Na2SO4 to give the product as yellow solid (72 mg, 0.08 mmol, 81%).
 1
H NMR (500 MHz, 
CDCl3): δ 9.98 (s, 2 H, NCHN), 7.88 (t, 1 H, C4–H), 7.73 (d, 2 H, C3/5–H), 7.55 (d, 2 H, Ar–H), 
7.47 (d, 2 H, Ar–H), 7.43–7.38 (m, 8 H, Ar–H), 7.31–7.27 (m, 6 H, Ar–H), 5.64 (s, 4 H, 




H} NMR (125.77 MHz, CDCl3): δ 171.7 (CO), 152.9 (C2/6), 143.1 (NCHN), 140.2 (C4), 
133.3, 132.3, 131.9, 130.0, 129.8, 128.9, 127.6 (Ar–C, two are coincident), 124.7 (C3/5), 114.3, 
114.2 (Ar–C), 52.1 (NCH2Ph), 46.5 (NCH2), 42.9 (CONCH2), 29.7 (CH2CH2CH2). 
19
F NMR 
(282.38 MHz, CDCl3): δ -74.44, -74.50 (BF4). Anal. Calcd for C41H39BClF4N7O2Pd: C, 55.30; H, 
4.41; N, 11.01. Found: C, 55.32; H, 4.56; N, 11.06. MS (ESI): m/z 802 [M –BF4]
+
.  
Palladium(II) (N’,N,N’)-pincer complex 78Me. This complex was prepared in analogy to 
78Bn from  MMe (68 mg, 0.10 mmol), NEt3 (30 µL, 0.22 mmol) and [PdCl2(CH3CN)2] (PdCl2: 18 
mg, 0.10 mmol). However, 78Me is soluble in H2O, which hampers the removal of the HNEt3Cl 




C NMR spectra. The crude product 
yield is 45 mg, 0.06 mmol, 61%. 
1
H NMR (500 MHz, CD3CN): δ 9.50 (s, 2 H, NCHN), 7.99 (t, 1 
H, C4–H), 7.88 (d, 2 H, C3/5–H), 7.69 (d, 2 H, Ar–H), 7.57 (m, 4 H, Ar–H), 7.48 (d, 2 H, Ar–H), 
4.47 (t, 
3
J(H,H) = 6.0 Hz, 4 H, NCH2), 3.99 (s, 6 H, NCH3), 4.00 (br–s, 4 H, CONCH2), 2.29 (m, 
3




H} NMR (125.77 MHz, CD3CN): δ 171.7 (CO), 
153.1 (C2/6), 143.4 (NCHN), 141.0 (C4), 133.2, 132.4, 127.6, 127.5 (Ar–C), 124.6 (C3/5), 114.6, 
113.8 (Ar–C), 46.6 (NCH2), 43.0 (CONCH2), 34.1 (NCH3), 29.8 (CH2CH2CH2). 
19
F NMR 




C NMR spectra are attached in the 





Tetrapalladium(II) tetracarbene complex 79. This 
complex could be obtained via reacting (A): 77Bn (84 mg, 
0.10 mmol), (B) 78Bn (89 mg, 0.10 mmol) or (C) 81 (85 mg, 
0.10 mmol) with Pd(OAc)2 (86 mg, 0.10 mmol) in the 
presence of tetramethylammonium chloride (33 mg, 0.30 
mmol) in DMSO (10 mL) at 90 ºC overnight. A common 
workup procedure was used to purify the product. After the 
solvent was removed by vacuum distillation, the residue was 
dissolved in CH2Cl2 (30 mL) and then extracted with H2O (5 
 20 mL). The organic layer was combined and dried over 
NaSO4. After concentrated to 5 mL, the filtrate was 
subjected to Colum chromatography (SiO2, CH2Cl2/MeOH: 20/1) to yield the product as yellow 
solids (Yields obtained from method A/B/C: 63/68/81 mg, 0.03/0.04/0.04 mmol, 67/72/86%). 
1
H 
NMR (500 MHz, CD3CN): δ 8.11 (t, 2 H, C4–H), 7.71 (d, 2 H, C3–H), 7.67 (d, 2 H, C5–H), 7.53 
(d, 2 H, Ar–H), 7.45–7.39 (m, 6 H, Ar–H), 7.36–7.20 (m, 20 H, Ar–H), 7.18–7.13 (m, 4 H, Ar–
H), 7.07 (t, 2 H, Ar–H), 6.97 (d, 2 H, Ar–H), 5.91 (d, 2J(H, H) = 15.8 Hz, 2 H, NCHHPh), 5.72 (d, 
2
J(H, H) = 15.8 Hz, 2 H, NCHHPh), 5.60–5.54 (m, 2 H, NCH2), 5.43 (d, 
2
J(H, H) = 16.4 Hz, 2 H, 
NCHHPh), 5.06–4.97 (m, 4 H, NCHHPh and NCH2), 4.75–4.70 (m, 2 H, NCH2), 4.57–4.53 (m, 2 
H, CONCH2), 4.35–4.30 (m, 4 H, NCH2 and CONCH2), 2.74–2.69 (m, 2 H, CH2CH2CH2), two 





NMR (125.77 MHz, CD3CN): δ 180.8 (C7carbene), 173.0, 171.7 (CO), 161.5 (C8carbene), 152.8, 
152.4 (C2 and C6), 142.2 (C4), 136.9, 136.2, 135.2, 134.9, 134.5, 134.1, 129.8, 129.6, 129.1, 
129.0, 128.8, 128.3, 124.8, 124.7, 124.4, 124.3, 124.2, 113.2, 112.4, 112.1, 111.9 (Ar–C and C3, 
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C5, two are coincident), 52.9, 52.3 (NCH2Ph), 47.7, 47.1 (NCH2), 45.1, 42.2 (CONCH2), 31.6, 
29.0 (CH2CH2CH2). Anal. Calcd for C82H74Cl4N14O4Pd4: C, 52.19; H, 3.95; N, 10.39. Found: C, 
52.38; H, 4.30; N, 10.01. MS (ESI): m/z 975 [M/2 + H + MeOH]
+




Dipalladium dicarbene pyridine complex 80. This 
complex was obtained by reacting the tetranuclear 
complex 79 (44 mg, 0.02 mmol) with pyridine (18 µL, 
0.22 mmol) in CH2Cl2 (10 mL) for 2 h. The reaction 
was dried and the residue washed with diethyl ether to 
afford the product as a yellow solid (46 mg, 0.04 mmol, 96%). 
1
H NMR (500 MHz, CD3CN): δ 
8.70 (d, 2 H, Py–H), 8.07 (t, 1 H, C4–H), 7.85 (t, 1 H, Py–H), 7.69 (d, 2 H, C3–H), 7.64 (d, 2 H, 
C5–H), 7.53–7.50 (m, 3 H, Ar–H), 7.44 (d, 2 H, Py–H), 7.37–7.17 (m, 13 H, Ar–H), 7.09 (t, 1 H, 
Ar–H), 7.03 (d, 1 H, Ar–H), 6.03 (d, 2J(H, H) = 15.8 Hz, 1 H, NCHHPh), 5.80 (d, 2J(H, H) = 
15.8 Hz, 1 H, NCHHPh), 5.66 (d, 
2
J(H, H) = 15.8 Hz, 1 H, NCHHPh), 5.53–5.46 (m, 1 H, 
NCHH), 5.18 (d, 
2
J(H, H) = 15.8 Hz, 1 H, NCHHPh), 5.14–5.08 (m, 1 H, NCHH), 4.85–4.79 (m, 
1 H, NCHH), 4.53–4.49 (m, 1 H, CONCH2), 4.41–4.35 (m, 1 H, NCHH), 4.32–4.28 (m, 1 H, 
CONCH2), 2.87–2.81 (m, 1 H, CH2CH2CH2), 2.35–2.29 (m, 1 H, CH2CH2CH2), 1.77–1.72 (m, 1 





H} NMR (125.77 MHz, CD3CN): δ 180.9 (C7carbene-cyclized), 173.0, 171.6 (CO), 
165.5 (C8carbene), 152.7, 152.4 (C2 and C6), 151.7 (Py–C), 142.2 (C4), 139.7 (Py–C), 137.0, 
136.7, 135.2, 135.1, 134.6, 134.5, 129.8, 129.6, 129.09, 129.06, 129.00, 128.3, 125.8, 124.82, 
124.76, 124.73, 124.23, 124.20, 124.1, 113.2, 112.3, 112.1, 111.8 (Ar–C, Py–C, C3 and C5), 52.9, 
52.4 (NCH2Ph), 47.8, 47.0 (NCH2), 45.1, 42.1 (CONCH2), 31.8, 29.0 (CH2CH2CH2). Anal. Calcd 
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for C46H42Cl2N8O2Pd2: C, 54.03; H, 4.14; N, 10.96. Found: C, 53.93; H, 4.38; N, 11.05. MS 
(ESI): m/z 976 [M  Py + MeOH + H]+. 
 
Palladium monocarbene complex 81. This complex 
was obtained by reacting complex 78Bn (89 mg, 0.10 
mmol) with Ag2O (14 mg, 0.06 mmol) in CH2Cl2 (30 
mL) overnight. The resulting suspension was filtered to 
afford the product as yellow solid (72 mg, 0.08 mmol, 
84%). 
1
H NMR (500 MHz, CDCl3): δ 9.67 (s, 1 H, NCHN), 8.03 (t, 2 H, C4–H), 7.81 (d, 2 H, 
C3–H), 7.76 (d, 2 H, C5–H), 7.52–7.45 (m, 4 H, Ar–H), 7.42 (d, 2 H, Ar–H), 7.38 (t, 4 H, Ar–H), 
7.33–7.28 (m, 6 H, Ar–H), 7.24–7.20 (m, 2 H, Ar–H), 5.94 (d, 2J(H, H) = 15.1 Hz, 2 H, 
NCHHPh), 5.62 (d, 
2
J(H, H) = 15.1 Hz, 2 H, NCHHPh), 5.59–5.53 (m, 2 H, NCH2), 5.51 (s, 2 H, 
NCH2Ph), 4.63–4.59 (m, 1 H, CONCH2), 4.51–4.44 (m, 3 H, NCH2 and CONCH2), 4.02–3.96 (m, 
2 H, NCH2), 2.99–2.94 (m, 1 H, CH2CH2CH2), 2.02–1.95 (m, 2 H, CH2CH2CH2), two CONCH2 





(125.77 MHz, CDCl3): δ 179.4 (Ccarbene), 173.3, 171.7 (CO), 152.3, 151.9 (C2 and C6), 142.5 
(NCHN), 141.5 (C4), 135.9, 134.8, 134.6, 133.1, 132.2, 131.8, 130.05, 129.95, 129.90, 129.7, 
129.0, 128.8, 128.1, 127.8, 125.1, 124.83, 124.79, 124.4, 114.3, 114.2, 113.4, 111.1 (Ar–C, C3 
and C5), 52.5, 52.0 (NCH2Ph), 46.3, 45.8 (NCH2), 44.4, 42.2 (CONCH2), 30.4, 28.9 
(CH2CH2CH2). 
19
F NMR (282.38 MHz, CDCl3): δ -74.58, -74.59 (s, BF4). Anal. Calcd for 
C41H38BF4N7O2Pd: C, 57.66; H, 4.48; N, 11.48. Found: C, 57.38; H, 4.34; N, 11.09. MS (ESI): 






Palladium(II) and gold(I) hetero-bimetallic 
dicarbene complex 82. Complex 81 (85 mg, 0.10 
mmol) was reacted with Ag2O (14 mg, 0.06 mmol) in 
the presence of tetramethylammonium chloride (16 mg, 
0.15 mmol) in CH2Cl2 (20 mL) and MeOH (2 mL) for 5 
h. The resulting suspension was filtered into a solution of [AuCl(THT)] (32 mg, 0.10 mmol) in 
CH2Cl2 (5 mL) through Celite. The combined mixture was stirred for 5 h before the solvent was 
removed in vacuo. Washing the residue with H2O (3  10 mL) gave the crude product, which was 
then subjected to column chromatography (SiO2, CH2Cl2/MeOH : 30/1) to afford the product as a 
yellow solid (63 mg, 0.06 mmol, 63%). 
1
H NMR (500 MHz, CD3CN): δ 8.06 (t, 1 H, C4–H), 
7.68–7.65 (t, 2 H, C3– and C5–H), 7.54 (d, 1 H, Ar–H), 7.48 (d, 1 H, Ar–H), 7.35–7.33 (m, 3 H, 
Ar–H), 7.27–7.19 (m, 13 H, Ar–H), 5.77 (d, 2J(H, H) = 15.2 Hz, 1 H, NCHHPh), 5.58–5.52 (m, 1 
H, NCH2), 5.31 (s, 2 H, NCH2Ph), 5.21 (d, 
2
J(H, H) = 15.2 Hz, 1 H, NCHHPh), 4.55–4.49 (m, 2 
H, NCH2), 4.39–4.29 (m, 2 H, NCH2 and CONCH2), 4.25–4.17 (m, 1 H, CONCH2), 2.78–2.72 
(m, 1 H, CH2CH2CH2), two CONCH2 and three CH2CH2CH2 protons were not resolved or 




H} NMR (125.77 MHz, CD3CN): δ 180.7 (Pd–Ccarbene), 
179.0 (Au–Ccarbene), 172.9, 171.8 (CO), 152.6, 152.5 (C2 and C6), 142.2 (C4), 136.8, 136.6, 
135.2, 134.7, 134.0, 133.5, 129.8, 129.18, 139.15, 128.4, 128.2, 125.4, 125.3, 125.0, 124.9, 124.8, 
124.5, 113.3, 112.9, 112.8, 112.1 (Ar–C, C3 and C5, two are coincident), 52.7, 52.3 (NCH2Ph), 
47.8, 45.7 (NCH2), 44.8, 42.1 (CONCH2), 32.6, 28.9 (CH2CH2CH2). Anal. Calcd for 
C41H37AuClN7O2Pd: C, 49.31; H, 3.73; N, 9.82. Found: C, 49.69; H, 4.02; N, 9.88. MS (ESI): 






X-ray Diffraction Studies 
X-ray data were collected with a Bruker AXS SMART APEX diffractometer, using Mo-
Kα radiation with the SMART suite of Programs.
105
 Data were processed and corrected for 
Lorentz and polarization effects with SAINT,
106
 and for absorption effect with SADABS.
107
 
Structural solution and refinement were carried out with the SHELXTL suite of programs.
108
 The 
structure was solved by direct methods to locate the heavy atoms, followed by difference maps 
for the light, non-hydrogen atoms. All non-hydrogen atoms were generally given anisotropic 
displacement parameters in the final model. All H-atoms were put at calculated positions. A 
summary of the most important crystallographic data is provided in the following section (see 




7. Selected Crystallographic Data 
 13 cis-15·CH2Cl2 cis-16·CHCl3 cis-17·2CHCl3 
formula C20H31Br2N5Pd C16H27Br2N2O3PPd·CH2Cl2 C22H39Br2N2O3PPd·CHCl3 C31H33Br2N2O3PPd·2CHCl3 
fw 607.72 677.51 796.11 1017.52 
color, habit orange, block colourless, rod colourless, block colourless, rod 
cryst size [mm] 0.600.440.10 0.540.100.08 0.700.600.40 0.160.240.40 
temp [K] 223(2) 223(2) 223(2) 100(2) 
crystsyst orthorhombic triclinic monoclinic monoclinic 
space group Pbca P-1 P2(1)/c P2(1)/n 
a[Å]  9.5113(4) 10.7930(9) 15.6417(8) 9.5178(8) 
b [Å] 17.3866(7) 11.3295(10) 11.2303(5) 29.221(2) 
c [Å] 28.6770(12) 12.8900(10) 19.3568(9) 14.4122(12) 
 [deg] 90.00 65.134(2) 90.00 90.00 
 [deg] 90.00 67.128(2) 97.7740(10) 93.881(2) 
 [deg] 90.00 82.651(2) 90.00 90.00 
V [Å
3
] 4742.3(3) 1316.43(19) 3369.0(3) 3999.2(6) 
Z 8 2 4 4 
Dc [g cm
3
] 1.702 1.709 1.570 1.690 
radiation used Mo K Mo K Mo K Mo K 
 [mm1] 4.168 4.022 3.233 2.938 
 range [deg] 2.3427.49 1.8825.00 2.1027.50 2.2627.50 
no. of unique data 31797 7783 23353 28805 
max., min. transmn 0.6806, 0.1888 0.7391, 0.2200 0.3579, 0.2106 0.6523, 0.5313 
final R indices 
[I> 2(I)] 
R1 = 0.0497, 
wR2 = 0.1062 
R1 = 0.0551 
wR2 = 0.1401 
R1 = 0.0391,  
wR2 = 0.0933 
R1 = 0.0453,  
wR2 = 0.1059 
R indices (all data) R1 = 0.0706, 
wR2 = 0.1140 
R1 = 0.0739 
wR2 = 0.1568 
R1 = 0.0555, 
wR2 = 0.0991 
R1 = 0.0652, 

















 cis-19 cis-20 22 23·CHCl3 
formula C31H33AsBr2N2Pd C31H33Br2N2PdSb C17H26Br2N2PdS C18H23Br2N3OPd·CHCl3 
fw 774.73 821.56 556.68 682.98 
color, habit colourless, block colourless, block yellow, block yellow, block 
cryst size [mm] 0.2080.0980.088 0.2930.2580.080 0.310.250.21 0.250.310.31 
temp [K] 100(2) 100(2) 100(2) 100(2) 
crystsyst monoclinic monoclinic monoclinic monoclinic 
space group P21/n P21/c P2(1)/c P21/n 
a[Å]  10.5639(5) 10.3243(4) 12.7531(7) 10.2308(6) 
b [Å] 17.5659(11) 14.7594(5) 9.9648(6) 17.7001(9) 
c [Å] 16.5458(10) 20.3602(6) 16.0437(9) 13.5874(7) 
 [deg] 90.00 90.00 90.00 90.00 
 [deg] 93.981(2) 97.7730(12) 105.1420(10) 93.122(2) 
 [deg] 90.00 90.00 90.00 90.00 
V [Å
3
] 3062.9(3) 3073.99(18) 1968.08(19) 2456.8(2) 
Z 4 4 4 4 
Dc [g cm
3
] 1.680 1.775 1.879 1.846 
radiation used Mo K Mo K Mo K Mo K 
 [mm1] 4.309 4.085 5.110 4.350 
 range [deg] 2.21927.50 2.42227.50 2.4327.49 2.3027.50 
no. of unique data 103804 54062 13499 43049 
max., min. transmn 0.7457, 0.6393 0.74, 0.53 0.5629, 0.4175 0.7457, 0.5143 
final R indices 
[I> 2(I)] 
R1 = 0.0228, 
wR2 = 0.0468 
R1 = 0.0299, 
wR2 = 0.0694 
R1 = 0.0292,  
wR2 = 0.0682 
R1 = 0.0240,  
wR2 = 0.0545 
R indices (all data) R1 = 0.0327, 
wR2 = 0.0494 
R1 = 0.0466, 
wR2 = 0.0745 
R1 = 0.0351, 
wR2 = 0.0707 
R1 = 0.0293, 

















 25CHCl3 300.25H2O 320.25H2O 340.5CH2Cl2 
formula C25H26BrF6N4PPdCHCl3 C31H38BrF6N4O2PPd·0.25H2O 
CN 
C20H28BrF6N8PPd0.25H2O C22H30BrF6N6PPd0.5CH2Cl2 
fw 833.15 835.77 715.78 752.27 
color, habit yellow, block orange, block colourless, block colourless, block 
cryst size [mm] 0.540.270.20 0.400.240.12 0.410.340.23 0.330.240.20 
temp [K] 100(2) 100(2) 100(2) 293(2) 
crystsyst monoclinic hexagonal monoclinic triclinic 
space group P2(1)/n P6(5) P2(1)/c P-1 
a[Å]  13.328(4) 13.0939(6) 18.5875(12) 13.372(12) 
b [Å] 10.822(3) 13.0939(6) 9.1218(6) 14.825(13) 
c [Å] 23.586(7) 34.369(3) 17.7695(11) 16.378(15) 
 [deg] 90.00 90.00 90.00 112.263(17) 
 [deg] 98.947(7) 90.00 116.2570(9) 99.074(18) 
 [deg] 90.00 120.00 90.00 98.184(18) 
V [Å
3
] 3360.6(16) 5103.1(6) 2702.0(3) 2894(5) 
Z 4 6 4 2 
Dc [g cm
3
] 1.647 1.632 1.760 1.727 
radiation used Mo K Mo K Mo K Mo K 
 [mm1] 2.084 1.836 2.293 2.233 
 range [deg] 1.7525.00 1.8027.50 2.2927.50 1.8427.50 
no. of unique data 18764 36526 19473 37912 
max., min.transmn 0.6807, 0.3991 0.8098, 0.5271 0.5633, 0.4503 0.6637, 0.5262 
final R indices 
[I> 2(I)] 
R1 = 0.0693, 
wR2 = 0.1977 
R1 = 0.0320 
wR2 = 0.0652 
R1 = 0.0244, 
wR2 = 0.0585 
R1 = 0.0449, 
wR2 = 0.1180 
R indices (all 
data) 
R1 = 0.0853, 
wR2 = 0.2106 
R1 = 0.0390 
wR2 = 0.0681 
R1 = 0.0272, 
wR2 = 0.0595 
R1 = 0.0566, 

















 37CH3CN 38CHCl3 40 41 
formula C35H40BrF6N6PPdCH3CN C36H42BrF6N6PPdCHCl3 C49H60Br4N8Pd2 C38H40Br4N4O4Pd2 
fw 917.06 1009.40 1293.49 1149.18 
color, habit colourless, block colourless, block yellow, thin plate orange, plate 
cryst size [mm] 0.470.190.12 0.190.130.07 0.560.260.04 0.28 x 0.14 x 0.06 
temp [K] 100(2) 100(2) 100(2) 223(2) 
crystsyst triclinic triclinic monoclinic monoclinic 
space group P-1 P-1 P21/c P2(1)/c 
a[Å]  9.0847(6) 9.6249(10) 8.5313(5) 9.0803(8) 
b [Å] 11.6841(8) 11.6858(12) 18.2138(11) 21.2409(19) 
c [Å] 18.3327(12) 18.6008(18) 32.4597(19) 10.8280(10) 
 [deg] 95.0090(10) 94.5110(16) 90.00 90.00 
 [deg] 98.1710(9) 102.3250(16) 91.9650(10) 90.902(2) 
 [deg] 92.6440(9) 99.6380(17) 90.00 90.00 
V [Å
3
] 1915.5(2) 2000.8(4) 5040.9(5) 2088.2(3) 
Z 2 2 4 2 
Dc [g cm
3
] 1.590 1.675 1.704 1.828 
radiation used Mo K Mo K Mo K Mo K 
 [mm1] 1.636 1.768 3.926 4.730 
 range [deg] 1.9927.50 1.1326.37 1.6827.50 1.9227.49 
no. of unique data 25415 24411 66154 14436 
max., min. transmn 0.5629, 0.4760 0.8863, 0.7300 0.5633, 0.3623 0.7645, 0.3509 
final R indices 
[I> 2(I)] 
R1 = 0.0328, 
wR2 = 0.0887 
R1 = 0.0466, 
wR2 = 0.1072 
R1 = 0.0380, 
wR2 = 0.0879 
R1 = 0.0541, 
wR2 = 0.1314 
R indices (all data) R1 = 0.0362, 
wR2 = 0.0905 
R1 = 0.0625, 
wR2 = 0.1190 
R1 = 0.0487, 
wR2 = 0.0919 
R1 = 0.0823, 

















 41  45 49·CHCl3 51·CHCl3 
formula C19H20Br3N3Pd  C34H34Br4N4Pd C22H22I3N3Pd·CH2Cl2 C23H22I2N4PdS·CHCl3 
fw 636.51 924.69 934.89 866.07 
color, habit yellow, block yellow, block orange, block  orange, thin plate  
cryst size [mm] 0.60 x 0.24 x 0.20 0.500.420.26 0.40 x 0.16 x 0.14 0.44 x 0.20 x 0.10 
temp [K] 223(2) 100(2) 100(2) 100(2) 
crystsyst monoclinic monoclinic triclinic triclinic 
space group P2(1)/n P2(1)/n P1 P1 
a[Å]  7.8905(9) 10.5266(13) 8.1776(9) 8.339(5) 
b [Å] 12.5212(14) 8.2026(10) 9.2817(11) 8.954(5) 
c [Å] 21.373(2) 19.370(2) 20.433(2) 11.504(7) 
 [deg] 90.00 90.00 82.449(2) 94.540(11) 
 [deg] 90.503(3) 96.087(3) 88.771(2) 103.912(11) 
 [deg] 90.00 90.00 66.713(2) 116.140(10) 
V [Å
3
] 2111.5(4) 1663.1(3) 1411.4(3) 731.4(7) 
Z 4 2 2 1 
Dc [g cm
3
] 2.002 1.847 2.200 1.966 
radiation used Mo K Mo K Mo K Mo K 
 [mm1] 6.564 5.394 4.240 3.111 
 range [deg] 1.8827.47 2.1127.49 2.0127.50 1.8727.45 
no. of unique data 14614 11359 18736 9659 
max., min. transmn 0.4915, 0.1529 0.3345, 0.1734 0.5883, 0.2818 0.4305, 0.3455 
final R indices 
[I> 2(I)] 
R1 = 0.0369 
wR2 = 0.0875 
R1 = 0.0393, 
wR2 = 0.1072 
R1 = 0.0275,  
wR2 = 0.0661 
R1 = 0.0345,  
wR2 = 0.0856 
R indices (all data) R1 = 0.0512, 
wR2 = 0.0927 
R1 = 0.0469, 
wR2 = 0.1110 
R1 = 0.0302, 
wR2 = 0.0674 
R1 = 0.0360,  

















 53·2CHCl3 55·0.5CHCl3·O (from H2O) 56 57·2CH3CN 
formula C34H34I2N4Pd2S2·C2H2Cl6 C44H38Br2N4Pd2S2·0.5CHCl3·O C28H34Br2N4O3PdS C38H40Br2N4O4Pd·2CH3CN 
fw 1268.11 1135.21 772.87 965.07 
color, habit yellow, thin plate orange, block colourless, plate  colourless, rod 
cryst size [mm] 0.46 x 0.24 x 0.04 0.20 x 0.14 x 0.14 0.46 x0.23 x0.12 0.370.130.07 
temp [K] 100(2) 293(2) 100(2) 100(2) 
crystsyst monoclinic tetragonal orthorhombic monoclinic 
space group P2(1)/n P4(3)2(1)2 P2(1)2(1)2(1) P2(1)/n 
a[Å]  12.340(5) 18.5291(16) 7.529(3) 8.4490(4) 
b [Å] 28.317(12) 18.5291 (16) 10.949(5) 23.3113(12) 
c [Å] 13.650(6) 14.087(2) 36.970(15) 10.4417(4) 
 [deg] 90.00 90.00 90.00 90.00 
 [deg] 113.731(9) 90.00 90.00 94.643(2) 
 [deg] 90.00 90.00 90.00 90.00 
V [Å
3
] 4366(3) 4836.4(12) 3048(2) 2049.82(16) 
Z 4 4 4 2 
Dc [g cm
3
] 1.929 1.559 1.684 1.564 
radiation used Mo K Mo K Mo K Mo K 
 [mm1] 2.732 2.601 3.335 2.451 
 range [deg] 1.7827.50 1.8227.49 1.9427.50 2.1428.35 
no. of unique data 29974 63459 22225 20988 
max., min. transmn 0.8986, 0.3663 0.6468, 0.5092 0.7457, 0.4883 0.7457, 0.6185 
final R indices 
[I> 2(I)] 
R1 = 0.0706, 
wR2 = 0.1479 
R1 = 0.0483, 
wR2 = 0.1425 
R1 = 0.0360,  
wR2 = 0.0817 
R1 = 0.0387 
wR2 = 0.0735 
R indices (all data) R1 = 0.1003, 
wR2 = 0.1587 
R1 = 0.0581, 
wR2 = 0.1501 
R1 = 0.0405, 
wR2 = 0.0835 
R1 = 0.0661 

















 61 62 63 67 
formula C58H54N4PdS4 C38H34N8PdS4 C36H22Br2N6PdS2 C36H34I2N6PdS2 
fw 1041.69 837.37 868.93 975.01 
color, habit orange, block yellow, block pale-yellow, block yellow, block 
cryst size [mm] 0.360.200.10 0.540.340.14 0.140.120.04 0.400.400.40 
temp [K] 100(2) 223(2) 100(2) 100(2) 
crystsyst triclinic monoclinic monoclinic monoclinic 
space group P-1 P2(1)/n C2/c P2(1)/n 
a[Å]  10.6360(9) 10.9426(8) 25.707(3) 7.8570(10) 
b [Å] 11.3645(9) 9.6095(7) 9.3604(12) 20.915(3) 
c [Å] 11.4680(10) 18.7276(14) 16.538(2) 11.3480(15) 
 [deg] 76.226(2) 90.00 90.00 90.00 
 [deg] 66.087(2) 103.262(2) 116.555(4) 109.728(3) 
 [deg] 76.168(2) 90.00 90.00 90.00 
V [Å
3
] 1214.77(18) 1916.7(2) 3559.7 (8) 1755.3(4) 
Z 1 2 4 2 
Dc [g cm
3
] 1.424 1.451 1.621 1.845 
radiation used Mo K Mo K Mo K Mo K 
 [mm1] 0.598 0.741 2.918 2.442 
 range [deg] 1.8727.49 1.9827.50 2.3527.50 1.9527.50 
no. of unique data 16132 13088 25486 12380 
max., min. transmn 0.7456, 0.6211 0.9033, 0.6903 0.7457, 0.6576 0.7673, 0.6022 
final R indices 
[I> 2(I)] 
R1 = 0.0398,  
wR2 = 0.1038 
R1 = 0.0564, 
wR2 = 0.1302 
R1 = 0.0501, 
wR2 = 0.1304 
R1 = 0.0294, 
wR2 = 0.0725 
R indices (all data) R1 = 0.0444, 
wR2 = 0.1079 
R1 = 0.0694, 
wR2 = 0.1367 
R1 = 0.0693, 
wR2 = 0.1404 
R1 = 0.0306, 

















 MBn(CH3)2CO 73Me 74Bn0.5H2O 760.25CH2Cl2 
formula C41H41B2F8N7O2(CH3)2CO C29H31AuBF4N7O2 C82H78Au2B2F8N14O40.5H2O C82H74Au2BCoF4N14O40.25CH2Cl2 
fw 895.51 793.38 1908.14 1883.45 
color, habit colourless, block colourless, plate colourless, needle yellow, block 
cryst size [mm] 0.340.240.15 0.360.260.10 0.130.100.06 0.360.260.10 
temp [K] 100(2) 100(2) 100(2) 100(2) 
crystsyst triclinic monoclinic monoclinic triclinic 
space group P-1 P2(1)/n P21/c P-1 
a[Å]  8.6769(11) 13.924(7) 23.2600(14) 15.0076(16) 
b [Å] 15.920(2) 15.956(8) 20.2750(11) 16.2066(16) 
c [Å] 17.935(3) 14.787(8) 8.2071(4) 17.9512(19) 
 [deg] 115.794(4) 90.00 90.00 63.780(3) 
 [deg] 103.951(3) 116.941(9) 94.156(4) 82.005(3) 
 [deg] 90.302(3) 90.00 90.00 79.629(3) 
V [Å
3
] 2147.5(5) 2929(3) 3860.3(4) 3844.1(7) 
Z 2 4 2 2 
Dc [g cm
3
] 1.385 1.799 1.642 1.627 
radiation used Mo K Mo K Cu K Mo K 
 [mm1] 0.111 5.090 7.732 4.108 
 range [deg] 1.4427.49 1.6727.50 2.89466.595 2.10527.499 
no. of unique data 28066 20375 27316 158525 
max., min. transmn 09835, 0.9631  0.7898, 0.5489 0.7528, 0.6022 0.7457, 0.5929 
final R indices 
[I> 2(I)] 
R1 = 0.0720,  
wR2 = 0.1545 
R1 = 0.0315, 
wR2 = 0.0685 
R1 = 0.0794, 
wR2 = 0.1700 
R1 = 0.0563, 
wR2 = 0.1493 
R indices (all data) R1 = 0.1026, 
wR2 = 0.1672 
R1 = 0.0445, 
wR2 = 0.0735 
R1 = 0.1296, 
wR2 = 0.1936 
R1 = 0.0767, 

















 77Bn 77Me·CHCl3 78Me6H2O 821.4(CH3)2O0.6CH3CN 
formula C41H39Cl2N7O2Pd C29H31Cl2N7O2Pd·CHCl3 C29H31BClF4N7O2Pd6H2O C41H37AuClN7O2Pd1.4(CH3)2O0.6CH3CN 
fw 839.09 806.27 846.36 1075.11 
color, habit colourless, block pale-yellow, block yellow, block yellow, needle 
cryst size [mm] 0.220.160.06 0.240.220.16 0.320.190.17 0.2290.0960.044 
temp [K] 100(2) 100(2) 100(2) 100(2) 
crystsyst triclinic monoclinic triclinic triclinic 
space group P-1 P21/n P-1 P-1 
a[Å]  12.8523(13) 9.43444(4) 10.9678(17) 10.0851(11) 
b [Å] 13.2254(13) 17.7459(8) 11.3697(17) 15.0164(16) 
c [Å] 13.9322(14) 19.0745(10) 15.235(2) 15.8093(18) 
 [deg] 114.339(2) 90.00 83.845(3) 108.918(3) 
 [deg] 109.288(2) 94.579(2) 69.378(3) 90.879(3) 
 [deg] 100.396(2) 90.00 84.171(3) 109.332(3) 
V [Å
3
] 1893.5(3) 3183.3(3) 1763.7(5) 2116.9(4) 
Z 2 4 2 2 
Dc [g cm
3
] 1.472 1.682 1.594 1.687 
radiation used Mo K Mo K Mo K Mo K 
 [mm1] 0.677 1.045 0.681 3.998 
 range [deg] 1.7927.50 2.33827.498 1.9925.00 2.39128.353 
no. of unique data 24851 30584 19103 70687 
max., min. transmn 0.5629, 0.5155 0.7457, 0.7076 0.5629, 0.5236 0.7457, 0.5986 
final R indices 
[I> 2(I)] 
R1 = 0.0494,  
wR2 = 0.1119 
R1 = 0.0587, 
wR2 = 0.1573 
R1 = 0.0337, 
wR2 = 0.0842 
R1 = 0.0336, 
wR2 = 0.0565 
R indices (all data) R1 = 0.0664, 
wR2 = 0.1192 
R1 = 0.0881, 
wR2 = 0.1712 
R1 = 0.0354, 
wR2 = 0.0852 
R1 = 0.0531, 


























H NMR spectrum was shown in Figure 2.1. 
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